<SEC-DOCUMENT>0001641172-25-003812.txt : 20250411
<SEC-HEADER>0001641172-25-003812.hdr.sgml : 20250411
<ACCEPTANCE-DATETIME>20250411160516
ACCESSION NUMBER:		0001641172-25-003812
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250408
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250411
DATE AS OF CHANGE:		20250411

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Scienture Holdings, Inc.
		CENTRAL INDEX KEY:			0001382574
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39199
		FILM NUMBER:		25831559

	BUSINESS ADDRESS:	
		STREET 1:		2420 BRUNELLO TRACE
		CITY:			LUTZ
		STATE:			FL
		ZIP:			33558
		BUSINESS PHONE:		(800) 261 0281

	MAIL ADDRESS:	
		STREET 1:		2420 BRUNELLO TRACE
		CITY:			LUTZ
		STATE:			FL
		ZIP:			33558

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRxADE HEALTH, INC
		DATE OF NAME CHANGE:	20210602

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRXADE GROUP, INC.
		DATE OF NAME CHANGE:	20140207

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	XCELLINK INTERNATIONAL INC.
		DATE OF NAME CHANGE:	20081230
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-k.htm
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xs="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:SCNX="http://scienture.com/20250408">
<head>
     <title></title>
<meta http-equiv="Content-Type" content="text/html"/>
</head>
<!-- Field: Set; Name: xdx; ID: xdx_02D_US%2DGAAP%2D2024 -->
<!-- Field: Set; Name: xdx; ID: xdx_036_SCNX_scienture.com_20250408 -->
<!-- Field: Set; Name: xdx; ID: xdx_04C_20250408_20250408 -->
<!-- Field: Set; Name: xdx; ID: xdx_059_edei%2D%2DAmendmentFlag_false -->
<!-- Field: Set; Name: xdx; ID: xdx_05F_edei%2D%2DEntityCentralIndexKey_0001382574 -->
<!-- Field: Set; Name: xdx; ID: xdx_06B_USD_1_iso4217%2D%2DUSD -->
<!-- Field: Set; Name: xdx; ID: xdx_062_Shares_2_xbrli%2D%2Dshares -->
<!-- Field: Set; Name: xdx; ID: xdx_06D_USDPShares_3_iso4217%2D%2DUSD_xbrli%2D%2Dshares -->
<body style="font: 10pt Times New Roman, Times, Serif">
<div style="display: none">
<ix:header>
 <ix:hidden>
  <ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000003" name="dei:AmendmentFlag">false</ix:nonNumeric>
  <ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000004" name="dei:EntityCentralIndexKey">0001382574</ix:nonNumeric>
  </ix:hidden>
 <ix:references>
  <link:schemaRef xlink:href="scnx-20250408.xsd" xlink:type="simple"/>
  </ix:references>
 <ix:resources>
    <xbrli:context id="AsOf2025-04-08">
      <xbrli:entity>
        <xbrli:identifier scheme="http://www.sec.gov/CIK">0001382574</xbrli:identifier>
      </xbrli:entity>
      <xbrli:period>
        <xbrli:startDate>2025-04-08</xbrli:startDate>
        <xbrli:endDate>2025-04-08</xbrli:endDate>
      </xbrli:period>
    </xbrli:context>
    <xbrli:unit id="USD">
      <xbrli:measure>iso4217:USD</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="Shares">
      <xbrli:measure>xbrli:shares</xbrli:measure>
    </xbrli:unit>
    <xbrli:unit id="USDPShares">
      <xbrli:divide>
        <xbrli:unitNumerator>
          <xbrli:measure>iso4217:USD</xbrli:measure>
        </xbrli:unitNumerator>
        <xbrli:unitDenominator>
          <xbrli:measure>xbrli:shares</xbrli:measure>
        </xbrli:unitDenominator>
      </xbrli:divide>
    </xbrli:unit>
  </ix:resources>
 </ix:header>
</div>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 4pt solid; border-bottom: Black 1pt solid; font: 1pt Times New Roman, Times, Serif">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-size: 18pt"><b>UNITED
STATES</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-size: 18pt"><b>SECURITIES
AND EXCHANGE COMMISSION</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-size: 12pt"><b>Washington,
D.C. 20549</b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-size: 18pt"><b>FORM
<span id="xdx_906_edei--DocumentType_c20250408__20250408_zwzxlDIrrAnk"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000009" name="dei:DocumentType">8-K</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>CURRENT REPORT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Pursuant to Section 13 OR 15(d) of the</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>Securities Exchange Act of 1934</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">Date of Report (Date of earliest event reported): <b><span id="xdx_90F_edei--DocumentPeriodEndDate_c20250408__20250408_zTm8MvQoSJM1"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:datemonthdayyearen" id="Fact000010" name="dei:DocumentPeriodEndDate">April
8, 2025</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><span style="font-size: 18pt"><b><span id="xdx_907_edei--EntityRegistrantName_c20250408__20250408_zTLcqn0Nf61g"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000011" name="dei:EntityRegistrantName">SCIENTURE
HOLDINGS, INC.</ix:nonNumeric></span></b></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(Exact Name of Registrant as Specified in Its Charter)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_900_edei--EntityIncorporationStateCountryCode_c20250408__20250408_zeUcbKJSKomg"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt-sec:stateprovnameen" id="Fact000012" name="dei:EntityIncorporationStateCountryCode">Delaware</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_905_edei--EntityFileNumber_c20250408__20250408_zXqbXScVCDL1"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000013" name="dei:EntityFileNumber">001-39199</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 32%; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90C_edei--EntityTaxIdentificationNumber_c20250408__20250408_zEKmwA98tYwg"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000014" name="dei:EntityTaxIdentificationNumber">46-3673928</ix:nonNumeric></span></b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(State or other jurisdiction</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">of incorporation)</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(Commission</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">File No.)</p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(I.R.S. Employer</p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">Identification No.)</p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b><span id="xdx_901_edei--EntityAddressAddressLine1_c20250408__20250408_zMvhIiiWyllc"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000015" name="dei:EntityAddressAddressLine1">6308 Benjamin Rd</ix:nonNumeric></span>, <span id="xdx_904_edei--EntityAddressAddressLine2_c20250408__20250408_zuP2akntE97b"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000016" name="dei:EntityAddressAddressLine2">Suite 708</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b><span id="xdx_90E_edei--EntityAddressCityOrTown_c20250408__20250408_zVaMyeC0OyD9"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000017" name="dei:EntityAddressCityOrTown">Tampa</ix:nonNumeric></span>, <span id="xdx_90F_edei--EntityAddressStateOrProvince_c20250408__20250408_zaKzmKG8qww9"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt-sec:stateprovnameen" id="Fact000018" name="dei:EntityAddressStateOrProvince">Florida</ix:nonNumeric></span> <span id="xdx_906_edei--EntityAddressPostalZipCode_c20250408__20250408_z55WFGV6kQC3"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000019" name="dei:EntityAddressPostalZipCode">33634</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(Address of Principal Executive Offices)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b><span id="xdx_902_edei--CityAreaCode_c20250408__20250408_zrGn2lcW0DDg"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000020" name="dei:CityAreaCode">(866)</ix:nonNumeric></span> <span id="xdx_901_edei--LocalPhoneNumber_c20250408__20250408_z2NJF4kS7z79"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000021" name="dei:LocalPhoneNumber">468-6535</ix:nonNumeric></span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(Registrant&#8217;s Telephone Number)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b><span>Not Applicable</span></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">(Former Name or Former Address, if Changed Since Last
Report)</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Check the appropriate box below if the Form 8-K filing
is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90A_edei--WrittenCommunications_c20250408__20250408_zYRAyERaoGH8"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:booleanfalse" id="Fact000022" name="dei:WrittenCommunications">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_907_edei--SolicitingMaterial_c20250408__20250408_zuvgxGH86hSg"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:booleanfalse" id="Fact000023" name="dei:SolicitingMaterial">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_90B_edei--PreCommencementTenderOffer_c20250408__20250408_zwf8fJqeBSJk"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:booleanfalse" id="Fact000024" name="dei:PreCommencementTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif; font-size: 10pt"><span id="xdx_904_edei--PreCommencementIssuerTenderOffer_c20250408__20250408_zctL04OZMfZ9"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:booleanfalse" id="Fact000025" name="dei:PreCommencementIssuerTenderOffer">&#9744;</ix:nonNumeric></span></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Securities registered pursuant to Section 12(b) of
the Act:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-size: 10pt">Title of each class</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: center"><span style="font-size: 10pt">Trading Symbol(s)</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 38%; text-align: center"><span style="font-size: 10pt">Name of each exchange on which registered</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_901_edei--Security12bTitle_c20250408__20250408_zq3AmoPDSNJ8"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000026" name="dei:Security12bTitle">Common stock, par value $0.00001 per share</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt"><b><span id="xdx_90A_edei--TradingSymbol_c20250408__20250408_zaxG9t360Uk6"><ix:nonNumeric contextRef="AsOf2025-04-08" id="Fact000027" name="dei:TradingSymbol">SCNX</ix:nonNumeric></span></b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b><span id="xdx_901_edei--SecurityExchangeName_c20250408__20250408_zPcxFgRi3vGg"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt-sec:exchnameen" id="Fact000028" name="dei:SecurityExchangeName">The Nasdaq Stock Market LLC</ix:nonNumeric></span></b></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>(The Nasdaq Capital Market)</b></p></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Indicate by check mark whether the registrant is an
emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities
Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">Emerging growth company <span style="font-family: Segoe UI Symbol,sans-serif"><span id="xdx_90C_edei--EntityEmergingGrowthCompany_c20250408__20250408_zxxIu6jwk6a1"><ix:nonNumeric contextRef="AsOf2025-04-08" format="ixt:booleanfalse" id="Fact000029" name="dei:EntityEmergingGrowthCompany">&#9744;</ix:nonNumeric></span></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">If an emerging growth company, indicate by check mark
if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards
provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family: Segoe UI Symbol,sans-serif">&#9744;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif">&#160;</span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif"></span></p>

<!-- Field: Rule-Page --><div style="font-family: Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><div style="border-top: Black 1pt solid; border-bottom: Black 4pt solid; font: 1pt Times New Roman, Times, Serif">&#160;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif"></span></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-family: Segoe UI Symbol,sans-serif">&#160;</span></p>


<!-- Field: Page; Sequence: 1 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><span style="font-size: 10pt"></span><b>Item
1.01. Entry into a Material Definitive Agreement.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">On
April 8, 2025, Scienture Holdings, Inc. (the &#8220;Company&#8221;) entered into a Membership Interest Purchase Agreement (the &#8220;IPS
MIPA&#8221;) with Tollo Health, Inc. (&#8220;Tollo&#8221;), pursuant to which Tollo agreed to purchase and the Company agreed to sell
all of the Company&#8217;s membership interests in Integra Pharmacy Solutions LLC (&#8220;IPS&#8221;), a wholly-owned subsidiary of the
Company. Suren Ajjarapu, the Company&#8217;s Chief Executive Officer, and Prashant Patel, the Company&#8217;s President and
Chief Operating Officer, each have a beneficial interest in Tollo.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">On April 8, 2025, the Company
also entered into a Stock Purchase Agreement (the &#8220;Bonum SPA&#8221; and together with the IPS MIPA, the &#8220;Agreements&#8221;)
with Tollo, pursuant to which Tollo agreed to purchase and the Company agreed to sell all issued and outstanding shares of common stock
of Bonum Health, Inc., a wholly-owned subsidiary of the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">In connection with each of
the Agreements, the Company agreed to retain certain excluded liabilities of IPS and Bonum including all liabilities: (i) related to,
in connection with or arising out of any claims, charges, complaints, actions, suits, settlements, hearings, investigations, proceedings,
or governmental or regulatory inquiries with respect to IPS or Bonum, respectively, prior to the closing under the applicable Agreement;
(ii) related to, in connection with or arising out of any breach by the Company of the applicable Agreement or any other agreements and
documents required to be delivered by the Company; (iii) not disclosed by the Company in accordance with each Agreement; (iv) related
to any actions threatened or initiated by a governmental entity against IPS or Bonum, respectively; and (v) related to tax returns or
tax matters of the Company, IPS, or Bonum, respectively, for any periods prior to closing under the applicable Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">The Company and Tollo have
agreed to consummate the closing of each of the Agreements on June 30, 2025, or such other time as the Company and Tollo may agree. Each
of the Agreements contains customary conditions to closing, including the following mutual conditions: (i) the Company, Tollo, and the
respective subsidiary shall have performed and complied in all material respects with all agreements and conditions in the applicable
Agreement; (ii) the representations and warranties of the Company, Tollo, and the respective subsidiary shall be true and correct in all
respects at and as of the closing date; (iii) the Company and the respective subsidiary shall have obtained any necessary consents and
approvals to close on the transactions; (iv) no action shall have been taken by any governmental entity, and no law shall have been proposed
or enacted, which would (or, in the case of a proposed law, if enacted) materially and adversely affect the financial condition, operations
or prospects of the applicable subsidiary or the regulatory compliance status of the applicable subsidiary; (v) all documents and instruments
required by the applicable Agreement to be delivered by the Company and the applicable subsidiary to Tollo at closing shall be delivered
in form and substance reasonably satisfactory to Tollo and its counsel; and (vi) no litigation seeking to enjoin the transactions contemplated
by the applicable Agreement or to obtain damages on account thereof shall be pending or threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">As consideration for acquiring
IPS and Bonum, Tollo has agreed to pay the Company $5 million in the form of a promissory note bearing interest at the prime rate. The
promissory note matures on June 30, 2030. However, Tollo is required to pay 20% of the proceeds of a future equity financing toward repayment
of the principal and accrued but unpaid interest owed under the promissory note.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>


<!-- Field: Page; Sequence: 2 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">Each of the Agreements contains
customary representations and warranties made by each of the Company and Tollo.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">The foregoing descriptions
of the IPS MIPA and the Bonum SPA do not purport to be complete and are qualified in their entirety by reference to the IPS MIPA and the
Bonum SPA, copies of which are attached hereto as Exhibits 1.01 and 1.02, respectively.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Item 7.01. Regulation FD Disclosure.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0"><b>&#160;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">On April 8, 2025, the Company issued a press release announcing the dispositions
contemplated by the Agreements. The press release is filed as Exhibit 99.1 hereto and is incorporated herein by reference.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">The corporate press release
shall not be deemed &#8220;filed&#8221; for any purpose, including for the purposes of Section 18 of the Securities Exchange Act of 1934,
as amended (the &#8220;Exchange Act&#8221;), or otherwise be subject to the liabilities of such Section 18. The information in this Item
7.01, as well as Exhibit 99.1, shall not be deemed incorporated by reference into any filing under the Securities Act or the Exchange
Act regardless of any general incorporation language in such filing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">The press release contains
forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. With the exception of historical
matters, the matters discussed in the press release include forward-looking statements within the meaning of applicable securities laws.
Such forward-looking statements include, among others, statements regarding the Company&#8217;s projects, potential financial performance,
and growth opportunities. The words &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;anticipates,&#8221;
&#8220;hopes,&#8221; &#8220;likely,&#8221; &#8220;will,&#8221; and similar expressions are intended to identify certain of these forward-looking
statements. These statements are based on the Company&#8217;s expectations and involve risks, uncertainties and other important factors
that could cause the actual results performance or achievements of the Company (or entities in which the Company has interests), or industry
results, to differ materially from future results, performance or achievements expressed or implied by such forward-looking statements.
Certain factors that could cause the Company&#8217;s actual future results to differ materially from those discussed are noted in connection
with such statements, but other unanticipated factors could arise. Certain risks regarding the Company&#8217;s forward-looking statements
are discussed in the Company&#8217;s filings with the Securities and Exchange Commission (&#8220;SEC&#8221;). Readers are cautioned not
to place undue reliance on these forward-looking statements which reflect management&#8217;s view only as of the date of this Current
Report on Form 8-K. The Company undertakes no obligation to publicly release any revisions to these forward-looking statements to reflect
events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, conditions or circumstances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify"><b>Item 9.01. Financial Statements and Exhibits.</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 0.75in; text-align: justify"><span style="font-size: 10pt"><b>Exhibit No.</b></span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.1in; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><b>Description</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">1.01</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><a href="ex1-01.htm">Membership Interest Purchase Agreement by and among Scienture Holdings, Inc., Integra Pharmacy Solutions LLC, and Tollo Health, Inc., dated April 8, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">1.02</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><a href="ex1-02.htm">Stock Purchase Agreement by and among Scienture Holdings, Inc. and Tollo Health, Inc., dated April 8, 2025.</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">1.03</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><a href="ex1-03.htm">Form of Promissory Note</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">99.1</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">&#160;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt"><a href="ex99-1.htm">Press Release dated April 8, 2025</a></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">104</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-size: 10pt">Cover Page Interactive Data File (embedded with the Inline XBRL document).</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>


<!-- Field: Page; Sequence: 3 -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&#160;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center"><b>SIGNATURES</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: center">&#160;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; text-indent: 0.5in">Pursuant to the requirements of
the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify">&#160;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><b>SCIENTURE HOLDINGS, INC.</b></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><span style="font-size: 10pt">&#160;</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">By: </span></td>
    <td style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt"><i>/s/ Surendra Ajjarapu</i></span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Surendra Ajjarapu</span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Chief Executive Officer </span></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">Date: April 11, 2025</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-size: 10pt">&#160;</span></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>


<!-- Field: Page; Sequence: 4; Options: Last -->
    <div style="border-bottom: Black 1pt solid; margin-bottom: 6pt"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&#160;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0">&#160;</p>


<!-- Field: Set; Name: xdx; ID: xdx_08B_extensions -->
<!-- eJxFjU0KwjAQhU/QOwxZS01Ku+nSoiJWkSLiNtqpBNtMmcS/I3lLY4s4DAzDe997QkzEkhamRYbjrCphj13fao9QYYOM9ozBUazWOYRb4cU4z9r64f2BBQUGA5PFSXYKwmC9G4d1DjKdKjVNMpAqTyXsNiL66gXZxtRovdEtaFvDjqlng17za0zY6ydZ6l5D1QHZGbI5qFiO8hsSqRLY0l0/iK8OyrIQ0WSYSCyZbn1wzZ8e7ZeEeYtdqHMj/d/oAwQ5Sog= -->
</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.01
<SEQUENCE>2
<FILENAME>ex1-01.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1in; text-align: right"><b>Exhibit</b> <b>1.01</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center">Membership Interest
PURCHASE AGREEMENT</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">This MEMBERSHIP INTEREST PURCHASE
AGREEMENT (&ldquo;<b>Agreement</b>&rdquo;) is made as of April 8, 2025, by and among SCIENTURE HOLDINGS, INC., a Delaware corporation
(&ldquo;<b>Seller</b>&rdquo;), Integra Pharma Solutions LLC, a Florida limited liability company (&ldquo;<b>Company</b>&rdquo;) and TOLLO
HEALTH, LLC., a Delaware limited liability company (<b>&ldquo;Buyer&rdquo;</b>). Buyer, Company and Seller are each referred to herein
as a &ldquo;<b>Party</b>&rdquo; and collectively as &ldquo;<b>Parties</b>.&rdquo;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>recitals</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">A. Seller owns all of the membership
interest in the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">B. Buyer desires to purchase from
Seller and Seller desires to sell to Buyer 100% of the Seller&rsquo;s membership interest in the Company (the &ldquo;<b>Membership Interest</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>agreement</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">Now, therefore, in consideration
of the foregoing and the mutual agreements and covenants set forth below, which are acknowledged by each Party to be fair and adequate
consideration for its obligations and commitments hereunder, the Parties hereby agree as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">1. <b>Definitions</b>. Except
as otherwise set forth therein, as used in the Agreement and the Exhibits, Schedules and deliveries pursuant to the Agreement, the following
definitions shall apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Company Assets</b>&rdquo;
means the assets used in the Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Action</b>&rdquo; means
any action, complaint, petition, investigation, suit or other proceeding, whether civil or criminal, in law or in equity, before any arbitrator
or Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Adjusted Net Income&rdquo;</b>
means net income of Company, determined in accordance with GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Affiliate</b>&rdquo; of
a Person means a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, such first Person</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Allocable Share</b>&rdquo;
means the ownership percentage of each Seller as set forth on <u>Schedule 1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Approvals</b>&rdquo; means
all franchises, grants, authorizations, licenses, permits, easements, consents, certificates, approvals and orders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Business</b>&rdquo; means
the business of Company taken as a whole and shall be deemed to include any of the following incidents of such business: income, cash
flow, operations, condition (financial or otherwise), assets, future revenues, prospects, liabilities, personnel and management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>COBRA</b>&rdquo; means
the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Code</b>&rdquo; means
the Internal Revenue Code of 1986, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Company Disclosure Schedule</b>&rdquo;
means the written disclosure schedule of even date herewith delivered on or prior to the date hereof by Company to Buyer corresponding
to each representation and warranty made hereunder by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Contract</b>&rdquo; means
any contract, agreement, indenture, note, bond, loan, instrument, lease, conditional sale contract, mortgage, license, franchise, insurance
policy, commitment or other arrangement or agreement, whether written or oral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Encumbrance</b>&rdquo;
means any option, pledge, security interest, claim, lien, charge, encumbrance, easement, covenant, lease, rights of others, restriction
(whether on voting, sale, transfer or disposition or otherwise), whether imposed by agreement, understanding, law or otherwise, except
those arising under applicable federal or state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>ERISA</b>&rdquo; means
the Employee Retirement Income Security Act of 1974, as amended, and the related regulations and published interpretations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>FMLA</b>&rdquo; means
the Family Medical Leave Act of 1993, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>GAAP</b>&rdquo; means
generally accepted accounting principles as promulgated by the Financial Accounting Standards Board, consistently applied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Governmental Entity</b>&rdquo;
means any court or tribunal in any jurisdiction or any federal, state, municipal, domestic, foreign or other administrative agency, department,
commission, board, bureau or other governmental authority or instrumentality.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>HIPAA</b>&rdquo; means
the Health Insurance Portability and Accountability Act of 1996, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Indebtedness</b>&rdquo;
means, as to Company, (a) all obligations for borrowed money (including, without limitation, reimbursement and all other obligations with
respect to surety bonds, letters of credit and bankers&rsquo; acceptances, whether or not matured), (b) all obligations to pay the deferred
purchase price of property or services, (c) all interest rate and currency swaps, caps, collars and similar agreements or hedging devices
under which payments are obligated to be made by Company, whether periodic-ally or upon the happening of a contingency, (d) all indebtedness
created or arising under any conditional sale or other title retention agreement with respect to property acquired by Company (even though
the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such
property), (e) all obligations under leases which have been or should be, in accordance with GAAP, recorded as capital leases, (f) all
indebtedness secured by any Encumbrance (other than Encumbrances in favor of lessors under leases other than leases included in clause
(e)) on any property or asset owned or held by Company regardless of whether the indebtedness secured thereby shall have been assumed
by Company or is non-recourse to the credit of Company, and (g) any direct or indirect liability with respect to any Indebtedness, lease,
dividend, guaranty, letter of credit or other obligation, contractual or otherwise (the &ldquo;<b>Primary Obligation</b>&rdquo;) of another
Person (the &ldquo;<b>Primary Obligor</b>&rdquo;), whether or not contingent, (i) to purchase, repurchase or otherwise acquire such Primary
Obligations or any property constituting direct or indirect security therefor, (ii) to advance or provide funds (x) for the payment or
discharge of any such Primary Obligation, or (y) to maintain working capital or equity capital of the Primary Obligor or otherwise to
maintain the net worth or solvency or any balance sheet item, level of income or financial condition of the Primary Obligor, (iii) to
purchase property, securities or services primarily for the purpose of assuring the owner of any such Primary Obligation of the ability
of the Primary Obligor to make payment of such Primary Obligation, or (iv) otherwise to assure or hold harmless the owner of any such
Primary Obligation against loss or failure or inability to perform in respect thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>IRS</b>&rdquo; means the
Internal Revenue Service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Laws</b>&rdquo; means
any constitutional provision, statute or other law, rule, regulation, or interpretation of any Governmental Entity and any Order.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><b>&ldquo;Management Agreement&rdquo;</b>
means that certain Master Service Agreement by and between the Buyer and the Seller dated as of even date herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Material Adverse Effect</b>&rdquo;
means any change, effect or circumstance that is materially adverse to the business, assets, condition (financial or otherwise) or results
of operations of Company, or Buyer and its subsidiaries, as the case may be, in each case taken as a whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Order</b>&rdquo; means
any order, injunction, judgment, decree, ruling, writ, assessment or arbitration award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Permit</b>&rdquo; means
any license, permit, franchise, certificate of authority, or order, or any waiver of the foregoing, required to be issued by any Governmental
Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Person</b>&rdquo; means
an individual, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust, a joint venture,
an unincorporated organization a Governmental Entity or any other entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Tax</b>&rdquo; or &ldquo;<b>Taxes</b>&rdquo;
means all taxes, charges, fees, levies or other assessments, including, without limitation, income, gross receipts, excise, property,
sales, use, license, payroll and franchise taxes, imposed by any Governmental Entity and includes any estimated tax, interest and penalties
or additions to tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Transaction Documents</b>&rdquo;
means this Agreement (and each of the exhibits and schedules attached hereto and incorporated by reference herein), the Non-Competition
and Non-Solicitation Agreements, the Employment agreement, the General Waiver and Releases and each of the other documents, agreements
and certificates delivered in connection with this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>WARN</b>&rdquo; means
the Worker Adjustment and Retraining Notification Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&ldquo;<b>Working Capital</b>&rdquo;
shall be calculated by subtracting the sum of all of Company&rsquo;s current liabilities as of the Closing Date from the sum of all of
Company&rsquo;s current assets as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">2. <b>Purchase and Sale of Membership
Interests</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">2.1. <u>Sale of Membership Interest
by Seller</u>. Subject to the terms and conditions herein set forth, Seller agrees to sell the Membership Interest to Buyer at the Closing,
free and clear of all Encumbrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">2.2. <u>Purchase Price</u>. In full
consideration for the purchase by Buyer of the Membership Interest, the purchase price (the &ldquo;<b>Purchase Price</b>&rdquo;) shall
be paid by Buyer to Seller as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <font style="letter-spacing: -0.1pt"><i>Closing
Payment</i>.</font> On the Closing Date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in">(i) Promissory Note of $3.5M</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in">(ii) All amounts due and owing to
from Buyer to Seller under the Management Agreement (collectively, the &ldquo;<b>Closing Payment</b>&rdquo;);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 2in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">2.3. <u>Closing</u>. Unless otherwise
agreed upon by the Parties, the closing of the transactions contemplated by this Agreement (the &ldquo;<b>Closing</b>&rdquo;) shall take
place on <b>June 30<sup>th</sup> 2025, </b>or such other time as the Parties may agree (the &ldquo;<b>Closing Date</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">2.4. <u>[Intentionally omitted.]</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">2.5. <u>Excluded Liabilities</u>.
After the Closing, and notwithstanding anything else to the contrary herein, Seller shall retain, and shall be responsible for paying,
performing and discharging, when due, and neither the Company, nor the Buyer, shall not assume or have any responsibility for, the following
excluded Liabilities (the &ldquo;<b>Excluded Liabilities</b>&rdquo;):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(a) all Liabilities related to,
in connection with or arising out of any claims, charges, complaints, actions, suits, settlements, hearings, investigations, proceedings,
or governmental or regulatory inquiries with respect to the operation of the Business or the Company prior to the Closing, whether such
Claim is brought prior to, on or after the Closing Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(b) all Liabilities related to,
in connection with or arising out of any breach by the Seller of this Agreement or any other agreements and documents required to be delivered
by Seller hereunder;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(c) all Liabilities not disclosed
in this Agreement under Section 3 hereof;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(d) all Litigation Obligations.
&ldquo;<b>Litigation Obligations</b>&rdquo; means any matters or Liabilities related to a breach of <u>Section 3.10</u> or any matters
disclosed in <u>Schedule 3.10</u>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(e) All Liabilities related to Tax
Returns or any other tax matters of the Company or the Seller for any periods prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">(f) All Liabilities listed on <u>Schedule
2.5</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&ldquo;<b>Liabilities</b>&rdquo;
shall mean any liabilities (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued
or unaccrued, whether liquidated or unliquidated, and whether due or to become due), including any liabilities for taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">3. <b>Representations and Warranties
of Seller</b>. As a material inducement to Buyer to enter into this Agreement, Seller makes the representations and warranties set forth
below to Buyer, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.1. <u>Organization and Qualification</u>.
Company is a limited liability company duly organized, validly existing and in good standing under Florida law, and Company has the requisite
power and authority and is in possession of Approvals necessary to own, lease and operate the properties it purports to own, lease or
operate and to carry on the Business as it is now being conducted. Company is duly qualified or licensed as a foreign limited liability
company to do business and is in good standing in each jurisdiction where the character of its properties owned, leased or operated by
it or the nature of its activities makes such qualification or licensing necessary. Except as set forth on <i><u>Schedule 3.1</u></i>,
Company does not own or lease property in any jurisdiction other than its jurisdiction of incorporation and the jurisdictions referred
to in the previous sentence. Except as set forth on <i><u>Schedule 3.1</u></i>, no jurisdiction has claimed, in writing or otherwise,
that Company is required to qualify as a foreign corporation or other entity therein, and (except as aforesaid) Company does not file
any franchise, income or other tax returns in any other jurisdiction based upon the ownership or use of property therein or the derivation
of income therefrom. Company has no subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.2. <u>Articles of Organization
and Operating Agreement</u>. Company has heretofore furnished to Buyer a true, complete and correct copy of its Articles of Organization
and Operating Agreement, each as amended to date. Such Articles of Organization and Operating Agreement are in full force and effect.
Company is not in violation of any of the provisions of its Articles of Organization or Operating Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.3. <u>Capitalization</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <i>Capitalization</i>. The
Company&rsquo;s membership interests (i) are duly authorized, validly issued, fully paid and non-assessable, (ii) are free of any liens
or encumbrances created by Company, and free of any liens or encumbrances created by or imposed upon the holders thereof, and (iii) were
not issued in violation of any preemptive rights or rights of first refusal created by statute, the Articles of Organization or Operating
Agreement of Company or any agreement to which Company is a party or by which it is bound. Except for the rights created pursuant to this
Agreement, there are no options, warrants, calls, rights, commitments or agreements that are outstanding to which Company is a party or
by which it is bound, obligating Company to issue, deliver, sell, repurchase or redeem, or cause to be issued, delivered, sold, repurchased
or redeemed, Company&rsquo;s membership interests or obligating Company to grant, extend, accelerate the vesting of, change the price
of, or otherwise amend or enter into any option, warrant, call, right, commitment or agreement regarding Company&rsquo;s membership interests.
There are no other contracts, commitments or agreements relating to the voting, purchase or sale of Company&rsquo;s membership interests
(A) between or among Company and any of its members; and (B) between or among any of Company&rsquo;s members. All issued and outstanding
membership interests of Company were issued in compliance with all applicable federal and state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.].</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) <i>The Membership Interests.</i>
The membership interests of Seller issued to Buyer in connection with this Agreement shall total One Hundred Percent (100%) of the total
membership interest in Company at Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.4. <u>Authority Relative to this
Agreement</u>. Company has all necessary corporate power and authority to execute and deliver the Transaction Documents to which it is
a party and to perform its obligations thereunder and to consummate the transactions contemplated hereby. The execution and delivery of
the Transaction Documents by Company and the consummation by Company of the transactions contemplated thereby have been duly and validly
authorized by all necessary corporate action on the part of Company, and no other corporate proceedings on the part of Company are necessary
to authorize the Transaction Documents or to consummate the transactions contemplated thereby. The Sole Member of Company has approved
the Transaction Documents and the transactions contemplated thereby and declared their advisability. The Transaction Documents to which
Company is a party have been duly and validly executed and delivered by Company and, assuming the due authorization, execution and delivery
by Buyer, constitute a legal, valid and binding obligation of Company enforceable against Company in accordance with their terms, except
as enforceability against Company may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer,
moratorium or similar laws affecting the enforcement of creditors&rsquo; rights and by general principles of equity relating to enforceability
(regardless of whether considered in a proceeding at law or in equity).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.5. <u>No Conflict; Required Filings
and Consents</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <i>Material Contracts</i>.
<i><u>[Intentionally omitted.]</u></i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) <i>No Conflict</i>. Except
as set forth in <i><u>Schedule 3.5(b)</u></i>, the execution and delivery of this Agreement by Company does not, and the performance of
this Agreement by Company will not, (i) conflict with or violate the Articles of Organization or Operating Agreement of Company, (ii)
conflict with or violate any law, rule, regulation, order, judgment or decree applicable to Company or by which its properties is bound
or affected, or (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or both would become
a default) under, or result in a modification of any right or benefit under, or impair Company&rsquo;s rights or alter the rights or obligations
of any third party under, or give to others any rights of termination, amendment, acceleration, repayment or repurchase, or result in
increased payments or cancellation under, or result in the creation of an Encumbrance on any of the properties or assets of Company pursuant
to, any Contract to which Company is a party or by which Company <b>[or any of its properties</b>] are bound or affected, except in the
case of (ii) or (iii) only for any such conflicts, violations, breaches, defaults or other occurrences that would not, individually or
in the aggregate, have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) <i>Required Filings and Consents.</i>
The execution and delivery of this Agreement by Company does not, and the performance of this Agreement by Company will not require any
consent, approval, exemption, authorization or permit of, or filing with or notification to, any Governmental Entity or any other Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.6. <u>Compliance, Permits</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <i>Compliance</i>. Except
as set forth in <i><u>Schedule 3.6(a)</u></i>, Company is not in conflict with, or in default or violation of (i) any law, rule, regulation,
order, judgment or decree applicable to Company or by which its or any of its respective properties is bound or affected or (ii) any Material
Contracts, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not have a Material Adverse
Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) <i>Permits</i>. Company holds
all Permits from Governmental Entities that are necessary to the operation of the Business as it is now being conducted, except when the
failure to have such Permits would not, individually or in the aggregate, have a Material Adverse Effect. Company is in compliance with
the terms of such Permits, except where the failure to so comply would not, individually or in the aggregate, have a Material Adverse
Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.7. <u>Financial Statements</u>.
<i><u>Schedule 3.7</u></i> contains the unaudited balance sheet and statements of operations for the period ended December 31st, 2024,
the unaudited financial statements for Company&rsquo;s 2024 and 2023 fiscal year (the &ldquo;<b>Financial Statements</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.8. <u>Absence of Certain Changes
or Events</u>. Except as set forth in <i><u>Schedule 3.8</u></i>, since December 31, 2024, Company has conducted the Business in the ordinary
course and there has not occurred any of the following: (i) any Material Adverse Effect; (ii) any amendments or changes in the Articles
of Organization or Operating Agreement of Company; (iii) any damage to, destruction or loss of any material asset of Company (whether
or not covered by insurance); (iv) any material change by Company in its accounting methods, principles or practices; (v) any material
revaluation by Company of any of its assets, including, without limitation, writing down the value of inventory or writing off notes or
accounts receivable other than in the ordinary course of business; (vi) any sale of a material amount of property of Company, except in
the ordinary course of business; (vii) any declaration, setting aside or payment of any dividend or distribution in respect of membership
interest in Company or any redemption, purchase or other acquisition of any of Company&rsquo;s securities (except as contemplated by this
Agreement); (viii) any increase in the compensation or benefits or establishment of any bonus, insurance, severance, deferred compensation,
pension, retirement, profit sharing, or other employee benefit plan, or any other increase in the compensation payable or to become payable
to any executive officers of Company, in each case except in the ordinary course of business consistent with past practice or except as
required by applicable law; (ix) any creation or assumption by Company of any Encumbrance on any material asset of Company, other than
in the ordinary course of business, consistent with past practice; (x) any making of any loan, advance or capital contribution to or investment
in any Person by Company, other than advances to employees to cover travel and other ordinary business-related expenses in the ordinary
course of business consistent with past practice; (xi) any incurrence or assumption by Company of any indebtedness for borrowed money
or any guarantee, endorsement or other incurrence or assumption of a material liability (whether directly, contingently or otherwise)
by Company for the obligations of any other Person, in each case other than in the ordinary course of business consistent with past practice;
or (xii) any material modification, amendment, assignment or termination of or relinquishment by Company of any rights under any Material
Contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.9. <u>No Undisclosed Liabilities</u>.
Except as set forth in <i><u>Schedule 3.9</u></i>, the Company has no liabilities (absolute, accrued, known contingent or otherwise) except
liabilities (i) in the aggregate adequately provided for in Company&rsquo;s unaudited balance sheet as of September 30, 2022 and (ii)
incurred since September 30, 2022 in the ordinary course of business consistent with past practice or in connection with the transactions
contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.10. <u>Absence of Litigation</u>.
Other than as described on <i><u>Schedule 3.10</u></i>, there are no Actions or, to the knowledge of Company, there are no Actions threatened
against Company, or any properties or rights of Company, before any Governmental Entity or body, nor are there, to the knowledge of Company,
any investigations or reviews by any Governmental Entity pending or threatened against, relating to or affecting, Company. Company is
not subject to any outstanding Order.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.11. <u>Employee Benefit Plans;
Employment agreement</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <i><u>Schedule 3.11(a)</u></i>
contains an accurate and complete list, with respect to Company and any Person under common control with Company within the meaning of
Section 414(b), (c), (m) or (o) of the Code, and the regulations issued thereunder (collectively an &ldquo;<b>ERISA Affiliate</b>&rdquo;)
of each plan, program, policy, practice, contract, agreement or other arrangement providing for compensation, severance, termination pay,
deferred compensation, performance awards, equity-related awards, welfare benefits, fringe benefits or other employee benefits or remuneration
of any kind, whether written, unwritten or otherwise, funded or unfunded, including each &ldquo;employee benefit plan,&rdquo; within the
meaning of Section 3(3) of ERISA, which is or has been maintained, contributed to, or required to be contributed to, by Company or any
ERISA Affiliate for the benefit of any employee (collectively, the &ldquo;<b>Company Employee Plans</b>&rdquo;). Company has not made
any plan or commitment to establish any new Company Employee Plan, to modify any Company Employee Plan (except to the extent required
by law or to conform any such Company Employee Plan to the requirements of any applicable law, in each case as previously disclosed to
Buyer in writing, or as required by this Agreement), or to enter into any Company Employee Plan. <i><u>Schedule 3.11(a)</u></i> sets forth
a table setting forth the name and salary of each employee of Company as of the date hereof. To the knowledge of Company, no employee
listed on <i><u>Schedule 3.11(a)</u></i> intends to terminate his or her employment for any reason. <i><u>Schedule 3.11(a)</u></i> contains
an accurate and complete list of all Persons that have a consulting or advisory relationship with Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) <i>Documents</i>. Company
has provided to Buyer: (i) correct and complete copies of all documents embodying each Company Employee Plan including all amendments
thereto and all related trust documents, (ii) the three most recent annual reports (Form Series 5500 and all schedules and financial statements
attached thereto), if any, required under ERISA or the Code in connection with each Company Employee Plan, (iii) if Company Employee Plan
is funded, the most recent annual and periodic accounting of Company Employee Plan assets, (iv) the most recent summary plan description
together with the summary(ies) of material modifications thereto, if any, required under ERISA with respect to each Company Employee Plan,
(v) all material written agreements and contracts relating to each Company Employee Plan, including administrative service agreements
and group insurance contracts, (vi) each affirmative action plan, if applicable, (vii) all communications material to any employee or
employees relating to any Company Employee Plan and any proposed Company Employee Plan, in each case, relating to any amendments, terminations,
establishments, increases or decreases in benefits, acceleration of payments or vesting schedules or other events which would result in
any liability to Company, (viii) all correspondence to or from any Governmental Entity relating to any Company Employee Plan, (ix) model
COBRA forms and related notices, (x) all policies pertaining to fiduciary liability insurance covering the fiduciaries for each Company
Employee Plan, (xi) all discrimination tests for each Company Employee Plan for the three most recent plan years, (xii) all registration
statements, annual reports (Form 11-K and all attachments thereto) and prospectuses prepared in connection with each Company Employee
Plan, (xiii) all HIPAA privacy notices and all business associate agreements to the extent required under HIPAA and (xiv) the most recent
IRS determination or opinion letter issued with respect to each Company Employee Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) <i>Company Employee Plan Compliance</i>.
Company has performed all obligations required to be performed by it under, is not in default or violation of, and Company has no knowledge
of any default or violation by any other party to, any Company Employee Plan, and each Company Employee Plan has been established and
maintained in accordance with its terms and in compliance with all applicable laws, statutes, orders, rules, and regulations, including
ERISA or the Code. Each Company Employee Plan intended to be qualified under Section 401(a) of the Code and each trust intended to qualify
under Section 501(a) of the Code has either (i) applied for, prior to the expiration of the requisite remedial amendment period under
applicable Treasury Regulations or IRS pronouncements, but has not yet received a response; (ii) obtained a favorable determination, notification,
advisory and/or opinion letter, as applicable, on which the employer is entitled to rely, as to its qualified status from the IRS since
January 1, 2000; or (iii) still has a remaining period of time to apply for such a determination letter from the IRS and to make any amendments
necessary to obtain a favorable determination and nothing has occurred since the date of the most recent determination that could reasonably
be expected to cause any such Company Employee Plan or trust to fail to qualify under Section 401(a) or 501(a) of the Code. No &ldquo;prohibited
transaction,&rdquo; within the meaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, and not otherwise exempt under Section
408 of ERISA, has occurred with respect to any Company Employee Plan. There are no actions, suits or claims pending or, to the knowledge
of Company, threatened or reasonably anticipated (other than routine claims for benefits) against any Company Employee Plan or against
the assets of any Company Employee Plan. Each Company Employee Plan can be amended, terminated, or otherwise discontinued after the Closing
Date in accordance with its terms, without liability to Buyer, Company or any ERISA Affiliate (other than ordinary administration expenses).
There are no audits, inquiries or proceedings pending or to the knowledge of Company or any ERISA Affiliates, threatened by the IRS, Department
of Labor, or any other governmental entity with respect to any Company Employee Plan. Neither Company nor any ERISA Affiliate is subject
to any penalty or Taxes with respect to any Company Employee Plan under Section 502(i) of ERISA or Sections 4975 through 4980 of the Code.
Company has timely made all contributions and other payments required by and due under the terms of each Company Employee Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) <i>No Pension Plan</i>. Neither
Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed to, any Company Employee
Plan that is an &ldquo;employee pension benefit plan,&rdquo; within the meaning of Section 3(2) of ERISA (a &ldquo;<b>Pension Plan</b>&rdquo;)
subject to Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA, or Section 412 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(e) <i>No Self-Insured Company
Employee Plan</i>. Neither Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed
to any self-insured plan that provides benefits to employees (including any such plan pursuant to which a stop-loss policy or contract
applies).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(f) <i>Collectively Bargained,
Multiemployer and Multiple-Employer Plan</i>. At no time has Company or any ERISA Affiliate contributed to or been obligated to contribute
to any multiemployer plan (as defined in Section 3(37) of ERISA). Neither Company nor any ERISA Affiliate has at any time ever maintained,
established, sponsored, participated in, or contributed to any multiple employer plan or to any plan described in Section 413 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(g) <i>No Post-Employment Obligations</i>.
No Company Employee Plan provides, or reflects or represents any liability to provide, post-termination or retiree life insurance, health
or other employee welfare benefits to any Person for any reason, except as may be required by COBRA or other applicable statute, and Company
has not ever represented, promised or contracted (whether in oral or written form) to any employee (either individually or to employees
as a group) or any other Person that such employee(s) or other Person would be provided with life insurance, health or other employee
welfare benefits, except to the extent required by statute.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(h) <i>COBRA; FMLA; HIPAA</i>.
Company and each ERISA Affiliate has, prior to the Closing Date, complied with COBRA, FMLA, HIPAA, the Women&rsquo;s Health and Cancer
Rights Act of 1998, the Newborns&rsquo; and Mothers&rsquo; Health Protection Act of 1996, and any similar provisions of state law applicable
to its employees. To the extent required under HIPAA and the regulations issued thereunder, Company has, prior to the Closing Date, performed
all obligations under the medical privacy rules of HIPAA, the electronic data interchange requirements of HIPAA, and the security requirements
of HIPAA. Company has no unsatisfied obligations to any employees or qualified beneficiaries pursuant to COBRA, HIPAA or any state law
governing health care coverage or extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(i) <i>Effect of Transaction</i>.
Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby or any termination of
employment or service in connection therewith will (i) result in any payment (including severance, golden parachute, bonus or otherwise)
becoming due to any employee, (ii) result in any forgiveness of indebtedness, (iii) materially increase any benefits otherwise payable
by Company or (iv) result in the acceleration of the time of payment or vesting of any such benefits except as required under Section
411(d)(3) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(j) <i>Deferred Compensation</i>.
Each Company Employee Plan that is a &ldquo;nonqualified deferred compensation plan,&rdquo; within the meaning of Section 409A of the
Code, has been operated and administered since the latter of inception or January 1, 2019, in good faith compliance with Section 409A
of the Code, to the extent Section 409A of the Code is applicable to such plan. No such plan has been &ldquo;materially modified,&rdquo;
within the meaning of IRS Notice 2005-1, at any time after October 3, 2004.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(k) <i>Parachute Payments</i>.
There is no agreement, plan, arrangement or other contract covering any employee that, considered individually or considered collectively
with any other such agreements, plans, arrangements or other contracts, will, or could reasonably be expected to, give rise directly or
indirectly to the payment of any amount that would be characterized as a &ldquo;parachute payment&rdquo; within the meaning of Section
280G(b)(1) of the Code. There is no agreement, plan, arrangement or other contract by which Company is bound to compensate any employee
for excise taxes paid pursuant to Section 4999 of the Code. <i><u>Schedule 3.11(k)</u></i> lists all Persons who Company reasonably believes
are &ldquo;disqualified individuals&rdquo; (within the meaning of Section 280G of the Code and the regulations promulgated thereunder)
as determined as of the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(l) <i>No Interference or Conflict</i>.
To the knowledge of Company, no member, manager, officer, employee or consultant of Company is obligated under any contract or agreement,
subject to any Order of any Governmental Entity that would interfere with such Person&rsquo;s efforts to promote the interests of Company
or that would interfere with the Business. Neither the execution nor delivery of this Agreement, nor the carrying on of the Business as
presently conducted or proposed to be conducted nor any activity of such officers, managers, employees or consultants in connection with
the carrying on of the Business as presently conducted or currently proposed to be conducted will, to the knowledge of Company, conflict
with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract or agreement under
which any of such officers, managers, employees, or consultants is now bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(m) <i>International Employee
Plan</i>. Neither Company nor any ERISA Affiliate currently or has it ever had the obligation to maintain, establish, sponsor, participate
in, be bound by or contribute to any each Company Employee Plan that has been adopted or maintained by Company or any ERISA Affiliate,
whether formally or informally or with respect to which Company or any ERISA Affiliate will or may have any liability with respect to
employees who perform services outside the United States (an &ldquo;<b>International Employee Plan</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.12. <u>Employment and Labor Matters</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) Company is in compliance with
all applicable Laws respecting employment, employment practices, terms and conditions of employment, employee safety and health and wages
and hours, and in each case, with respect to employees: (i) has withheld and reported all amounts required by law or by agreement to be
withheld and reported with respect to wages, salaries and other payments to employees, (ii) is not liable for any arrears of wages, severance
pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any trust
or other fund governed by or maintained by or on behalf of any Governmental Entity, with respect to unemployment compensation benefits,
social security or other benefits or obligations for employees (other than routine payments to be made in the normal course of business
and consistent with past practice). There are no Actions pending, threatened or reasonably anticipated against Company or any of their
employees relating to any employee or Company Employee Plan. There are no pending or threatened or reasonably anticipated claims or actions
against Company, any Company trustee or any trustee of any subsidiary under any worker&rsquo;s compensation policy. The services provided
by each of Company&rsquo;s, each subsidiary&rsquo;s and their ERISA Affiliates&rsquo; employees is terminable at the will of Company and
its ERISA Affiliates and any such termination would result in no liability to Company or any ERISA Affiliate. <i><u>Schedule 3.12(a)</u></i>
lists all liabilities of Company to any employee, that result from the termination by Company of such employee&rsquo;s employment or provision
of services, a change of control of Company, or a combination thereof. To the knowledge of Company, neither Company nor any ERISA Affiliate
has direct or indirect liability with respect to any misclassification of any Person as an independent contractor rather than as an employee,
or with respect to any employee leased from another employer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) No work stoppage or labor
strike against Company is pending, or to the knowledge of Company, threatened, or reasonably anticipated. Company has no knowledge of
any activities or proceedings of any labor union to organize any employees. There are no Actions pending or threatened or reasonably anticipated
relating to any labor matters involving any employee, including charges of unfair labor practices. Company has not engaged in any unfair
labor practices within the meaning of the National Labor Relations Act. Company is not presently, nor has it been in the past, a party
to, or bound by, any collective bargaining agreement or union contract with respect to employees, and no collective bargaining agreement
is being negotiated by Company. Within the past year, Company has not incurred any liability or obligation under WARN or any similar state
or local law that remains unsatisfied, nor shall any terminations prior to the Closing Date result in unsatisfied liability or obligation
under WARN or any similar state or local law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.13. <u>Restrictions on Business
Activities</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) Except for this Agreement,
there is no material agreement, Action or Order binding upon Company which has or could reasonably be expected to have the effect of prohibiting
or impairing any material business practice of Company or any acquisition of property by Company or any acquisition of property by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) None of Company&rsquo;s officers,
managers or key employees is a party to any agreement which, by virtue of such Person&rsquo;s relationship with Company, restricts in
any material respect Company from continuing such entity&rsquo;s business activities as presently conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.14. <u>Title to Property</u>.
Except as set forth in <i><u>Schedule 3.14</u></i>, Company has good record, marketable and defensible title to all of their owned properties
and assets, free and clear of all material Encumbrances. <i><u>Schedule 3.14</u></i> is a true, complete and correct schedule of all leases
of real property as of the date of this Agreement (&ldquo;<b>Real Property Leases</b>&rdquo;) pursuant to which Company leases from others
which schedule sets forth (i) the date of each lease and the premises covered thereby, (ii) the term thereof, and (iii) the rent payable
thereunder. No real property is owned by Company. The Real Property Leases and all leases of personal property by Company from others
are in good standing, valid and effective in accordance with their respective terms and to Company&rsquo;s knowledge there is not, under
any of such leases, any existing default or event of default (or event which with notice or lapse of time, or both, would constitute a
default).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.15. <u>Sufficiency and Condition
of Assets</u>. The Company Assets are adequate to conduct the Business as it is presently being conducted, and will be adequate to enable
Buyer to continue to conduct the Business as it is presently being conducted. The Company Assets are in good operating condition and repair,
normal wear and tear excepted, are suitable for the uses intended therefor, are free from any latent defects and have been maintained
in accordance with normal industry practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.16. <u>Taxes</u>. Except as set
forth in <i><u>Schedule 3.16</u></i>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) Company has timely filed in
accordance with applicable law all Tax Returns required to be filed by or with respect to it, its operations and assets, and all Taxes
shown as due on such Tax Returns have been paid. All Tax Returns filed by Company with respect to Taxes were true, complete, and correct
in all material respects as of the date on which they were filed or as subsequently amended to the date of this Agreement. Complete copies
of federal, state, local, and foreign Tax Returns of Company for the year ended December 31, 2021 have heretofore been delivered or made
available to Buyer. Prior to the date of this Agreement, Company has provided to Buyer all revenue agents&rsquo; reports and other written
assertions of deficiencies or other liabilities for Taxes of Company with respect to past periods for which the applicable statute of
limitations has not expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) Company has timely paid all
Taxes for which a notice of, or assessment or demand for, payment has been received, or which are otherwise due and payable with respect
to Company, its operations and assets (in each case, whether or not shown on any Tax Return), except for Taxes that are being contested
in good faith by appropriate proceedings, all of which are disclosed in <i><u>Schedule 3.16(b)</u></i> and for payment of which Taxes
adequate reserves have been established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) Company has complied with
all applicable law, rules and regulations relating to the withholding of Taxes and has timely collected or withheld and paid over, and
up to the Closing Date will have timely collected and withheld and paid over to the proper governmental authorities all amounts required
to be so collected or withheld and paid over for all periods up to the Closing Date under all applicable laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) There are no outstanding agreements,
waivers or arrangements extending the statutory period of limitations for the assessment or collection of Taxes with respect to any Tax
Return that relates to Company, which waivers or extensions currently are in effect, and no request for any such waiver or extension is
currently pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(e) There are no Tax rulings of
which Company is a subject, requests for rulings by Company, or closing agreements entered into by Company that could affect its liability
for Taxes for any period after the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(f) No action, suit, proceeding,
investigation, audit, claim or assessment is presently pending or, to the knowledge of Company, proposed with regard to any Taxes that
relate to Company for which Company would or could be liable. There are no requests from any taxing authority for information or with
respect to Taxes of Company. Company has no knowledge of any fact or condition that, if known to any taxing authority having jurisdiction,
would likely result in the issuance of a notice of proposed deficiency or similar notice of intention to assess Taxes against Company,
and no issue has arisen in any examination of Company by any taxing authority that if raised and upheld with respect to any other period
not so examined would result in a material deficiency for any other period not so examined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(g) Company (i) has not agreed
to nor is required to make any adjustment pursuant to Section 481 of the Code (or any predecessor or similar provision of other laws or
regulations) by reason of a change in accounting method or otherwise; (ii) has no knowledge that any taxing authority has proposed any
such adjustment or change, which proposal is currently pending; and (iii) does not have an application pending with any taxing authority
requesting permission for any change in accounting methods that relates to the Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(h) Neither Company nor any of
its members is a &ldquo;foreign person&rdquo; within the meaning of Code Section 1445(f)(3) and Treasury Regulation Section 1.1445-2(b)(2)(i)
(or any corresponding provision of state, local, or foreign Tax law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(i) Company (i) is not a party
to, is not bound by, nor has any obligation under, any Tax sharing agreement or similar contract; (ii) has no current or potential contractual
obligation to indemnify any other Person with respect to Taxes; and (iii) has no obligation to make distributions in respect of Taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(j) <i><u>Schedule 3.16(j)</u></i>
contains a list of states, territories and jurisdictions (whether foreign or domestic) in which Company is required to file Tax Returns.
No claim has ever been made in writing against Company by a taxing authority in a jurisdiction where Company does not file Tax Returns
that Company is or may be subject to taxation by such jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(k) No Taxes are delinquent or
constitute a lien against Company, except for the current year&rsquo;s ad valorem Taxes not yet due and payable, and except with respect
to Taxes being contested in good faith by appropriate proceedings (all of which are disclosed in <i><u>Schedule 3.16(k)</u></i>) and for
payment of which Taxes adequate reserves have been established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(l) Company has not disposed of
any property in a transaction being accounted for under the installment method pursuant to Section 453 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(m) No power of attorney has been
granted by Company with respect to any matter relating to Taxes of Company, which power of attorney is currently in force. Any such power
of attorney will be revoked prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(n) Company has not filed any
consent under Section 341(f) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(o) Any adjustment of Taxes of
Company made by the Internal Revenue Service, which adjustment is required to be reported to the appropriate state, local, or foreign
taxing authorities, has been so reported.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(p) All Tax Returns with respect
to Taxes of Company filed or given after the date hereof shall be prepared, and all elections with respect to such Tax Returns shall be
made, to the extent permitted by law, in a manner consistent with prior practice of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(q) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(r) Company has not taken any
reporting position on a Tax Return, which reporting position (i) if not sustained would be reasonably likely, absent disclosure, to give
rise to a penalty for substantial understatement of federal income Tax under and within the meaning of Section 6662 of the Code (or any
predecessor statute or any corresponding provision of any such predecessor statute, or state, local, or foreign Tax law), and (ii) has
not adequately been disclosed on such Tax Return in accordance with Section 6662(d)(2)(B) of the Code (or corresponding provision of any
such predecessor statute, or state, local, or foreign Tax law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(s) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(t) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(u) No property of Company is
required to be treated as owned by another Person pursuant to Section 168(f)(8) of the Code (as in effect prior to its amendment by the
Tax Reform Act of 1986) or is &ldquo;tax-exempt use property&rdquo; within the meaning of Section 168 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(v) Company is not a party to
any lease arrangement involving a defeasance of rent, interest, or principal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(w) Company is a not a direct
or indirect beneficiary of a guarantee of Tax benefits or any other arrangement that has the same economic effect (including an indemnity
from a seller or lessee of property, or other insurance) with respect to any transaction or tax opinion relating to Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(x) Company does not own any &ldquo;corporate
acquisition indebtedness&rdquo; within the meaning of Section 279 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(y) Company has never been (i)
a &ldquo;passive foreign investment company,&rdquo; (ii) a &ldquo;foreign personal holding company,&rdquo; (iii) a &ldquo;foreign sales
corporation,&rdquo; (iv) a &ldquo;foreign investment company,&rdquo; or (v) a Person other than a United States Person, each within the
meaning of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(z) There are no Encumbrances
for Taxes (other than for current Taxes not yet due and payable or for any state or local Taxes that may result from an election under
Section 338(h)(10) of the Code) upon Company&rsquo;s assets or real property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(aa) The Company has made a valid
election to be taxed as a C corporation within the meaning of Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.17. <u>Environmental Matters</u>.
Company (i) has obtained all applicable permits, licenses and other authorizations (collectively, the &ldquo;<b>Environmental Permits</b>&rdquo;),
which are required to be obtained under all applicable Laws, Orders, notice or demand letter issued, entered, promulgated or approved
thereunder relating to pollution or protection of the environment, including laws relating to emissions, discharges, releases or threatened
releases of pollutants, contaminants, or hazardous or toxic materials or wastes into ambient air, surface water, ground water, or land
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling of pollutants,
contaminants or hazardous or toxic materials or wastes (&ldquo;<b>Environmental Laws</b>&rdquo;) by Company (or its respective agents),
which Environmental Permits are in full force and effect, (ii) to the knowledge of Company, is in compliance with all terms and conditions
of such Environmental Permits, (iii) is in material compliance with all limitations, restrictions, conditions, standards, prohibitions,
requirements, obligations, schedules and timetables contained in applicable Environmental Laws, (iv) as of the date of this Agreement,
is not aware of nor has received notice of any past or present violations of Environmental Laws or Environmental Permits or any event,
condition, circumstance, activity, practice, incident, action or plan which is reasonably likely to interfere with or prevent continued
compliance with Environmental Permits or which would give rise to any common law or statutory liability, or otherwise form the basis of
any claim, action, suit or proceeding, against Company based on or resulting from the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling, or the emission, discharge or release into the environment, of any pollutant, contaminant or
hazardous toxic material or waste, and (v) has taken all actions necessary under applicable Environmental Laws to register any products
or materials required to be registered by Company (or any of its respective agents) thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.18. <u>Intellectual Property</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) <i><u>Schedule 3.18(a)</u></i>
sets forth a true and complete list of all Intellectual Property owned or used by Company. Company owns free and clear of all Encumbrances,
or is licensed or otherwise possesses legally enforceable right to use all patents, trademarks, trade names, service marks, domain names
and any applications therefor, and computer software programs or applications (the &ldquo;<b>Intellectual Property</b>&rdquo;) that are
used in the Business as currently conducted, and such rights constitute all the rights necessary for Company to conduct the Business as
currently conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) Except as would not, individually
or in the aggregate, have a Material Adverse Effect, Company is not, nor will it be, as a result of the execution and delivery of this
Agreement or the performance of its obligations hereunder, in violation of any licenses, sublicenses and other agreements as to which
Company is a party and pursuant to which Company is authorized to use any third party Intellectual Property (&ldquo;<b>Third Party Intellectual
Property Rights</b>&rdquo;). Except as set forth in <i><u>Schedule 3.18(b)</u></i>, immediately after the Closing Date, Company will continue
to own all right, title and interest in, and to have a license to use all Intellectual Property material to its business and operations
on terms and conditions identical in all respects to those enjoyed by Company immediately prior to such transactions. Except as set forth
in <i><u>Schedule 3.18(b)</u></i>, no claims with respect to the Intellectual Property owned by Company (the &ldquo;<b>Company Intellectual
Property Rights</b>&rdquo;), any trade secret material to Company, or Third Party Intellectual Property Rights to the extent arising out
of any use, sale of, reproduction or distribution of such Third Party Intellectual Property Rights by or through Company, are currently
pending or, to the knowledge of Company, are threatened by any Person. Except as set forth in <i><u>Schedule 3.18(b)</u></i>, Company
does not know of any valid grounds for any bona fide claims (i) to the effect that the manufacture, sale, licensing or use of any Intellectual
Property as now used, sold or licensed by Company, infringes on the Intellectual Property Rights of any third party; (ii) against the
use by Company of any Intellectual Property used in the Business as currently conducted; (iii) challenging the ownership, validity or
effectiveness of any of Company Intellectual Property Rights or other trade secret material to Company; or (iv) challenging the license
or legally enforceable right to use of the Third Party Intellectual Property Rights by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) Company has made available
to Buyer copies of all agreements executed by Company employees with regard to (i) assignment of right, title and interest in such employee&rsquo;s
work product to Company, including any underlying Intellectual Property Rights, (ii) cooperation whether during or after employment with
Company in perfecting Company&rsquo;s rights in such assigned Intellectual Property Rights, including the execution of any applications,
assignment forms and the like, and (iii) prohibition on disclosure of Company proprietary information, including, without limitation,
Company know-how, business plans, techniques, methods, customer lists and supplier lists (collectively, &ldquo;<b>Trade Secrets</b>&rdquo;)
during their employment and thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) <i><u>Schedule 3.18(d)</u></i>
sets forth the names of all Company contractors that invented Company proprietary technology or software or that invented technology or
software specifically for Company. Company has made available to Buyer copies of all agreements executed by Company contractors with regard
to (i) assignment of right, title and interest in such contractor&rsquo;s work product to Company, including any underlying Intellectual
Property Rights, and (ii) prohibition on disclosure of any Company proprietary information, including, without limitation, Company Trade
Secrets during their engagement and thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.19. <u>Interested Party Transactions</u>.
Except as set forth in <i><u>Schedule 3.19</u></i>, there has been no transaction between Company, on the one hand, and any Affiliate
of Company, any officer, manager or employee of Company, or any spouse, parent, child, grandchild or sibling of any officer, manager or
employee of Company, on the other hand, other than transactions related to employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.20. <u>Insurance</u>. All material
fire and casualty, general liability, business interruption, product liability, professional liability and sprinkler and water damage
insurance policies maintained by Company are of kind, in the amounts and against the risks customarily maintained by organizations similarly
situated. <i><u>Schedule 3.20</u></i> lists all of the material insurance policies held by or on behalf of Company with the effective
date and coverage amounts indicated thereon. Such policies and binders are valid and enforceable in accordance with their terms and are
in full force and effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.21. <u>Brokers</u>. Except as
disclosed in <i><u>Schedule 3.21</u></i>, no broker, finder or investment banker is entitled to any brokerage, finder&rsquo;s or other
fee or commission from Company in connection with the transactions contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.22. <u>Bank Accounts</u>. <i><u>Schedule
3.22</u></i> provides, as of the date of this Agreement, accurate information with respect to each account maintained by or for the benefit
of Company at any bank or other financial institution including the name of the bank or financial institution, the account number and
the names of all individuals authorized to draw on or make withdrawals from such accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.23. <u>Certain Payments</u>. Neither
Company nor to its knowledge any manager, officer, agent or employee of Company, nor any other Person acting for or on behalf of Company,
has directly or indirectly, on behalf of Company made any contribution, gift, bribe, rebate, payoff, influence payment, kickback or other
payment to any entity or Person, private or public, regardless of form, whether in money, property or services in material violation of
any federal, state, local or foreign statute, law, ordinance, rule or regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.24. <u>[Intentionally omitted.]</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.25. <u>Complete Copies of Materials</u>.
Each document that Company has delivered to Buyer (or made available in a data room for review by Buyer), other than documents that have
been redacted, is a true and complete copy of each such document, and in each case where a representation and warranty of Company in this
Agreement requires the listing of documents and agreements, a true and complete copy of all such documents and agreements have been delivered
to Buyer (or made available in a data room for review by Buyer).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.26. <u>Investment Company Act</u>.
Company either (i) is not an &ldquo;investment company,&rdquo; or a company &ldquo;controlled&rdquo; by, or an &ldquo;affiliated company&rdquo;
with respect to, an &ldquo;investment company,&rdquo; within the meanings of the Investment Company Act of 1940, as amended (the &ldquo;<b>Investment
Company Act</b>&rdquo;), or (ii) satisfies all conditions for an exemption from the Investment Company Act, and, accordingly, Company
is not required to be registered under the Investment Company Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.27. <u>Computer Back-Up</u>. Except
as set forth in <i><u>Schedule 3.27</u></i>, Company has made back-ups of all material computer software programs, source code, object
code, data, documentation and databases owned or licensed by it and maintains such computer software programs, source code, object code,
data, documentation and databases at an off-site location.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.28. <u>Trade Relations</u>. There
exists no actual or, to the knowledge of Company, threatened termination, cancellation or limitation of, or any other adverse modification
or change in, the business relationship of Company, or the Business, with any customer or supplier or any group of customers or suppliers
(including, without limitation, Company&rsquo;s affiliate contractors), that could reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.29. <u>Outstanding Borrowing</u>.
<i><u>Schedule 3.29</u></i> sets forth the amount of all Indebtedness of Company as of the date hereof (which amount, for all Indebtedness
other than capital lease obligations, shall not exceed $5,000 as of the Closing Date), the Encumbrances that relate to such Indebtedness
and that encumber the assets and the name of each lender thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.30. <u>Change of Control Provisions</u>.
Company is not party to any agreement that contains a change of control provision that would be triggered by the transactions contemplated
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.31. <u>Potential Conflicts of
Interest</u>. Except as set forth in <i><u>Schedule 3.31</u></i>, to the knowledge of Seller, no officer, manager or member of Company,
no spouse of any such officer, manager or member, no relative of such spouse or of any such officer, manager or member and no Affiliate
of any of the foregoing: (a) owns, directly or indirectly, any interest in (excepting less than one percent (1%) stock holdings for investment
purposes in securities of publicly held and traded companies), or is an officer, manager, employee or consultant of, any Person which
is, or is engaged in business as, a competitor, lessor, lessee, supplier, distributor, sales agent or customer of, or lender to or borrower
from, Company; (b) owns, directly or indirectly, in whole or in part, any tangible or intangible property that Company has used in the
conduct of the Business; or (c) has any cause of action or other claim whatsoever against, or owes or has advanced any amount to, Company,
except for claims in the ordinary course of business such as for accrued vacation pay, accrued benefits under employee benefit plans,
and similar matters and agreements existing on the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.32. <u>Product and Service Warranties</u>.
Each product or service sold, licensed, distributed, delivered or offered by the Company is in conformity with all applicable contractual
commitments and all express warranties in all material respects, and Company has no liability (and, to the Knowledge of Company, there
is no basis for any present or future Claim against the Company giving rise to any liability) for violations thereof or other damages
in connection therewith, subject only to the reserve set forth in the Financial Statements. No product sold, licensed, distributed or
delivered by the Company is subject to any guaranty, warranty or other indemnity beyond the applicable standard terms and conditions of
sale or lease, except for such guarantees, warranties and indemnities that are implied under applicable law and not disclaimable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.33. <u>Customers and Suppliers</u>.
<i><u>[Intentionally omitted.]</u></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">3.34. <u>Disclosure</u>. This
<u>Section 3</u>, as supplemented by the Company Disclosure Schedule, does not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements contained herein or therein, in the light of the circumstances under
which they were made, not misleading.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">4. <b>Representations and Warranties
of Seller</b>. As a material inducement to Buyer to enter into this Agreement, Seller makes the representations and warranties set forth
below to Buyer, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">4.1. <u>Authority</u>. Seller has
all requisite power and authority to enter into the Transaction Documents to which it is a party and to consummate the transactions contemplated
hereby and thereby, as applicable. Seller has duly approved the Transaction Documents, as applicable. This Agreement has been duly executed
and delivered, and the other Transaction Documents to which such Seller is a party, when delivered, will have been duly executed and delivered
by such Seller, as applicable, and constitute the valid and binding obligation of such Seller, as applicable, enforceable in accordance
with its terms except as such enforceability may be limited by principles of public policy and subject to the laws of general application
relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other
equitable remedies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">4.2. <u>Title to Membership Interests</u>.
Seller has good and marketable title to the Membership Interests free and clear of any Encumbrances. Seller has the full right, power
and authority to transfer, convey and sell the Membership Interests to Buyer, and Buyer will acquire from Seller good and marketable title
to the Membership Interests free and clear of all Encumbrances. Seller is not a party to, subject to or bound by any Order which would
prevent the transfer, conveyance and sale of the Membership Interests to Buyer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">4.3. <u>[Intentionally omitted.]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">5. <b>Representations and Warranties
of Buyer</b>. As a material inducement to Seller to enter into this Agreement, Buyer makes the following representations and warranties
to Seller, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">5.1. <u>Organization and Qualification;
subsidiaries</u>. Buyer is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization, and Buyer has the requisite corporate power and authority and is in possession of all Approvals necessary to own, lease
and operate the properties it purports to own, operate or lease and to carry on its business as it is now being conducted, except where
the failure to be so organized, existing and in good standing or to have such power, authority and Approvals would not, individually or
in the aggregate, have a Material Adverse Effect. Buyer is duly qualified or licensed as a foreign entity to do business, and is in good
standing, in each jurisdiction where the character of its properties owned, leased or operated by it or the nature of its activities makes
such qualification or licensing necessary, except for such failures to be so duly qualified or licensed and in good standing that would
not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">5.2. <u>Authority Relative to this
Agreement</u>. Buyer has all necessary corporate power and authority to execute and deliver the Transaction Documents and to perform its
obligations thereunder and to consummate the transactions contemplated thereby. The execution and delivery of the Transaction Documents
by Buyer and the consummation by Buyer of the transactions contemplated thereby have been duly and validly authorized by all necessary
corporate action on the part of Buyer, and no other corporate proceedings on the part of Buyer or the stockholders of Buyer are necessary
to authorize the Transaction Documents or to consummate the transactions contemplated thereby. The Transaction Documents have been duly
and validly executed and delivered by Buyer and, assuming the due authorization, execution and delivery by Company, constitute a legal,
valid and binding obligation of Buyer enforceable against it in accordance with their terms, except as enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement
of creditors&rsquo; rights generally and by general principles of equity relating to enforceability (regardless of whether considered
in a proceeding of law or in equity).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">5.3. <u>No Conflict, Required Filings
and Consents</u>. The execution and delivery of this Agreement by Buyer does not, and the performance of this Agreement by Buyer will
not, (i) conflict with or violate the Articles of Incorporation (or equivalent organizational documents) or bylaws of Buyer, (ii) conflict
with or violate any law, rule, regulation, order, judgment or decree applicable to Buyer or any of its subsidiaries or by which its or
their respective properties are bound or affected, or (iii) result in any breach of or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or modification in a manner materially adverse to Buyer or its subsidiaries of
any right or benefit under, or impair Buyer&rsquo;s or any of its subsidiaries&rsquo; rights or alter the rights or obligations of any
third party under, or give to others any rights of termination, amendment, acceleration, repayment or repurchase, increased payments or
cancellation under, or result in the creation of a Encumbrance on any of the properties or assets of Buyer or any of its subsidiaries
pursuant to, any Contract, Law or Order to which Buyer or any of its subsidiaries or its or any of their respective properties are bound
or affected, except in the case of (ii) or (iii) only, for any such conflicts, violations, breaches, defaults or other occurrences that
would not, individually or in the aggregate, have a Material Adverse Effect. The execution and delivery of this Agreement by Buyer does
not, and the performance of this Agreement by Buyer will not require any consent, approval, exemption, authorization or permit of, or
filing with or notification to, any Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">5.4. <u>Brokers</u>. No broker,
finder or investment banker is entitled to any brokerage, finder&rsquo;s or other fee or commission in connection with the transactions
contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">5.5. <u>Disclosure</u>. This <u>Section
5</u> does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
contained herein or therein, in the light of the circumstances under which they were made, not misleading</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">6. <b>Additional Agreements</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.1. Buyer agrees that until such
time as Buyer has fully discharged that certain promissory of even date herewith made by Buyer in favor of Seller in the amount of $5,000,000
and given in connection herewith, Buyer shall not dispose of any assets acquired under this agreement and not in the ordinary course of
business without Seller approval, including without limitation any equity granted to Buyer in connection with Lafayette Energy Corp, a
Delaware corporation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.2. <u>[Intentionally omitted.]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.3. [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.4. <u>[</u>Intentionally omitted<u>]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.5. <u>Cooperation</u>. Subject
to the terms and conditions of this Agreement, each of the Parties hereto shall use his, her or its best efforts to take, or cause to
be taken, all actions to do, or cause to be done, all things necessary, proper or advisable under applicable laws and regulations to consummate
and make effective the transactions contemplated by this Agreement, including providing information and using reasonable efforts necessary
or appropriate to obtain waivers, consents and approvals to this Agreement and the transactions contemplated hereby, including specifically
obtaining any consent to transfer the Membership Interests to Buyer, to effect all necessary registrations and filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.6. <u>Public Announcements</u>.
Buyer and Seller, acting on behalf of Seller and Company, shall consult with each other before issuing any press release with respect
to this Agreement, the Transaction Documents and the transactions contemplated hereby and shall not issue any such press release or make
any such public statement, except as required by Law or any listing agreement with any applicable national securities exchange, without
the prior consent of the other Party, which shall not be unreasonably withheld, delayed or conditioned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">6.7. <u>Tax Cooperation</u>. After
the Closing, Seller shall, and shall cause Seller and their Affiliates to, cooperate fully with Buyer and Company in the preparation of
all tax returns and shall provide, or cause to be provided at Buyer&rsquo;s sole cost and expense, to Buyer and Company any records and
other information requested by such Parties in connection therewith. Seller shall, and shall Seller and their Affiliates to, cooperate
fully with Buyer and Company in connection with any tax investigation, audit or other proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">7. <b>Deliveries at Closing</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">7.1. <u>Seller Closing Deliveries</u>.
At the Closing, Seller and/or Company shall deliver or cause to be delivered to Buyer:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) an Agreement of Membership
Interest in favor of Buyer or its nominee as Buyer may have directed prior to the Closing Date and otherwise in a form acceptable for
transfer on the books of Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.] ;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(e) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(f) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(g) the consents and approvals
as set forth on <i><u>Schedule 3.5(a)</u></i>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(h) written resignations by each
of the officers and Managers of Company in office immediately prior to the Closing Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(i) a certificate, dated as of
the Closing Date, of the Secretary or an Assistant Secretary of Company evidencing all necessary or appropriate corporate action to enable
such Company to comply with the terms of this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(j) a certificate of good standing
for Company issued by the Florida Secretary of State within a reasonable date of the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(k) good standing and tax good
standing bring-down certificates for Company issued as of the date of the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(l) such documents as Buyer or
its counsel may reasonably require.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">7.2. <u>Buyer&rsquo;s Closing Deliveries</u>.
At the Closing, Buyer shall deliver or cause to be delivered to Seller:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) the Closing Payment;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(e) such other documents as Seller
or his, her or its counsel may reasonably require.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">8. <b>Conditions to Obligations
of Buyer</b>. The obligation of Buyer to consummate the transactions contemplated by this Agreement and the Transaction Documents is subject
to the following conditions, any of which may be waived by it in writing in its sole discretion:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.1. <u>[Intentionally omitted.]</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.2. <u>Compliance by Seller and
Company</u>. Seller and Company shall have performed and complied in all material respects with all agreements and conditions required
by this Agreement to be performed or complied with by Seller and Company, as applicable prior to or on the Closing Date, including, but
not limited to the delivery by Seller and Company of the items set forth in <u>Section 7.1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.3. <u>Accuracy of the Representations</u>.
The representations and warranties of Seller and Company contained in this Agreement or any schedule, certificate or other instrument
delivered pursuant to the provisions hereof or in connection with the transactions contemplated hereby shall be true and correct in all
respects at and as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.4. <u>Consents</u>. Seller and/or
Company shall have obtained each of the consents and approvals set forth on <i><u>Schedule 3.5(a)</u></i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.5. <u>[</u> Intentionally omitted<u>]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.6. <u>No Regulatory Changes</u>.
No action shall have been taken by any Governmental Entity, and no law shall have been proposed or enacted, which would (or, in the case
of a proposed law, if enacted) materially and adversely affect the financial condition, operations or prospects of Company or the regulatory
compliance status of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.7. <u>Documents</u>. All documents
and instruments required hereunder to be delivered by Company and Seller to Buyer at the Closing shall be delivered in form and substance
reasonably satisfactory to Buyer and its counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">8.8. <u>Litigation</u>. No litigation
seeking to enjoin the transactions contemplated by this Agreement or to obtain damages on account hereof shall be pending or threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">9. <b>Conditions to Obligations
of Seller</b>. The obligation of Seller to consummate the transaction contemplated by this Agreement is subject to the following conditions,
any of which may be waived by him, her or it in his, her or its sole discretion:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">9.1. <u>Compliance by Buyer</u>.
Buyer shall have performed and complied in all material respects with all agreements and conditions required by this Agreement to be performed
or complied with by Buyer prior to or on the Closing Date, including, but not limited to the delivery by Buyer of the items set forth
in <u>Section 7.2</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">9.2. <u>Accuracy of Buyer&rsquo;s
Representations</u>. Buyer&rsquo;s representations and warranties contained in this Agreement or any schedule, certificate or other instrument
delivered pursuant to the provisions hereof or in connection with the transactions contemplated hereby shall be true and correct in all
material respects at and as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">9.3. <u>Documents</u>. All documents
and instruments required hereunder to be delivered by Buyer to Seller at the Closing shall be delivered in form and substance reasonably
satisfactory to Seller and his, her or its counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">9.4. <u>Litigation</u>. No litigation
seeking to enjoin the transactions contemplated by this Agreement or to obtain damages on account hereof shall be pending or threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">10. <b>[</b> Intentionally omitted<b>]</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">11. <b>Indemnification</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">11.1. <u>Indemnification</u>. Except
as otherwise provided in this <u>Section 11</u>, Seller (the &ldquo;<b>Indemnifying Party</b>&rdquo;) agrees to indemnify, defend and
hold harmless each of Buyer, Company and their Affiliates and their respective officers, directors, managers, agents, employees, subsidiaries,
partners, members and controlling Persons (each, an &ldquo;<b>Indemnified Party</b>&rdquo;) to the fullest extent permitted by law from
and against any and all losses, actions, suits, proceedings, claims, complaints, disputes, arbitrations or investigations or written threats
thereof (collectively, &ldquo;<b>Claims</b>&rdquo;) (including, without limitation, any Claim by a third party), damages, expenses (including
reasonable fees, disbursements and other charges of counsel incurred by the Indemnified Party in any action between Seller and an Indemnified
Party or between an Indemnified Party and any third party or otherwise) or other liabilities resulting from or arising out of any breach
of any representation or warranty, covenant or agreement by Seller in this Agreement, or relating to any Excluded Liabilities (collectively,
&ldquo;<b>Losses</b>&rdquo;). In connection with the obligation of Seller to indemnify for Losses as set forth above, Seller shall, upon
presentation of appropriate invoices containing reasonable detail, reimburse each Indemnified Party for all such Losses (including reasonable
fees, disbursements and other charges of counsel incurred by the Indemnified Party in any action between Seller and the Indemnified Party
or between the Indemnified Party and any third party) as they are incurred by such Indemnified Party. The Parties agree to treat indemnification
payments under this <u>Section 11.1</u> as adjustments to the Purchase Price for Tax purposes. If Seller contest a Claim by the Buyer
against them, they will not be responsible for paying the submitted invoice until either they agree as to the validity and amount of the
Claim or the validity and amount of the Claim have been adjudicated by an arbitration as provided in <u>Section 13.6</u> or by a court
of competent jurisdiction after exhaustion of all appeals. Buyer likewise agrees to indemnify, defend and hold harmless each of Seller
and its Affiliates and their respective officers, directors, managers, agents, employees, subsidiaries, partners, members and controlling
Persons (each, a &ldquo;<b>Seller Indemnified Party</b>&rdquo;) to the fullest extent permitted by law from and against any and all Claims
(including, without limitation, any Claim by a third party), damages, expenses (including reasonable fees, disbursements and other charges
of counsel incurred by the Seller Indemnified Party in any action between Buyer and a Seller Indemnified Party or between a Seller Indemnified
Party and any third party or otherwise) or other liabilities resulting from or arising out of any breach of any representation or warranty,
covenant or agreement by Buyer in this Agreement, or relating to operation of the Business after the Closing Date. An Indemnified Party
or Seller Indemnified Party may each be referred to herein as an Indemnified Party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">11.2. <u>Procedure for Third Party
Claim Indemnification</u>. Each Indemnified Party under this <u>Section 11</u> shall, promptly after the receipt of notice of the commencement
of any Claim by a third party against such Indemnified Party in respect of which indemnity may be sought from Seller under this <u>Section
11.2</u>, notify Seller in writing of the commencement thereof. The omission of any Indemnified Party to so notify Seller of any such
action shall not relieve any Indemnifying Party from any liability which it may have to such Indemnified Party under this <u>Section 11</u>
unless, and only to the extent that, such omission results in the Indemnifying Party&rsquo;s loss of substantive or practical rights or
defenses. In case any such Claim shall be brought against any Indemnified Party, and it shall notify the Indemnifying Party of the commencement
thereof, the Indemnifying Party shall be entitled to assume the defense thereof at its own expense, with counsel satisfactory to such
Indemnified Party in its reasonable judgment; provided, however, that any Indemnified Party may, at its own expense, retain separate counsel
to participate in such defense at its own expense. Notwithstanding the foregoing, in any Claim in which both the Indemnifying Party, on
the one hand, and an Indemnified Party, on the other hand, are, or are reasonably likely to become, a party, such Indemnified Party shall
have the right to employ separate counsel and to control its own defense of such Claim if, in the reasonable opinion of counsel to such
Indemnified Party, either (x) one or more defenses are available to the Indemnified Party that are not available to the Indemnifying Party
or (y) a conflict or potential conflict exists between the Indemnifying Party, on the one hand, and such Indemnified Party, on the other
hand, that would make such separate representation advisable; provided, however, that the Indemnifying Party (i) shall not be liable for
the fees and expenses of more than one counsel to all Indemnified Parties and (ii) shall reimburse the Indemnified Parties for all of
such fees and expenses of such counsel incurred in any action between the Indemnifying Party and the Indemnified Parties or between the
Indemnified Parties and any third party, as such expenses are incurred. The Indemnifying Party agrees that it will not, without the prior
written consent of the Indemnified Party, settle, compromise or consent to the entry of any judgment in any pending or threatened Claim
relating to the matters contemplated hereby unless such settlement, compromise or consent includes an unconditional release of each Indemnified
Party from all liability arising or that may arise out of such Claim. Upon making any payment to an Indemnified Party for a loss under
this <u>Section 11</u>, the Indemnifying Party shall be subrogated to any rights that the Indemnified Party may have against any other
Person with respect to the subject matter underlying such indemnification claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">11.3. <u>Limitations on Indemnification</u>.
Notwithstanding any other provision of this <u>Section 11</u> no Claims shall be brought for indemnification after the survival period
set forth in <u>Section 10</u> hereof, and the Indemnifying Parties shall not be obligated, individually or collectively, to make any
payment or payments pursuant to this <u>Section 11</u> in an aggregate amount in excess cash the Purchase Price (the &ldquo;<b>Cap</b>&rdquo;).
No claim shall be filed against Seller until the aggregate potential liability exceeds $25,000 at which time the Seller will be responsible
for the $25,000 plus the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">11.4. <u>Exclusive Remedy</u>. Indemnification
pursuant to this <u>Section 11</u> shall be the sole means for redress of Claims under this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">12. <b>Termination</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">12.1. <u>Termination of Agreement</u>.
Certain of the Parties may terminate this Agreement as provided below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(a) Buyer and Seller may terminate
this Agreement by mutual written consent at any time prior to the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(c) Buyer may terminate this Agreement
by giving written notice to Seller at any time prior to the Closing in the event Company or Seller have breached any representation, warranty,
or covenant contained in this Agreement in any material respect; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">(d) Seller may terminate this
Agreement by giving written notice to Buyer at any time prior to the Closing in the event Buyer has breached any representation, warranty,
or covenant contained in this Agreement in any material respect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">12.2. <u>Effect of Termination</u>.
If any Party terminates this Agreement pursuant to <u>Section 11.5</u>, all rights and obligations of the Parties hereunder shall terminate
without any liability of any Party to any other Party (except for any liability of any Party then in breach).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">13. <b>Miscellaneous</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.1. <u>Expenses</u>. Except as
otherwise provided herein, Seller (and not Company on behalf of Seller or on behalf of itself) and Buyer shall each pay its own expenses
incident to the negotiation, preparation, and carrying out of this Agreement, including all fees and expenses of its counsel and accountants
for all activities of such counsel and accountants undertaken pursuant to this Agreement, irrespective of whether or not the transactions
contemplated hereby are consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.2. <u>Notices</u>. All notices
and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made if and
when delivered personally or by overnight courier to the Parties at the following addresses or sent by electronic transmission, with confirmation
received, to the email address specified below (or at such other address or email address for a Party as shall be specified by like notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">To Seller:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">Scienture Holdings, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">ATTN: CEO</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">20 Austin Blvd, Commack,
NY 11725</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: justify">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">To Buyer:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">TOLLO HEALTH, LLC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 1.5in; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">ATTN: Gerald Commissiong</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">6308 Benjamin Rd Suite 708, Tampa
FL 33634</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">Any such notice shall, when sent in accordance with
the preceding sentence, be deemed to have been given and received on the earliest of (i) the day delivered to such address, (ii) the day
sent by email, (iii) the fifth Business Day following the date deposited with the United States Postal Service, or (iv) 24 hours after
shipment by such courier service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.3. <u>Assignment; Third Party
Beneficiaries</u>. Neither this Agreement nor any rights or obligations under it are assignable except that Buyer may assign its rights
hereunder. There shall be no third-party beneficiaries of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">13.4.
<u>GOVERNING LAW</u>. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF FLORIDA
APPLICABLE TO CONTRACTS EXECUTED AND FULLY PERFORMED WITHIN THE STATE OF FLORIDA.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">13.5.
</font><u>Jurisdiction, Venue and Waiver of Jury Trial</u>. The Parties intend that all disputes concerning this Agreement shall be resolved
by arbitration as provided below. However, to the extent arbitration shall be held by a court of competent jurisdiction to be unenforceable
or shall otherwise be impossible, and any party submits any matter to a court, the Parties agrees as follows: any suit, action or proceeding
with respect to this Agreement shall be brought exclusively in the Florida state courts of competent jurisdiction or in the United States
District Court in each case located in Tampa, Florida. <font style="text-transform: uppercase">ALL PARTIES HEREBY IRREVOCABLY WAIVE ANY
OBJECTIONS WHICH THEY MAY NOW OR HEREAFTER HAVE TO THE PERSONAL JURISDICTION OR VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF
OR RELATING TO THIS AGREEMENT BROUGHT IN ANY SUCH COURT AND HEREBY FURTHER IRREVOCABLY WAIVE ANY CLAIM THAT SUCH SUIT, ACTION OR PROCEEDING
BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. The PARTIES HEREBY FURTHER IRREVOCABLY WAIVE ANY RIGHT TO A JURY
TRIAL IN ANY ACTION ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.6. <u>Dispute Resolution</u>.
Except as otherwise provided herein, in the event of any dispute, controversy or claim arising out of or relating to this Agreement or
the breach thereof, the parties shall meet promptly (through representatives with authority to resolve the dispute). If the parties cannot
resolve the dispute within thirty (30) days, the parties shall arbitrate the dispute in accordance with the Commercial Arbitration Rules
the American Arbitration Association, pursuant to the Commercial Arbitration Rules then in effect. The arbitrator selected shall be an
independent third party and shall have knowledge and experience in the matters addressed by the claim. Demand for arbitration must be
made no later than the time that such action would be permitted under the applicable Florida statute of limitation. Except as set forth
in <u>Section 13.5</u> and this <u>Section 13.6</u>, arbitration shall be the sole and exclusive remedy between the parties with respect
to any dispute, protest, controversy or claim arising out of or relating to this Agreement, provided, the arbitrators shall not have the
power or authority to award consequential, incidental or punitive damages. Unless all the parties to an arbitration otherwise consent
in writing, the location of the arbitration hearings and the place of entry of the award shall be in Tampa, Florida. The Parties consent
to exclusive jurisdiction of, and agree that sole venue will lie in, the state and federal courts applicable to Tampa, Florida, for any
allowable judicial proceeding relating to any arbitration under this Agreement, including entry of a judgment on the award. The arbitration
award shall be final and binding and shall not be reviewable in any court on any grounds except corruption, fraud or undue means of a
party or for evident partiality or corruption of the arbitrator. The parties intend to eliminate all other court review of the award and
the arbitration proceedings. Except as necessary in a judicial proceeding allowable under this <u>Section 13.6</u>, all matters relating
to any arbitration shall be confidential. The matters include the existence and subject of the arbitration. The parties hereby acknowledge
that any breach of the provisions of <u>Section 6.3</u> and <u>6.6</u> may give rise to irreparable injury to Buyer or Company (as the
case may be), inadequately compensable in monetary damages. Notwithstanding anything to the contrary stated herein, the non-breaching
party will be able to seek and obtain equitable relief, including injunctive relief, against the breach or threatened breach of any of
such provisions and the prevailing party shall be entitled to recover from the other party its reasonable attorneys&rsquo; fees and costs
incurred. This <u>Section 13.6</u> shall survive the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.7. <u>Counterparts</u>. This
Agreement may be executed in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed
shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. It is the express intent
of the Parties to be bound by the exchange of signatures on this Agreement via facsimile or email with scan attachment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.8. <u>No Implied Waiver; Remedies</u>.
No failure or delay on the part of the Parties to exercise any right, power, or privilege hereunder or under any instrument executed pursuant
hereto shall operate as a waiver nor shall any single or partial exercise of any right, power, or privilege preclude any other or further
exercise thereof or the exercise of any other right, power, or privilege. All rights, powers, and privileges granted herein shall be in
addition to other rights and remedies to which the Parties may be entitled at law or in equity, except as provided otherwise herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.9. <u>Entire Agreement</u>. This
Agreement, including the Exhibits and Schedules attached hereto and the other Transaction Documents, set forth the entire understandings
of the Parties with respect to the subject matter hereof, and it incorporates and merges any and all previous communications, understandings,
oral or written as to the subject matter hereof and thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.10. <u>Amendments; Actual Waivers</u>.
This Agreement may not be amended except by an instrument in writing signed on behalf of Buyer and Seller. Any agreement on the part of
Buyer or Seller to any such extension or waiver shall be valid if set forth in an instrument in writing signed on behalf of Buyer or Seller,
as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.11. <u>Headings</u>. The headings
of the Sections of this Agreement, where employed, are for convenience only and do not form a part hereof and in no way modify, interpret
or construe the meanings of the Parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.12. <u>Severability</u>. Any
provision of this Agreement which is invalid or unenforceable shall be ineffective only to the extent of such invalidity or unenforceability
without invalidating or rendering unenforceable the remaining provisions of this Agreement. Provided, however, in the event the provision
which is invalid or unenforceable pertains to a material element of the transaction such that the principal objectives of the transaction
provided for herein are materially impaired or are invalid or unenforceable, this Agreement shall be terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.13. <u>Specific Performance</u>.
Seller, Buyer and Company each acknowledge that, in view of the uniqueness of the Business and the transactions contemplated by this Agreement,
each Party would not have an adequate remedy at law for money damages in the event that this Agreement has not been performed in accordance
with its terms, and therefore agrees that the other party shall be entitled to specific enforcement of the terms hereof in addition to
any other remedy to which it may be entitled, at law or in equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.14. <u>No Presumption Regarding
Drafter</u>. The Parties acknowledge and agree that the terms and provisions of this Agreement have been negotiated and discussed between
them, and that this Agreement reflects their mutual agreement regarding the subject matter of this Agreement. Because of the nature of
such negotiations and discussions, it would not be appropriate to deem either Buyer or Seller to be the drafter of this Agreement, and
therefore no presumption for or against the drafter shall be applicable in interpreting or enforcing this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.15. <u>Other Interpretation Rules</u>.
As used in this Agreement, any reference to the masculine, feminine or neuter gender shall include all genders, the plural shall include
the singular, and the singular shall include the plural. Unless the context otherwise requires, the words &ldquo;hereof,&rdquo; &ldquo;hereby&rdquo;
and &ldquo;herein&rdquo; and words of similar meaning when used in this Agreement refer to this Agreement in its entirety and not to any
particular article, section or provision hereof. In interpreting the representations and warranties of this Agreement, the principle that
the specific governs and controls the general shall apply. Any representation and warranty made as to any past fact, situation, circumstance,
status, condition, activity, practice, plan, occurrence, event, incident, action, failure to act, or transaction relates any of the foregoing
that first occurred or came into existence within the three (3) years period prior to the date hereof, unless a different time period
is expressly provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">13.16. <u>Further Assurances</u>.
Each Party shall execute such documents and other papers and take such further actions as may be reasonably required or desirable to carry
out the provisions hereof and the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">[<b>SIGNATURE PAGE FOLLOWS</b>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center; text-indent: 0in">&nbsp;</p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have executed this Agreement as of the date first set forth above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<b>BUYER</b>&rdquo;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;<font style="text-transform: uppercase"><b>SELLER</b></font>&rdquo;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: center">&nbsp;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>TOLLO
    HEALTH, LLC.</b>, </font><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware limited liability company</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><b>Scienture
    Holdings, INC.</b></font> <font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a Delaware corporation</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Gerald Commissiong</i></font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 2%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; width: 3%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>/s/
    Eric Sherb</i></font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Gerald
    Commissiong</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Name:</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Eric
    Sherb</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">CEO</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Title:</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal</font></td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-decoration: none; text-transform: uppercase">&nbsp;</font></p>


<!-- Field: Page; Sequence: 28 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><u>Schedule
1</u></font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-decoration: none; text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>Schedule
of Seller</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="vertical-align: middle; padding-bottom: 1pt; font-weight: bold; text-align: left"><u>Name</u></td><td style="text-align: right; font-weight: bold; padding-bottom: 1pt; vertical-align: middle">&nbsp;</td>
    <td colspan="2" style="vertical-align: middle; font-weight: bold; text-align: right"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><b><u>Allocation of</u></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><b><u>Membership Interest</u></b></p>

<p style="margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></p></td><td style="text-align: right; padding-bottom: 1pt; font-weight: bold; vertical-align: middle">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 66%; text-align: left">SCIENTURE HOLDINGS, INC</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 30%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">100.00</td><td style="font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-decoration: none">&nbsp;</font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-decoration: none">&nbsp;</font></p>


<!-- Field: Page; Sequence: 29 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><b>&nbsp;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><u>Schedule
2</u></font></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-decoration: none; text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>PURCHASE
PRICE</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <tr style="vertical-align: bottom">
    <td style="padding-bottom: 1pt; vertical-align: middle; font-weight: bold; text-align: left"><u>Name</u></td><td style="text-align: right; font-weight: bold; padding-bottom: 1pt">&nbsp;</td>
    <td colspan="2" style="padding-bottom: 1pt; font-weight: bold; text-align: right"><p style="margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><b><u>Allocation of</u></b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><b><u>Purchase Price</u></b></p>
<p style="margin-right: 0pt; text-align: right; margin-top: 0pt; margin-bottom: 0pt"></P></td><td style="text-align: right; padding-bottom: 1pt; font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="vertical-align: middle; padding-bottom: 1pt; font-weight: bold; text-align: left; width: 66%">Tollo Health, LLC</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 30%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">100</td><td style="font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt 0pt 0pt auto; width: 100%"><div style="border-top: Black 1pt solid; margin-top: 0pt; font-size: 1pt; border-bottom: Black 1pt solid; margin-right: 0pt; margin-bottom: 0pt">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left">&nbsp;</p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>MEMBERSHIP INTEREST PURCHASE AGREEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">dated as of <b>April 8, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">by and among</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>Tollo Health,
LLC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">as Buyer,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>SCIENTURE
HOLDINGS, INC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">as Seller</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin-left: auto; margin-right: auto; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>

<!-- Field: Page; Sequence: 31; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"></p>



</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.02
<SEQUENCE>3
<FILENAME>ex1-02.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: right; text-indent: 0.5in"><b>Exhibit 1.02</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center">Stock PURCHASE AGREEMENT</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">This STOCK PURCHASE AGREEMENT
(&ldquo;<b>Agreement</b>&rdquo;) is made as of April 8, 2025, by and among SCIENTURE HEALTH, INC., a Delaware corporation (&ldquo;<b>Seller</b>&rdquo;),
BONUM HEALTH, INC., a Delaware corporation and Softell Inc, a Florida corporation (collectively known as the &ldquo;<b>Company</b>&rdquo;)
and TOLLO HEALTH, LLC., a Delaware corporation (<b>&ldquo;Buyer&rdquo;</b>). Buyer, Company and Seller are each referred to herein as
a &ldquo;<b>Party</b>&rdquo; and collectively as &ldquo;<b>Parties</b>.&rdquo;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>recitals</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">A. Seller owns all of the shares
of stock in the Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">B. Buyer desires to purchase from
Seller and Seller desires to sell to Buyer 100% of the Seller&rsquo;s shares of stock in the Company (the &ldquo;<b>Shares of Stock</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-transform: uppercase; text-align: center"><font style="text-decoration: none"><b>agreement</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">Now, therefore, in consideration
of the foregoing and the mutual agreements and covenants set forth below, which are acknowledged by each Party to be fair and adequate
consideration for its obligations and commitments hereunder, the Parties hereby agree as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">1. <b>Definitions</b>. Except
as otherwise set forth therein, as used in the Agreement and the Exhibits, Schedules and deliveries pursuant to the Agreement, the following
definitions shall apply.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Company Assets</b>&rdquo;
means the assets used in the Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Action</b>&rdquo; means
any action, complaint, petition, investigation, suit or other proceeding, whether civil or criminal, in law or in equity, before any arbitrator
or Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Adjusted Net Income&rdquo;</b>
means net income of Company, determined in accordance with GAAP.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Affiliate</b>&rdquo; of
a Person means a Person that directly, or indirectly through one or more intermediaries, controls, or is controlled by, or is under common
control with, such first Person</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Allocable Share</b>&rdquo;
means the ownership percentage of each Seller as set forth on <u>Schedule 1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Approvals</b>&rdquo; means
all franchises, grants, authorizations, licenses, permits, easements, consents, certificates, approvals and orders.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Business</b>&rdquo; means
the business of Company taken as a whole and shall be deemed to include any of the following incidents of such business: income, cash
flow, operations, condition (financial or otherwise), assets, future revenues, prospects, liabilities, personnel and management.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 1 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>COBRA</b>&rdquo; means
the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Code</b>&rdquo; means
the Internal Revenue Code of 1986, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Company Disclosure Schedule</b>&rdquo;
means the written disclosure schedule of even date herewith delivered on or prior to the date hereof by Company to Buyer corresponding
to each representation and warranty made hereunder by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Contract</b>&rdquo; means
any contract, agreement, indenture, note, bond, loan, instrument, lease, conditional sale contract, mortgage, license, franchise, insurance
policy, commitment or other arrangement or agreement, whether written or oral.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Encumbrance</b>&rdquo;
means any option, pledge, security interest, claim, lien, charge, encumbrance, easement, covenant, lease, rights of others, restriction
(whether on voting, sale, transfer or disposition or otherwise), whether imposed by agreement, understanding, law or otherwise, except
those arising under applicable federal or state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>ERISA</b>&rdquo; means
the Employee Retirement Income Security Act of 1974, as amended, and the related regulations and published interpretations.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>FMLA</b>&rdquo; means
the Family Medical Leave Act of 1993, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>GAAP</b>&rdquo; means
generally accepted accounting principles as promulgated by the Financial Accounting Standards Board, consistently applied.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Governmental Entity</b>&rdquo;
means any court or tribunal in any jurisdiction or any federal, state, municipal, domestic, foreign or other administrative agency, department,
commission, board, bureau or other governmental authority or instrumentality.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>HIPAA</b>&rdquo; means
the Health Insurance Portability and Accountability Act of 1996, as amended.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Indebtedness</b>&rdquo;
means, as to Company, (a) all obligations for borrowed money (including, without limitation, reimbursement and all other obligations with
respect to surety bonds, letters of credit and bankers&rsquo; acceptances, whether or not matured), (b) all obligations to pay the deferred
purchase price of property or services, (c) all interest rate and currency swaps, caps, collars and similar agreements or hedging devices
under which payments are obligated to be made by Company, whether periodic-ally or upon the happening of a contingency, (d) all indebtedness
created or arising under any conditional sale or other title retention agreement with respect to property acquired by Company (even though
the rights and remedies of the seller or lender under such agreement in the event of default are limited to repossession or sale of such
property), (e) all obligations under leases which have been or should be, in accordance with GAAP, recorded as capital leases, (f) all
indebtedness secured by any Encumbrance (other than Encumbrances in favor of lessors under leases other than leases included in clause
(e)) on any property or asset owned or held by Company regardless of whether the indebtedness secured thereby shall have been assumed
by Company or is non-recourse to the credit of Company, and (g) any direct or indirect liability with respect to any Indebtedness, lease,
dividend, guaranty, letter of credit or other obligation, contractual or otherwise (the &ldquo;<b>Primary Obligation</b>&rdquo;) of another
Person (the &ldquo;<b>Primary Obligor</b>&rdquo;), whether or not contingent, (i) to purchase, repurchase or otherwise acquire such Primary
Obligations or any property constituting direct or indirect security therefor, (ii) to advance or provide funds (x) for the payment or
discharge of any such Primary Obligation, or (y) to maintain working capital or equity capital of the Primary Obligor or otherwise to
maintain the net worth or solvency or any balance sheet item, level of income or financial condition of the Primary Obligor, (iii) to
purchase property, securities or services primarily for the purpose of assuring the owner of any such Primary Obligation of the ability
of the Primary Obligor to make payment of such Primary Obligation, or (iv) otherwise to assure or hold harmless the owner of any such
Primary Obligation against loss or failure or inability to perform in respect thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 2; Options: NewSection; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>IRS</b>&rdquo; means the
Internal Revenue Service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Laws</b>&rdquo; means
any constitutional provision, statute or other law, rule, regulation, or interpretation of any Governmental Entity and any Order.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><b>&nbsp;</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><b>&ldquo;Management Agreement&rdquo;</b>
means that certain Master Service Agreement by and between the Buyer and the Seller dated as of even date herewith.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Material Adverse Effect</b>&rdquo;
means any change, effect or circumstance that is materially adverse to the business, assets, condition (financial or otherwise) or results
of operations of Company, or Buyer and its subsidiaries, as the case may be, in each case taken as a whole.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Order</b>&rdquo; means
any order, injunction, judgment, decree, ruling, writ, assessment or arbitration award.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Permit</b>&rdquo; means
any license, permit, franchise, certificate of authority, or order, or any waiver of the foregoing, required to be issued by any Governmental
Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Person</b>&rdquo; means
an individual, a partnership, a corporation, an association, a limited liability company, a joint stock company, a trust, a joint venture,
an unincorporated organization a Governmental Entity or any other entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Tax</b>&rdquo; or &ldquo;<b>Taxes</b>&rdquo;
means all taxes, charges, fees, levies or other assessments, including, without limitation, income, gross receipts, excise, property,
sales, use, license, payroll and franchise taxes, imposed by any Governmental Entity and includes any estimated tax, interest and penalties
or additions to tax.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Transaction Documents</b>&rdquo;
means this Agreement (and each of the exhibits and schedules attached hereto and incorporated by reference herein), the Non-Competition
and Non-Solicitation Agreements, the Employment agreement, the General Waiver and Releases and each of the other documents, agreements
and certificates delivered in connection with this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>WARN</b>&rdquo; means
the Worker Adjustment and Retraining Notification Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&ldquo;<b>Working Capital</b>&rdquo;
shall be calculated by subtracting the sum of all of Company&rsquo;s current liabilities as of the Closing Date from the sum of all of
Company&rsquo;s current assets as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 3; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">2. <b>Purchase and Sale of Shares
of Stocks</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.1. <u>Sale of Shares of Stock
by Seller</u>. Subject to the terms and conditions herein set forth, Seller agrees to sell the Shares of Stock to Buyer at the Closing,
free and clear of all Encumbrances.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.2. <u>Purchase Price</u>. In full
consideration for the purchase by Buyer of the Shares of Stock, the purchase price (the &ldquo;<b>Purchase Price</b>&rdquo;) shall be
paid by Buyer to Seller as follows:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <font style="letter-spacing: -0.1pt"><i>Closing
Payment</i>.</font> On the Closing Date:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in">(i) <i>$1.5M promissory note</i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 2in">(ii) All amounts due and owing to
from Buyer to Seller under the Management Agreement (collectively, the &ldquo;<b>Closing Payment</b>&rdquo;);</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.3. <u>Closing</u>. Unless otherwise
agreed upon by the Parties, the closing of the transactions contemplated by this Agreement (the &ldquo;<b>Closing</b>&rdquo;) shall take
place on <b>June 30<sup>th</sup>, 2025, </b>or such other time as the Parties may agree (the &ldquo;<b>Closing Date</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.4. <u>[Intentionally omitted.]</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">2.5. <u>Excluded Liabilities</u>.
After the Closing, and notwithstanding anything else to the contrary herein, Seller shall retain, and shall be responsible for paying,
performing and discharging, when due, and neither the Company, nor the Buyer, shall not assume or have any responsibility for, the following
excluded Liabilities (the &ldquo;<b>Excluded Liabilities</b>&rdquo;):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(a) all Liabilities related to,
in connection with or arising out of any claims, charges, complaints, actions, suits, settlements, hearings, investigations, proceedings,
or governmental or regulatory inquiries with respect to the operation of the Business or the Company prior to the Closing, whether such
Claim is brought prior to, on or after the Closing Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(b) all Liabilities related to,
in connection with or arising out of any breach by the Seller of this Agreement or any other agreements and documents required to be delivered
by Seller hereunder;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(c) all Liabilities not disclosed
in this Agreement under Section 3 hereof;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(d) all Litigation Obligations.
&ldquo;<b>Litigation Obligations</b>&rdquo; means any matters or Liabilities related to a breach of <u>Section 3.10</u> or any matters
disclosed in <u>Schedule 3.10</u>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(e) All Liabilities related to Tax
Returns or any other tax matters of the Company or the Seller for any periods prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 4; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">(f) All Liabilities listed on <u>Schedule
2.5</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&ldquo;<b>Liabilities</b>&rdquo;
shall mean any liabilities (whether known or unknown, whether asserted or unasserted, whether absolute or contingent, whether accrued
or unaccrued, whether liquidated or unliquidated, and whether due or to become due), including any liabilities for taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">3. <b>Representations and Warranties
of Seller</b>. As a material inducement to Buyer to enter into this Agreement, Seller makes the representations and warranties set forth
below to Buyer, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.1. <u>Organization and Qualification</u>.
Company is a corporation duly organized, validly existing and in good standing under Florida law, and Company has the requisite power
and authority and is in possession of Approvals necessary to own, lease and operate the properties it purports to own, lease or operate
and to carry on the Business as it is now being conducted. Company is duly qualified or licensed as a foreign corporation to do business
and is in good standing in each jurisdiction where the character of its properties owned, leased or operated by it or the nature of its
activities makes such qualification or licensing necessary. Except as set forth on <i><u>Schedule 3.1</u></i>, Company does not own or
lease property in any jurisdiction other than its jurisdiction of incorporation and the jurisdictions referred to in the previous sentence.
Except as set forth on <i><u>Schedule 3.1</u></i>, no jurisdiction has claimed, in writing or otherwise, that Company is required to qualify
as a foreign corporation or other entity therein, and (except as aforesaid) Company does not file any franchise, income or other tax returns
in any other jurisdiction based upon the ownership or use of property therein or the derivation of income therefrom. Company has no subsidiaries.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.2. <u>Articles of Incorporation
and Bylaws</u>. Company has heretofore furnished to Buyer a true, complete and correct copy of its Articles of Incorporation and Bylaws,
each as amended to date. Such Articles of Incorporation and Bylaws are in full force and effect. Company is not in violation of any of
the provisions of its Articles of Incorporation or Bylaws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.3. <u>Capitalization</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <i>Capitalization</i>. The
Company&rsquo;s capital stock (i) are duly authorized, validly issued, fully paid and non-assessable, (ii) are free of any liens or encumbrances
created by Company, and free of any liens or encumbrances created by or imposed upon the holders thereof, and (iii) were not issued in
violation of any preemptive rights or rights of first refusal created by statute, the Articles of Incorporation or Bylaws of Company or
any agreement to which Company is a party or by which it is bound. Except for the rights created pursuant to this Agreement, there are
no options, warrants, calls, rights, commitments or agreements that are outstanding to which Company is a party or by which it is bound,
obligating Company to issue, deliver, sell, repurchase or redeem, or cause to be issued, delivered, sold, repurchased or redeemed, Company&rsquo;s
capital stock or obligating Company to grant, extend, accelerate the vesting of, change the price of, or otherwise amend or enter into
any option, warrant, call, right, commitment or agreement regarding Company&rsquo;s capital stock. There are no other contracts, commitments
or agreements relating to the voting, purchase or sale of Company&rsquo;s capital stock (A) between or among Company and any of its shareholders;
and (B) between or among any of Company&rsquo;s shareholders. All issued and outstanding capital stock of Company were issued in compliance
with all applicable federal and state securities laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 5; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.].</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) <i>The Shares of Stocks.</i>
The capital stock of Seller issued to Buyer in connection with this Agreement shall total One Hundred Percent (100%) of the total capital
stock of the Company at Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.4. <u>Authority Relative to this
Agreement</u>. Company has all necessary corporate power and authority to execute and deliver the Transaction Documents to which it is
a party and to perform its obligations thereunder and to consummate the transactions contemplated hereby. The execution and delivery of
the Transaction Documents by Company and the consummation by Company of the transactions contemplated thereby have been duly and validly
authorized by all necessary corporate action on the part of Company, and no other corporate proceedings on the part of Company are necessary
to authorize the Transaction Documents or to consummate the transactions contemplated thereby. The Sole Member of Company has approved
the Transaction Documents, and the transactions contemplated thereby and declared their advisability. The Transaction Documents to which
Company is a party have been duly and validly executed and delivered by Company and, assuming the due authorization, execution and delivery
by Buyer, constitute a legal, valid and binding obligation of Company enforceable against Company in accordance with their terms, except
as enforceability against Company may be limited by applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer,
moratorium or similar laws affecting the enforcement of creditors&rsquo; rights and by general principles of equity relating to enforceability
(regardless of whether considered in a proceeding at law or in equity).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.5. <u>No Conflict; Required Filings
and Consents</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <i>Material Contracts</i>.
<i><u>[Intentionally omitted.]</u></i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) <i>No Conflict</i>. Except
as set forth in <i><u>Schedule 3.5(b)</u></i>, the execution and delivery of this Agreement by Company does not, and the performance of
this Agreement by Company will not, (i) conflict with or violate the Articles of Incorporation or Bylaws of Company, (ii) conflict with
or violate any law, rule, regulation, order, judgment or decree applicable to Company or by which its properties is bound or affected,
or (iii) result in any breach of or constitute a default (or an event that with notice or lapse of time or both would become a default)
under, or result in a modification of any right or benefit under, or impair Company&rsquo;s rights or alter the rights or obligations
of any third party under, or give to others any rights of termination, amendment, acceleration, repayment or repurchase, or result in
increased payments or cancellation under, or result in the creation of an Encumbrance on any of the properties or assets of Company pursuant
to, any Contract to which Company is a party or by which Company <b>[or any of its properties</b>] are bound or affected, except in the
case of (ii) or (iii) only for any such conflicts, violations, breaches, defaults or other occurrences that would not, individually or
in the aggregate, have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) <i>Required Filings and Consents.</i>
The execution and delivery of this Agreement by Company does not, and the performance of this Agreement by Company will not require any
consent, approval, exemption, authorization or permit of, or filing with or notification to, any Governmental Entity or any other Person.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 6; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.6. <u>Compliance, Permits</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <i>Compliance</i>. Except
as set forth in <i><u>Schedule 3.6(a)</u></i>, Company is not in conflict with, or in default or violation of (i) any law, rule, regulation,
order, judgment or decree applicable to Company or by which its or any of its respective properties is bound or affected or (ii) any Material
Contracts, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not have a Material Adverse
Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) <i>Permits</i>. Company holds
all Permits from Governmental Entities that are necessary to the operation of the Business as it is now being conducted, except when the
failure to have such Permits would not, individually or in the aggregate, have a Material Adverse Effect. Company is in compliance with
the terms of such Permits, except where the failure to so comply would not, individually or in the aggregate, have a Material Adverse
Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.7. <u>Financial Statements</u>.
<i><u>Schedule 3.7</u></i> contains the unaudited balance sheet and statements of operations for the period ended September 30, 2022,
the unaudited financial statements for Company&rsquo;s 2022 and 2021 fiscal year (the &ldquo;<b>Financial Statements</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.8. <u>Absence of Certain Changes
or Events</u>. Except as set forth in <i><u>Schedule 3.8</u></i>, since September 30, 2022, Company has conducted the Business in the
ordinary course and there has not occurred any of the following: (i) any Material Adverse Effect; (ii) any amendments or changes in the
Articles of Incorporation or Bylaws of Company; (iii) any damage to, destruction or loss of any material asset of Company (whether or
not covered by insurance); (iv) any material change by Company in its accounting methods, principles or practices; (v) any material revaluation
by Company of any of its assets, including, without limitation, writing down the value of inventory or writing off notes or accounts receivable
other than in the ordinary course of business; (vi) any sale of a material amount of property of Company, except in the ordinary course
of business; (vii) any declaration, setting aside or payment of any dividend or distribution in respect of the capital stock of the Company
or any redemption, purchase or other acquisition of any of Company&rsquo;s securities (except as contemplated by this Agreement); (viii)
any increase in the compensation or benefits or establishment of any bonus, insurance, severance, deferred compensation, pension, retirement,
profit sharing, or other employee benefit plan, or any other increase in the compensation payable or to become payable to any executive
officers of Company, in each case except in the ordinary course of business consistent with past practice or except as required by applicable
law; (ix) any creation or assumption by Company of any Encumbrance on any material asset of Company, other than in the ordinary course
of business, consistent with past practice; (x) any making of any loan, advance or capital contribution to or investment in any Person
by Company, other than advances to employees to cover travel and other ordinary business-related expenses in the ordinary course of business
consistent with past practice; (xi) any incurrence or assumption by Company of any indebtedness for borrowed money or any guarantee, endorsement
or other incurrence or assumption of a material liability (whether directly, contingently or otherwise) by Company for the obligations
of any other Person, in each case other than in the ordinary course of business consistent with past practice; or (xii) any material modification,
amendment, assignment or termination of or relinquishment by Company of any rights under any Material Contract.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 7; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.9. <u>No Undisclosed Liabilities</u>.
Except as set forth in <i><u>Schedule 3.9</u></i>, the Company has no liabilities (absolute, accrued, known contingent or otherwise) except
liabilities (i) in the aggregate adequately provided for in Company&rsquo;s unaudited balance sheet as of September 30, 2022 and (ii)
incurred since September 30, 2022 in the ordinary course of business consistent with past practice or in connection with the transactions
contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.10. <u>Absence of Litigation</u>.
Other than as described on <i><u>Schedule 3.10</u></i>, there are no Actions or, to the knowledge of Company, there are no Actions threatened
against Company, or any properties or rights of Company, before any Governmental Entity or body, nor are there, to the knowledge of Company,
any investigations or reviews by any Governmental Entity pending or threatened against, relating to or affecting, Company. Company is
not subject to any outstanding Order.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.11. <u>Employee Benefit Plans;
Employment agreement</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <i><u>Schedule 3.11(a)</u></i>
contains an accurate and complete list, with respect to Company and any Person under common control with Company within the meaning of
Section 414(b), (c), (m) or (o) of the Code, and the regulations issued thereunder (collectively an &ldquo;<b>ERISA Affiliate</b>&rdquo;)
of each plan, program, policy, practice, contract, agreement or other arrangement providing for compensation, severance, termination pay,
deferred compensation, performance awards, equity-related awards, welfare benefits, fringe benefits or other employee benefits or remuneration
of any kind, whether written, unwritten or otherwise, funded or unfunded, including each &ldquo;employee benefit plan,&rdquo; within the
meaning of Section 3(3) of ERISA, which is or has been maintained, contributed to, or required to be contributed to, by Company or any
ERISA Affiliate for the benefit of any employee (collectively, the &ldquo;<b>Company Employee Plans</b>&rdquo;). Company has not made
any plan or commitment to establish any new Company Employee Plan, to modify any Company Employee Plan (except to the extent required
by law or to conform any such Company Employee Plan to the requirements of any applicable law, in each case as previously disclosed to
Buyer in writing, or as required by this Agreement), or to enter into any Company Employee Plan. <i><u>Schedule 3.11(a)</u></i> sets forth
a table setting forth the name and salary of each employee of Company as of the date hereof. To the knowledge of Company, no employee
listed on <i><u>Schedule 3.11(a)</u></i> intends to terminate his or her employment for any reason. <i><u>Schedule 3.11(a)</u></i> contains
an accurate and complete list of all Persons that have a consulting or advisory relationship with Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) <i>Documents</i>. Company
has provided to Buyer: (i) correct and complete copies of all documents embodying each Company Employee Plan including all amendments
thereto and all related trust documents, (ii) the three most recent annual reports (Form Series 5500 and all schedules and financial statements
attached thereto), if any, required under ERISA or the Code in connection with each Company Employee Plan, (iii) if Company Employee Plan
is funded, the most recent annual and periodic accounting of Company Employee Plan assets, (iv) the most recent summary plan description
together with the summary(ies) of material modifications thereto, if any, required under ERISA with respect to each Company Employee Plan,
(v) all material written agreements and contracts relating to each Company Employee Plan, including administrative service agreements
and group insurance contracts, (vi) each affirmative action plan, if applicable, (vii) all communications material to any employee or
employees relating to any Company Employee Plan and any proposed Company Employee Plan, in each case, relating to any amendments, terminations,
establishments, increases or decreases in benefits, acceleration of payments or vesting schedules or other events which would result in
any liability to Company, (viii) all correspondence to or from any Governmental Entity relating to any Company Employee Plan, (ix) model
COBRA forms and related notices, (x) all policies pertaining to fiduciary liability insurance covering the fiduciaries for each Company
Employee Plan, (xi) all discrimination tests for each Company Employee Plan for the three most recent plan years, (xii) all registration
statements, annual reports (Form 11-K and all attachments thereto) and prospectuses prepared in connection with each Company Employee
Plan, (xiii) all HIPAA privacy notices and all business associate agreements to the extent required under HIPAA and (xiv) the most recent
IRS determination or opinion letter issued with respect to each Company Employee Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 8; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) <i>Company Employee Plan Compliance</i>.
Company has performed all obligations required to be performed by it under, is not in default or violation of, and Company has no knowledge
of any default or violation by any other party to, any Company Employee Plan, and each Company Employee Plan has been established and
maintained in accordance with its terms and in compliance with all applicable laws, statutes, orders, rules, and regulations, including
ERISA or the Code. Each Company Employee Plan intended to be qualified under Section 401(a) of the Code and each trust intended to qualify
under Section 501(a) of the Code has either (i) applied for, prior to the expiration of the requisite remedial amendment period under
applicable Treasury Regulations or IRS pronouncements, but has not yet received a response; (ii) obtained a favorable determination, notification,
advisory and/or opinion letter, as applicable, on which the employer is entitled to rely, as to its qualified status from the IRS since
January 1, 2000; or (iii) still has a remaining period of time to apply for such a determination letter from the IRS and to make any amendments
necessary to obtain a favorable determination and nothing has occurred since the date of the most recent determination that could reasonably
be expected to cause any such Company Employee Plan or trust to fail to qualify under Section 401(a) or 501(a) of the Code. No &ldquo;prohibited
transaction,&rdquo; within the meaning of Section 4975 of the Code or Sections 406 and 407 of ERISA, and not otherwise exempt under Section
408 of ERISA, has occurred with respect to any Company Employee Plan. There are no actions, suits or claims pending or, to the knowledge
of Company, threatened or reasonably anticipated (other than routine claims for benefits) against any Company Employee Plan or against
the assets of any Company Employee Plan. Each Company Employee Plan can be amended, terminated, or otherwise discontinued after the Closing
Date in accordance with its terms, without liability to Buyer, Company or any ERISA Affiliate (other than ordinary administration expenses).
There are no audits, inquiries or proceedings pending or to the knowledge of Company or any ERISA Affiliates, threatened by the IRS, Department
of Labor, or any other governmental entity with respect to any Company Employee Plan. Neither Company nor any ERISA Affiliate is subject
to any penalty or Taxes with respect to any Company Employee Plan under Section 502(i) of ERISA or Sections 4975 through 4980 of the Code.
Company has timely made all contributions and other payments required by and due under the terms of each Company Employee Plan.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) <i>No Pension Plan</i>. Neither
Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed to, any Company Employee
Plan that is an &ldquo;employee pension benefit plan,&rdquo; within the meaning of Section 3(2) of ERISA (a &ldquo;<b>Pension Plan</b>&rdquo;)
subject to Part 3 of Subtitle B of Title I of ERISA, Title IV of ERISA, or Section 412 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 9; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(e) <i>No Self-Insured Company
Employee Plan</i>. Neither Company nor any ERISA Affiliate has ever maintained, established, sponsored, participated in, or contributed
to any self-insured plan that provides benefits to employees (including any such plan pursuant to which a stop-loss policy or contract
applies).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(f) <i>Collectively Bargained,
Multiemployer and Multiple-Employer Plan</i>. At no time has Company or any ERISA Affiliate contributed to or been obligated to contribute
to any multiemployer plan (as defined in Section 3(37) of ERISA). Neither Company nor any ERISA Affiliate has at any time ever maintained,
established, sponsored, participated in, or contributed to any multiple employer plan or to any plan described in Section 413 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(g) <i>No Post-Employment Obligations</i>.
No Company Employee Plan provides, or reflects or represents any liability to provide, post-termination or retiree life insurance, health
or other employee welfare benefits to any Person for any reason, except as may be required by COBRA or other applicable statute, and Company
has not ever represented, promised or contracted (whether in oral or written form) to any employee (either individually or to employees
as a group) or any other Person that such employee(s) or other Person would be provided with life insurance, health or other employee
welfare benefits, except to the extent required by statute.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(h) <i>COBRA; FMLA; HIPAA</i>.
Company and each ERISA Affiliate has, prior to the Closing Date, complied with COBRA, FMLA, HIPAA, the Women&rsquo;s Health and Cancer
Rights Act of 1998, the Newborns&rsquo; and Mothers&rsquo; Health Protection Act of 1996, and any similar provisions of state law applicable
to its employees. To the extent required under HIPAA and the regulations issued thereunder, Company has, prior to the Closing Date, performed
all obligations under the medical privacy rules of HIPAA, the electronic data interchange requirements of HIPAA, and the security requirements
of HIPAA. Company has no unsatisfied obligations to any employees or qualified beneficiaries pursuant to COBRA, HIPAA or any state law
governing health care coverage or extension.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) <i>Effect of Transaction</i>.
Neither the execution and delivery of this Agreement nor the consummation of the transactions contemplated hereby or any termination of
employment or service in connection therewith will (i) result in any payment (including severance, golden parachute, bonus or otherwise)
becoming due to any employee, (ii) result in any forgiveness of indebtedness, (iii) materially increase any benefits otherwise payable
by Company or (iv) result in the acceleration of the time of payment or vesting of any such benefits except as required under Section
411(d)(3) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(j) <i>Deferred Compensation</i>.
Each Company Employee Plan that is a &ldquo;nonqualified deferred compensation plan,&rdquo; within the meaning of Section 409A of the
Code, has been operated and administered since the latter of inception or January 1, 2019, in good faith compliance with Section 409A
of the Code, to the extent Section 409A of the Code is applicable to such plan. No such plan has been &ldquo;materially modified,&rdquo;
within the meaning of IRS Notice 2005-1, at any time after October 3, 2004.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 10; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(k) <i>Parachute Payments</i>.
There is no agreement, plan, arrangement or other contract covering any employee that, considered individually or considered collectively
with any other such agreements, plans, arrangements or other contracts, will, or could reasonably be expected to, give rise directly or
indirectly to the payment of any amount that would be characterized as a &ldquo;parachute payment&rdquo; within the meaning of Section
280G(b)(1) of the Code. There is no agreement, plan, arrangement or other contract by which Company is bound to compensate any employee
for excise taxes paid pursuant to Section 4999 of the Code. <i><u>Schedule 3.11(k)</u></i> lists all Persons who Company reasonably believes
are &ldquo;disqualified individuals&rdquo; (within the meaning of Section 280G of the Code and the regulations promulgated thereunder)
as determined as of the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(l) <i>No Interference or Conflict</i>.
To the knowledge of Company, no member, manager, officer, employee or consultant of Company is obligated under any contract or agreement,
subject to any Order of any Governmental Entity that would interfere with such Person&rsquo;s efforts to promote the interests of Company
or that would interfere with the Business. Neither the execution nor delivery of this Agreement, nor the carrying on of the Business as
presently conducted or proposed to be conducted nor any activity of such officers, managers, employees or consultants in connection with
the carrying on of the Business as presently conducted or currently proposed to be conducted will, to the knowledge of Company, conflict
with or result in a breach of the terms, conditions, or provisions of, or constitute a default under, any contract or agreement under
which any of such officers, managers, employees, or consultants is now bound.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(m) <i>International Employee
Plan</i>. Neither Company nor any ERISA Affiliate currently or has it ever had the obligation to maintain, establish, sponsor, participate
in, be bound by or contribute to any each Company Employee Plan that has been adopted or maintained by Company or any ERISA Affiliate,
whether formally or informally or with respect to which Company or any ERISA Affiliate will or may have any liability with respect to
employees who perform services outside the United States (an &ldquo;<b>International Employee Plan</b>&rdquo;).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.12. <u>Employment and Labor Matters</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) Company is in compliance with
all applicable Laws respecting employment, employment practices, terms and conditions of employment, employee safety and health and wages
and hours, and in each case, with respect to employees: (i) has withheld and reported all amounts required by law or by agreement to be
withheld and reported with respect to wages, salaries and other payments to employees, (ii) is not liable for any arrears of wages, severance
pay or any Taxes or any penalty for failure to comply with any of the foregoing, and (iii) is not liable for any payment to any trust
or other fund governed by or maintained by or on behalf of any Governmental Entity, with respect to unemployment compensation benefits,
social security or other benefits or obligations for employees (other than routine payments to be made in the normal course of business
and consistent with past practice). There are no Actions pending, threatened or reasonably anticipated against Company or any of their
employees relating to any employee or Company Employee Plan. There are no pending or threatened or reasonably anticipated claims or actions
against Company, any Company trustee or any trustee of any subsidiary under any worker&rsquo;s compensation policy. The services provided
by each of Company&rsquo;s, each subsidiary&rsquo;s and their ERISA Affiliates&rsquo; employees is terminable at the will of Company and
its ERISA Affiliates and any such termination would result in no liability to Company or any ERISA Affiliate. <i><u>Schedule 3.12(a)</u></i>
lists all liabilities of Company to any employee, that result from the termination by Company of such employee&rsquo;s employment or provision
of services, a change of control of Company, or a combination thereof. To the knowledge of Company, neither Company nor any ERISA Affiliate
has direct or indirect liability with respect to any misclassification of any Person as an independent contractor rather than as an employee,
or with respect to any employee leased from another employer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 11; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) No work stoppage or labor
strike against Company is pending, or to the knowledge of Company, threatened, or reasonably anticipated. Company has no knowledge of
any activities or proceedings of any labor union to organize any employees. There are no Actions pending or threatened or reasonably anticipated
relating to any labor matters involving any employee, including charges of unfair labor practices. Company has not engaged in any unfair
labor practices within the meaning of the National Labor Relations Act. Company is not presently, nor has it been in the past, a party
to, or bound by, any collective bargaining agreement or union contract with respect to employees, and no collective bargaining agreement
is being negotiated by Company. Within the past year, Company has not incurred any liability or obligation under WARN or any similar state
or local law that remains unsatisfied, nor shall any terminations prior to the Closing Date result in unsatisfied liability or obligation
under WARN or any similar state or local law.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.13. <u>Restrictions on Business
Activities</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) Except for this Agreement,
there is no material agreement, Action or Order binding upon Company which has or could reasonably be expected to have the effect of prohibiting
or impairing any material business practice of Company or any acquisition of property by Company or any acquisition of property by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) None of Company&rsquo;s officers,
managers or key employees is a party to any agreement which, by virtue of such Person&rsquo;s relationship with Company, restricts in
any material respect Company from continuing such entity&rsquo;s business activities as presently conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.14. <u>Title to Property</u>.
Except as set forth in <i><u>Schedule 3.14</u></i>, Company has good record, marketable and defensible title to all of their owned properties
and assets, free and clear of all material Encumbrances. <i><u>Schedule 3.14</u></i> is a true, complete and correct schedule of all leases
of real property as of the date of this Agreement (&ldquo;<b>Real Property Leases</b>&rdquo;) pursuant to which Company leases from others
which schedule sets forth (i) the date of each lease and the premises covered thereby, (ii) the term thereof, and (iii) the rent payable
thereunder. No real property is owned by Company. The Real Property Leases and all leases of personal property by Company from others
are in good standing, valid and effective in accordance with their respective terms and to Company&rsquo;s knowledge there is not, under
any of such leases, any existing default or event of default (or event which with notice or lapse of time, or both, would constitute a
default).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.15. <u>Sufficiency and Condition
of Assets</u>. The Company Assets are adequate to conduct the Business as it is presently being conducted and will be adequate to enable
Buyer to continue to conduct the Business as it is presently being conducted. The Company Assets are in good operating condition and repair,
normal wear and tear excepted, are suitable for the uses intended therefor, are free from any latent defects and have been maintained
in accordance with normal industry practice.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 12; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.16. <u>Taxes</u>. Except as set
forth in <i><u>Schedule 3.16</u></i>:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) Company has timely filed in
accordance with applicable law all Tax Returns required to be filed by or with respect to it, its operations and assets, and all Taxes
shown as due on such Tax Returns have been paid. All Tax Returns filed by Company with respect to Taxes were true, complete, and correct
in all material respects as of the date on which they were filed or as subsequently amended to the date of this Agreement. Complete copies
of federal, state, local, and foreign Tax Returns of Company for the year ended December 31, 2021, have heretofore been delivered or made
available to Buyer. Prior to the date of this Agreement, Company has provided to Buyer all revenue agents&rsquo; reports and other written
assertions of deficiencies or other liabilities for Taxes of Company with respect to past periods for which the applicable statute of
limitations has not expired.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) Company has timely paid all
Taxes for which a notice of, or assessment or demand for, payment has been received, or which are otherwise due and payable with respect
to Company, its operations and assets (in each case, whether or not shown on any Tax Return), except for Taxes that are being contested
in good faith by appropriate proceedings, all of which are disclosed in <i><u>Schedule 3.16(b)</u></i> and for payment of which Taxes
adequate reserves have been established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) Company has complied with
all applicable law, rules and regulations relating to the withholding of Taxes and has timely collected or withheld and paid over, and
up to the Closing Date will have timely collected and withheld and paid over to the proper governmental authorities all amounts required
to be so collected or withheld and paid over for all periods up to the Closing Date under all applicable laws.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) There are no outstanding agreements,
waivers or arrangements extending the statutory period of limitations for the assessment or collection of Taxes with respect to any Tax
Return that relates to Company, which waivers or extensions currently are in effect, and no request for any such waiver or extension is
currently pending.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(e) There are no Tax rulings of
which Company is a subject, requests for rulings by Company, or closing agreements entered into by Company that could affect its liability
for Taxes for any period after the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(f) No action, suit, proceeding,
investigation, audit, claim or assessment is presently pending or, to the knowledge of Company, proposed with regard to any Taxes that
relate to Company for which Company would or could be liable. There are no requests from any taxing authority for information or with
respect to Taxes of Company. Company has no knowledge of any fact or condition that, if known to any taxing authority having jurisdiction,
would likely result in the issuance of a notice of proposed deficiency or similar notice of intention to assess Taxes against Company,
and no issue has arisen in any examination of Company by any taxing authority that if raised and upheld with respect to any other period
not so examined would result in a material deficiency for any other period not so examined.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 13; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(g) Company (i) has not agreed
to nor is required to make any adjustment pursuant to Section 481 of the Code (or any predecessor or similar provision of other laws or
regulations) by reason of a change in accounting method or otherwise; (ii) has no knowledge that any taxing authority has proposed any
such adjustment or change, which proposal is currently pending; and (iii) does not have an application pending with any taxing authority
requesting permission for any change in accounting methods that relates to the Business.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(h) Neither Company nor any of
its shareholders is a &ldquo;foreign person&rdquo; within the meaning of Code Section 1445(f)(3) and Treasury Regulation Section 1.1445-2(b)(2)(i)
(or any corresponding provision of state, local, or foreign Tax law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) Company (i) is not a party
to, is not bound by, nor has any obligation under, any Tax sharing agreement or similar contract; (ii) has no current or potential contractual
obligation to indemnify any other Person with respect to Taxes; and (iii) has no obligation to make distributions in respect of Taxes.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(j) <i><u>Schedule 3.16(j)</u></i>
contains a list of states, territories and jurisdictions (whether foreign or domestic) in which Company is required to file Tax Returns.
No claim has ever been made in writing against Company by a taxing authority in a jurisdiction where Company does not file Tax Returns
that Company is or may be subject to taxation by such jurisdiction.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(k) No Taxes are delinquent or
constitute a lien against Company, except for the current year&rsquo;s ad valorem Taxes not yet due and payable, and except with respect
to Taxes being contested in good faith by appropriate proceedings (all of which are disclosed in <i><u>Schedule 3.16(k)</u></i>) and for
payment of which Taxes adequate reserves have been established.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(l) Company has not disposed of
any property in a transaction being accounted for under the installment method pursuant to Section 453 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(m) No power of attorney has been
granted by Company with respect to any matter relating to Taxes of Company, which power of attorney is currently in force. Any such power
of attorney will be revoked prior to the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(n) Company has not filed any
consent under Section 341(f) of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(o) Any adjustment of Taxes of
Company made by the Internal Revenue Service, which adjustment is required to be reported to the appropriate state, local, or foreign
taxing authorities, has been so reported.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(p) All Tax Returns with respect
to Taxes of Company filed or given after the date hereof shall be prepared, and all elections with respect to such Tax Returns shall be
made, to the extent permitted by law, in a manner consistent with prior practice of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(q) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 14; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(r) Company has not taken any
reporting position on a Tax Return, which reporting position (i) if not sustained would be reasonably likely, absent disclosure, to give
rise to a penalty for substantial understatement of federal income Tax under and within the meaning of Section 6662 of the Code (or any
predecessor statute or any corresponding provision of any such predecessor statute, or state, local, or foreign Tax law), and (ii) has
not adequately been disclosed on such Tax Return in accordance with Section 6662(d)(2)(B) of the Code (or corresponding provision of any
such predecessor statute, or state, local, or foreign Tax law).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(s) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(t) [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(u) No property of Company is
required to be treated as owned by another Person pursuant to Section 168(f)(8) of the Code (as in effect prior to its amendment by the
Tax Reform Act of 1986) or is &ldquo;tax-exempt use property&rdquo; within the meaning of Section 168 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(v) Company is not a party to
any lease arrangement involving a defeasance of rent, interest, or principal.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(w) Company is a not a direct
or indirect beneficiary of a guarantee of Tax benefits or any other arrangement that has the same economic effect (including an indemnity
from a seller or lessee of property, or other insurance) with respect to any transaction or tax opinion relating to Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(x) Company does not own any &ldquo;corporate
acquisition indebtedness&rdquo; within the meaning of Section 279 of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(y) Company has never been (i)
a &ldquo;passive foreign investment company,&rdquo; (ii) a &ldquo;foreign personal holding company,&rdquo; (iii) a &ldquo;foreign sales
corporation,&rdquo; (iv) a &ldquo;foreign investment company,&rdquo; or (v) a Person other than a United States Person, each within the
meaning of the Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(z) There are no Encumbrances
for Taxes (other than for current Taxes not yet due and payable or for any state or local Taxes that may result from an election under
Section 338(h)(10) of the Code) upon Company&rsquo;s assets or real property.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(aa) The Company has made a valid
election to be taxed as a C corporation within the meaning of Code.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 15; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.17. <u>Environmental Matters</u>.
Company (i) has obtained all applicable permits, licenses and other authorizations (collectively, the &ldquo;<b>Environmental Permits</b>&rdquo;),
which are required to be obtained under all applicable Laws, Orders, notice or demand letter issued, entered, promulgated or approved
thereunder relating to pollution or protection of the environment, including laws relating to emissions, discharges, releases or threatened
releases of pollutants, contaminants, or hazardous or toxic materials or wastes into ambient air, surface water, ground water, or land
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport, or handling of pollutants,
contaminants or hazardous or toxic materials or wastes (&ldquo;<b>Environmental Laws</b>&rdquo;) by Company (or its respective agents),
which Environmental Permits are in full force and effect, (ii) to the knowledge of Company, is in compliance with all terms and conditions
of such Environmental Permits, (iii) is in material compliance with all limitations, restrictions, conditions, standards, prohibitions,
requirements, obligations, schedules and timetables contained in applicable Environmental Laws, (iv) as of the date of this Agreement,
is not aware of nor has received notice of any past or present violations of Environmental Laws or Environmental Permits or any event,
condition, circumstance, activity, practice, incident, action or plan which is reasonably likely to interfere with or prevent continued
compliance with Environmental Permits or which would give rise to any common law or statutory liability, or otherwise form the basis of
any claim, action, suit or proceeding, against Company based on or resulting from the manufacture, processing, distribution, use, treatment,
storage, disposal, transport or handling, or the emission, discharge or release into the environment, of any pollutant, contaminant or
hazardous toxic material or waste, and (v) has taken all actions necessary under applicable Environmental Laws to register any products
or materials required to be registered by Company (or any of its respective agents) thereunder.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.18. <u>Intellectual Property</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) <i><u>Schedule 3.18(a)</u></i>
sets forth a true and complete list of all Intellectual Property owned or used by Company. Company owns free and clear of all Encumbrances,
or is licensed or otherwise possesses legally enforceable right to use all patents, trademarks, trade names, service marks, domain names
and any applications therefor, and computer software programs or applications (the &ldquo;<b>Intellectual Property</b>&rdquo;) that are
used in the Business as currently conducted, and such rights constitute all the rights necessary for Company to conduct the Business as
currently conducted.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) Except as would not, individually
or in the aggregate, have a Material Adverse Effect, Company is not, nor will it be, as a result of the execution and delivery of this
Agreement or the performance of its obligations hereunder, in violation of any licenses, sublicenses and other agreements as to which
Company is a party and pursuant to which Company is authorized to use any third party Intellectual Property (&ldquo;<b>Third Party Intellectual
Property Rights</b>&rdquo;). Except as set forth in <i><u>Schedule 3.18(b)</u></i>, immediately after the Closing Date, Company will continue
to own all right, title and interest in, and to have a license to use all Intellectual Property material to its business and operations
on terms and conditions identical in all respects to those enjoyed by Company immediately prior to such transactions. Except as set forth
in <i><u>Schedule 3.18(b)</u></i>, no claims with respect to the Intellectual Property owned by Company (the &ldquo;<b>Company Intellectual
Property Rights</b>&rdquo;), any trade secret material to Company, or Third Party Intellectual Property Rights to the extent arising out
of any use, sale of, reproduction or distribution of such Third Party Intellectual Property Rights by or through Company, are currently
pending or, to the knowledge of Company, are threatened by any Person. Except as set forth in <i><u>Schedule 3.18(b)</u></i>, Company
does not know of any valid grounds for any bona fide claims (i) to the effect that the manufacture, sale, licensing or use of any Intellectual
Property as now used, sold or licensed by Company, infringes on the Intellectual Property Rights of any third party; (ii) against the
use by Company of any Intellectual Property used in the Business as currently conducted; (iii) challenging the ownership, validity or
effectiveness of any of Company Intellectual Property Rights or other trade secret material to Company; or (iv) challenging the license
or legally enforceable right to use of the Third Party Intellectual Property Rights by Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 16; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) Company has made available
to Buyer copies of all agreements executed by Company employees with regard to (i) assignment of right, title and interest in such employee&rsquo;s
work product to Company, including any underlying Intellectual Property Rights, (ii) cooperation whether during or after employment with
Company in perfecting Company&rsquo;s rights in such assigned Intellectual Property Rights, including the execution of any applications,
assignment forms and the like, and (iii) prohibition on disclosure of Company proprietary information, including, without limitation,
Company know-how, business plans, techniques, methods, customer lists and supplier lists (collectively, &ldquo;<b>Trade Secrets</b>&rdquo;)
during their employment and thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) <i><u>Schedule 3.18(d)</u></i>
sets forth the names of all Company contractors that invented Company proprietary technology or software or that invented technology or
software specifically for Company. Company has made available to Buyer copies of all agreements executed by Company contractors with regard
to (i) assignment of right, title and interest in such contractor&rsquo;s work product to Company, including any underlying Intellectual
Property Rights, and (ii) prohibition on disclosure of any Company proprietary information, including, without limitation, Company Trade
Secrets during their engagement and thereafter.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.19. <u>Interested Party Transactions</u>.
Except as set forth in <i><u>Schedule 3.19</u></i>, there has been no transaction between Company, on the one hand, and any Affiliate
of Company, any officer, manager or employee of Company, or any spouse, parent, child, grandchild or sibling of any officer, manager or
employee of Company, on the other hand, other than transactions related to employment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.20. <u>Insurance</u>. All material
fire and casualty, general liability, business interruption, product liability, professional liability and sprinkler and water damage
insurance policies maintained by Company are of kind, in the amounts and against the risks customarily maintained by organizations similarly
situated. <i><u>Schedule 3.20</u></i> lists all of the material insurance policies held by or on behalf of Company with the effective
date and coverage amounts indicated thereon. Such policies and binders are valid and enforceable in accordance with their terms and are
in full force and effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.21. <u>Brokers</u>. Except as
disclosed in <i><u>Schedule 3.21</u></i>, no broker, finder or investment banker is entitled to any brokerage, finder&rsquo;s or other
fee or commission from Company in connection with the transactions contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.22. <u>Bank Accounts</u>. <i><u>Schedule
3.22</u></i> provides, as of the date of this Agreement, accurate information with respect to each account maintained by or for the benefit
of Company at any bank or other financial institution including the name of the bank or financial institution, the account number and
the names of all individuals authorized to draw on or make withdrawals from such accounts.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.23. <u>Certain Payments</u>. Neither
Company nor to its knowledge any manager, officer, agent or employee of Company, nor any other Person acting for or on behalf of Company,
has directly or indirectly, on behalf of Company made any contribution, gift, bribe, rebate, payoff, influence payment, kickback or other
payment to any entity or Person, private or public, regardless of form, whether in money, property or services in material violation of
any federal, state, local or foreign statute, law, ordinance, rule or regulation.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 17; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.24. <u>[Intentionally omitted.]</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.25. <u>Complete Copies of Materials</u>.
Each document that Company has delivered to Buyer (or made available in a data room for review by Buyer), other than documents that have
been redacted, is a true and complete copy of each such document, and in each case where a representation and warranty of Company in this
Agreement requires the listing of documents and agreements, a true and complete copy of all such documents and agreements have been delivered
to Buyer (or made available in a data room for review by Buyer).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.26. <u>Investment Company Act</u>.
Company either (i) is not an &ldquo;investment company,&rdquo; or a company &ldquo;controlled&rdquo; by, or an &ldquo;affiliated company&rdquo;
with respect to, an &ldquo;investment company,&rdquo; within the meanings of the Investment Company Act of 1940, as amended (the &ldquo;<b>Investment
Company Act</b>&rdquo;), or (ii) satisfies all conditions for an exemption from the Investment Company Act, and, accordingly, Company
is not required to be registered under the Investment Company Act.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.27. <u>Computer Back-Up</u>. Except
as set forth in <i><u>Schedule 3.27</u></i>, Company has made back-ups of all material computer software programs, source code, object
code, data, documentation and databases owned or licensed by it and maintains such computer software programs, source code, object code,
data, documentation and databases at an off-site location.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.28. <u>Trade Relations</u>. There
exists no actual or, to the knowledge of Company, threatened termination, cancellation or limitation of, or any other adverse modification
or change in, the business relationship of Company, or the Business, with any customer or supplier or any group of customers or suppliers
(including, without limitation, Company&rsquo;s affiliate contractors), that could reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.29. <u>Outstanding Borrowing</u>.
<i><u>Schedule 3.29</u></i> sets forth the amount of all Indebtedness of Company as of the date hereof (which amount, for all Indebtedness
other than capital lease obligations, shall not exceed $5,000 as of the Closing Date), the Encumbrances that relate to such Indebtedness
and that encumber the assets and the name of each lender thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.30. <u>Change of Control Provisions</u>.
Company is not party to any agreement that contains a change of control provision that would be triggered by the transactions contemplated
herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.31. <u>Potential Conflicts of
Interest</u>. Except as set forth in <i><u>Schedule 3.31</u></i>, to the knowledge of Seller, no officer, manager or member of Company,
no spouse of any such officer, manager or member, no relative of such spouse or of any such officer, manager or member and no Affiliate
of any of the foregoing: (a) owns, directly or indirectly, any interest in (excepting less than one percent (1%) stock holdings for investment
purposes in securities of publicly held and traded companies), or is an officer, manager, employee or consultant of, any Person which
is, or is engaged in business as, a competitor, lessor, lessee, supplier, distributor, sales agent or customer of, or lender to or borrower
from, Company; (b) owns, directly or indirectly, in whole or in part, any tangible or intangible property that Company has used in the
conduct of the Business; or (c) has any cause of action or other claim whatsoever against, or owes or has advanced any amount to, Company,
except for claims in the ordinary course of business such as for accrued vacation pay, accrued benefits under employee benefit plans,
and similar matters and agreements existing on the date hereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 18; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.32. <u>Product and Service Warranties</u>.
Each product or service sold, licensed, distributed, delivered or offered by the Company is in conformity with all applicable contractual
commitments and all express warranties in all material respects, and Company has no liability (and, to the Knowledge of Company, there
is no basis for any present or future Claim against the Company giving rise to any liability) for violations thereof or other damages
in connection therewith, subject only to the reserve set forth in the Financial Statements. No product sold, licensed, distributed or
delivered by the Company is subject to any guaranty, warranty or other indemnity beyond the applicable standard terms and conditions of
sale or lease, except for such guarantees, warranties and indemnities that are implied under applicable law and not disclaimable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.33. <u>Customers and Suppliers</u>.
<i><u>[Intentionally omitted.]</u></i></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">3.34. <u>Disclosure</u>. This
<u>Section 3</u>, as supplemented by the Company Disclosure Schedule, does not contain any untrue statement of a material fact or omit
to state a material fact necessary in order to make the statements contained herein or therein, in the light of the circumstances under
which they were made, not misleading.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">4. <b>Representations and Warranties
of Seller</b>. As a material inducement to Buyer to enter into this Agreement, Seller makes the representations and warranties set forth
below to Buyer, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">4.1. <u>Authority</u>. Seller has
all requisite power and authority to enter into the Transaction Documents to which it is a party and to consummate the transactions contemplated
hereby and thereby, as applicable. Seller has duly approved the Transaction Documents, as applicable. This Agreement has been duly executed
and delivered, and the other Transaction Documents to which such Seller is a party, when delivered, will have been duly executed and delivered
by such Seller, as applicable, and constitute the valid and binding obligation of such Seller, as applicable, enforceable in accordance
with its terms except as such enforceability may be limited by principles of public policy and subject to the laws of general application
relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive relief or other
equitable remedies.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">4.2. <u>Title to Shares of Stocks</u>.
Seller has good and marketable title to the Shares of Stocks free and clear of any Encumbrances. Seller has the full right, power and
authority to transfer, convey and sell the Shares of Stocks to Buyer, and Buyer will acquire from Seller good and marketable title to
the Shares of Stocks free and clear of all Encumbrances. Seller is not a party to, subject to or bound by any Order which would prevent
the transfer, conveyance and sale of the Shares of Stocks to Buyer.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">4.3. <u>[Intentionally omitted.]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 19; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">5. <b>Representations and Warranties
of Buyer</b>. As a material inducement to Seller to enter into this Agreement, Buyer makes the following representations and warranties
to Seller, all of which are true and correct as of the date hereof and the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.1. <u>Organization and Qualification;
subsidiaries</u>. Buyer is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization, and Buyer has the requisite corporate power and authority and is in possession of all Approvals necessary to own, lease
and operate the properties it purports to own, operate or lease and to carry on its business as it is now being conducted, except where
the failure to be so organized, existing and in good standing or to have such power, authority and Approvals would not, individually or
in the aggregate, have a Material Adverse Effect. Buyer is duly qualified or licensed as a foreign entity to do business, and is in good
standing, in each jurisdiction where the character of its properties owned, leased or operated by it or the nature of its activities makes
such qualification or licensing necessary, except for such failures to be so duly qualified or licensed and in good standing that would
not, individually or in the aggregate, have a Material Adverse Effect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.2. <u>Authority Relative to this
Agreement</u>. Buyer has all necessary corporate power and authority to execute and deliver the Transaction Documents and to perform its
obligations thereunder and to consummate the transactions contemplated thereby. The execution and delivery of the Transaction Documents
by Buyer and the consummation by Buyer of the transactions contemplated thereby have been duly and validly authorized by all necessary
corporate action on the part of Buyer, and no other corporate proceedings on the part of Buyer or the stockholders of Buyer are necessary
to authorize the Transaction Documents or to consummate the transactions contemplated thereby. The Transaction Documents have been duly
and validly executed and delivered by Buyer and, assuming the due authorization, execution and delivery by Company, constitute a legal,
valid and binding obligation of Buyer enforceable against it in accordance with their terms, except as enforceability may be limited by
applicable bankruptcy, insolvency, reorganization, fraudulent conveyance or transfer, moratorium or similar laws affecting the enforcement
of creditors&rsquo; rights generally and by general principles of equity relating to enforceability (regardless of whether considered
in a proceeding of law or in equity).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.3. <u>No Conflict, Required Filings
and Consents</u>. The execution and delivery of this Agreement by Buyer does not, and the performance of this Agreement by Buyer will
not, (i) conflict with or violate the Articles of Incorporation (or equivalent organizational documents) or bylaws of Buyer, (ii) conflict
with or violate any law, rule, regulation, order, judgment or decree applicable to Buyer or any of its subsidiaries or by which its or
their respective properties are bound or affected, or (iii) result in any breach of or constitute a default (or an event that with notice
or lapse of time or both would become a default) under, or modification in a manner materially adverse to Buyer or its subsidiaries of
any right or benefit under, or impair Buyer&rsquo;s or any of its subsidiaries&rsquo; rights or alter the rights or obligations of any
third party under, or give to others any rights of termination, amendment, acceleration, repayment or repurchase, increased payments or
cancellation under, or result in the creation of a Encumbrance on any of the properties or assets of Buyer or any of its subsidiaries
pursuant to, any Contract, Law or Order to which Buyer or any of its subsidiaries or its or any of their respective properties are bound
or affected, except in the case of (ii) or (iii) only, for any such conflicts, violations, breaches, defaults or other occurrences that
would not, individually or in the aggregate, have a Material Adverse Effect. The execution and delivery of this Agreement by Buyer does
not, and the performance of this Agreement by Buyer will not require any consent, approval, exemption, authorization or permit of, or
filing with or notification to, any Governmental Entity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 20; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.4. <u>Brokers</u>. No broker,
finder or investment banker is entitled to any brokerage, finder&rsquo;s or other fee or commission in connection with the transactions
contemplated by this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">5.5. <u>Disclosure</u>. This <u>Section
5</u> does not contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements
contained herein or therein, in the light of the circumstances under which they were made, not misleading</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">6. <b>Additional Agreements</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.1. <u>[Intentionally omitted.]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.2. <u>[Intentionally omitted.]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.3. [Intentionally omitted.]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.4. <u>[</u>Intentionally omitted<u>]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.5. <u>Cooperation</u>. Subject
to the terms and conditions of this Agreement, each of the Parties hereto shall use his, her or its best efforts to take, or cause to
be taken, all actions to do, or cause to be done, all things necessary, proper or advisable under applicable laws and regulations to consummate
and make effective the transactions contemplated by this Agreement, including providing information and using reasonable efforts necessary
or appropriate to obtain waivers, consents and approvals to this Agreement and the transactions contemplated hereby, including specifically
obtaining any consent to transfer the Shares of Stocks to Buyer, to effect all necessary registrations and filings.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.6. <u>Public Announcements</u>.
Buyer and Seller, acting on behalf of Seller and Company, shall consult with each other before issuing any press release with respect
to this Agreement, the Transaction Documents and the transactions contemplated hereby and shall not issue any such press release or make
any such public statement, except as required by Law or any listing agreement with any applicable national securities exchange, without
the prior consent of the other Party, which shall not be unreasonably withheld, delayed or conditioned.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">6.7. <u>Tax Cooperation</u>. After
the Closing, Seller shall, and shall cause Seller and their Affiliates to, cooperate fully with Buyer and Company in the preparation of
all tax returns and shall provide, or cause to be provided at Buyer&rsquo;s sole cost and expense, to Buyer and Company any records and
other information requested by such Parties in connection therewith. Seller shall, and shall Seller and their Affiliates to, cooperate
fully with Buyer and Company in connection with any tax investigation, audit or other proceeding.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 21; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">7. <b>Deliveries at Closing</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">7.1. <u>Seller Closing Deliveries</u>.
At the Closing, Seller and/or Company shall deliver or cause to be delivered to Buyer:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) an Agreement of Shares of
Stock in favor of Buyer or its nominee as Buyer may have directed prior to the Closing Date and otherwise in a form acceptable for transfer
on the books of Company;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.] ;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(e) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(f) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(g) the consents and approvals
as set forth on <i><u>Schedule 3.5(a)</u></i>;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(h) written resignations by each
of the officers and Managers of Company in office immediately prior to the Closing Date;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(i) a certificate, dated as of
the Closing Date, of the Secretary or an Assistant Secretary of Company evidencing all necessary or appropriate corporate action to enable
such Company to comply with the terms of this Agreement;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(j) a certificate of good standing
for Company issued by the Florida Secretary of State within a reasonable date of the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(k) good standing and tax good
standing bring-down certificates for Company issued as of the date of the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(l) such documents as Buyer or
its counsel may reasonably require.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">7.2. <u>Buyer&rsquo;s Closing Deliveries</u>.
At the Closing, Buyer shall deliver or cause to be delivered to Seller:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) the Closing Payment;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(e) such other documents as Seller
or his, her or its counsel may reasonably require.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 22; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">8. <b>Conditions to Obligations
of Buyer</b>. The obligation of Buyer to consummate the transactions contemplated by this Agreement and the Transaction Documents is subject
to the following conditions, any of which may be waived by it in writing in its sole discretion:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.1. <u>[Intentionally omitted.]</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.2. <u>Compliance by Seller and
Company</u>. Seller and Company shall have performed and complied in all material respects with all agreements and conditions required
by this Agreement to be performed or complied with by Seller and Company, as applicable prior to or on the Closing Date, including, but
not limited to the delivery by Seller and Company of the items set forth in <u>Section 7.1</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.3. <u>Accuracy of the Representations</u>.
The representations and warranties of Seller and Company contained in this Agreement, or any schedule, certificate or other instrument
delivered pursuant to the provisions hereof or in connection with the transactions contemplated hereby shall be true and correct in all
respects at and as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.4. <u>Consents</u>. Seller and/or
Company shall have obtained each of the consents and approvals set forth on <i><u>Schedule 3.5(a)</u></i>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.5. <u>[</u> Intentionally omitted<u>]
</u></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.6. <u>No Regulatory Changes</u>.
No action shall have been taken by any Governmental Entity, and no law shall have been proposed or enacted, which would (or, in the case
of a proposed law, if enacted) materially and adversely affect the financial condition, operations or prospects of Company or the regulatory
compliance status of Company.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.7. <u>Documents</u>. All documents
and instruments required hereunder to be delivered by Company and Seller to Buyer at the Closing shall be delivered in form and substance
reasonably satisfactory to Buyer and its counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">8.8. <u>Litigation</u>. No litigation
seeking to enjoin the transactions contemplated by this Agreement or to obtain damages on account hereof shall be pending or threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">9. <b>Conditions to Obligations
of Seller</b>. The obligation of Seller to consummate the transaction contemplated by this Agreement is subject to the following conditions,
any of which may be waived by him, her or it in his, her or its sole discretion:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.1. <u>Compliance by Buyer</u>.
Buyer shall have performed and complied in all material respects with all agreements and conditions required by this Agreement to be performed
or complied with by Buyer prior to or on the Closing Date, including, but not limited to the delivery by Buyer of the items set forth
in <u>Section 7.2</u>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.2. <u>Accuracy of Buyer&rsquo;s
Representations</u>. Buyer&rsquo;s representations and warranties contained in this Agreement, or any schedule, certificate or other instrument
delivered pursuant to the provisions hereof or in connection with the transactions contemplated hereby shall be true and correct in all
material respects at and as of the Closing Date.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 23; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.3. <u>Documents</u>. All documents
and instruments required hereunder to be delivered by Buyer to Seller at the Closing shall be delivered in form and substance reasonably
satisfactory to Seller and his, her or its counsel.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">9.4. <u>Litigation</u>. No litigation
seeking to enjoin the transactions contemplated by this Agreement or to obtain damages on account hereof shall be pending or threatened.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">10. <b>[</b>Intentionally omitted<b>]</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">11. <b>Indemnification</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">11.1. <u>Indemnification</u>. Except
as otherwise provided in this <u>Section 11</u>, Seller (the &ldquo;<b>Indemnifying Party</b>&rdquo;) agrees to indemnify, defend and
hold harmless each of Buyer, Company and their Affiliates and their respective officers, directors, managers, agents, employees, subsidiaries,
partners, shareholders or members, as the case may be and controlling Persons (each, an &ldquo;<b>Indemnified Party</b>&rdquo;) to the
fullest extent permitted by law from and against any and all losses, actions, suits, proceedings, claims, complaints, disputes, arbitrations
or investigations or written threats thereof (collectively, &ldquo;<b>Claims</b>&rdquo;) (including, without limitation, any Claim by
a third party), damages, expenses (including reasonable fees, disbursements and other charges of counsel incurred by the Indemnified Party
in any action between Seller and an Indemnified Party or between an Indemnified Party and any third party or otherwise) or other liabilities
resulting from or arising out of any breach of any representation or warranty, covenant or agreement by Seller in this Agreement, or relating
to any Excluded Liabilities (collectively, &ldquo;<b>Losses</b>&rdquo;). In connection with the obligation of Seller to indemnify for
Losses as set forth above, Seller shall, upon presentation of appropriate invoices containing reasonable detail, reimburse each Indemnified
Party for all such Losses (including reasonable fees, disbursements and other charges of counsel incurred by the Indemnified Party in
any action between Seller and the Indemnified Party or between the Indemnified Party and any third party) as they are incurred by such
Indemnified Party. The Parties agree to treat indemnification payments under this <u>Section 11.1</u> as adjustments to the Purchase Price
for Tax purposes. If Seller contest a Claim by the Buyer against them, they will not be responsible for paying the submitted invoice until
either they agree as to the validity and amount of the Claim or the validity and amount of the Claim have been adjudicated by an arbitration
as provided in <u>Section 13.6</u> or by a court of competent jurisdiction after exhaustion of all appeals. Buyer likewise agrees to indemnify,
defend and hold harmless each of Seller and its Affiliates and their respective officers, directors, managers, agents, employees, subsidiaries,
partners, shareholders or members, as the case may be and controlling Persons (each, a &ldquo;<b>Seller Indemnified Party</b>&rdquo;)
to the fullest extent permitted by law from and against any and all Claims (including, without limitation, any Claim by a third party),
damages, expenses (including reasonable fees, disbursements and other charges of counsel incurred by the Seller Indemnified Party in any
action between Buyer and a Seller Indemnified Party or between a Seller Indemnified Party and any third party or otherwise) or other liabilities
resulting from or arising out of any breach of any representation or warranty, covenant or agreement by Buyer in this Agreement, or relating
to operation of the Business after the Closing Date. An Indemnified Party or Seller Indemnified Party may each be referred to herein as
an Indemnified Party.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 24; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">11.2. <u>Procedure for Third Party
Claim Indemnification</u>. Each Indemnified Party under this <u>Section 11</u> shall, promptly after the receipt of notice of the commencement
of any Claim by a third party against such Indemnified Party in respect of which indemnity may be sought from Seller under this <u>Section
11.2</u>, notify Seller in writing of the commencement thereof. The omission of any Indemnified Party to so notify Seller of any such
action shall not relieve any Indemnifying Party from any liability which it may have to such Indemnified Party under this <u>Section 11</u>
unless, and only to the extent that, such omission results in the Indemnifying Party&rsquo;s loss of substantive or practical rights or
defenses. In case any such Claim shall be brought against any Indemnified Party, and it shall notify the Indemnifying Party of the commencement
thereof, the Indemnifying Party shall be entitled to assume the defense thereof at its own expense, with counsel satisfactory to such
Indemnified Party in its reasonable judgment; provided, however, that any Indemnified Party may, at its own expense, retain separate counsel
to participate in such defense at its own expense. Notwithstanding the foregoing, in any Claim in which both the Indemnifying Party, on
the one hand, and an Indemnified Party, on the other hand, are, or are reasonably likely to become, a party, such Indemnified Party shall
have the right to employ separate counsel and to control its own defense of such Claim if, in the reasonable opinion of counsel to such
Indemnified Party, either (x) one or more defenses are available to the Indemnified Party that are not available to the Indemnifying Party
or (y) a conflict or potential conflict exists between the Indemnifying Party, on the one hand, and such Indemnified Party, on the other
hand, that would make such separate representation advisable; provided, however, that the Indemnifying Party (i) shall not be liable for
the fees and expenses of more than one counsel to all Indemnified Parties and (ii) shall reimburse the Indemnified Parties for all of
such fees and expenses of such counsel incurred in any action between the Indemnifying Party and the Indemnified Parties or between the
Indemnified Parties and any third party, as such expenses are incurred. The Indemnifying Party agrees that it will not, without the prior
written consent of the Indemnified Party, settle, compromise or consent to the entry of any judgment in any pending or threatened Claim
relating to the matters contemplated hereby unless such settlement, compromise or consent includes an unconditional release of each Indemnified
Party from all liability arising or that may arise out of such Claim. Upon making any payment to an Indemnified Party for a loss under
this <u>Section 11</u>, the Indemnifying Party shall be subrogated to any rights that the Indemnified Party may have against any other
Person with respect to the subject matter underlying such indemnification claim.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">11.3. <u>Limitations on Indemnification</u>.
Notwithstanding any other provision of this <u>Section 11</u> no Claims shall be brought for indemnification after the survival period
set forth in <u>Section 10</u> hereof, and the Indemnifying Parties shall not be obligated, individually or collectively, to make any
payment or payments pursuant to this <u>Section 11</u> in an aggregate amount in excess cash the Purchase Price (the &ldquo;<b>Cap</b>&rdquo;).
No claim shall be filed against Seller until the aggregate potential liability exceeds $25,000 at which time the Seller will be responsible
for the $25,000 plus the excess.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">11.4. <u>Exclusive Remedy</u>. Indemnification
pursuant to this <u>Section 11</u> shall be the sole means for redress of Claims under this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>


<!-- Field: Page; Sequence: 25; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">12. <b>Termination</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">12.1. <u>Termination of Agreement</u>.
Certain of the Parties may terminate this Agreement as provided below:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(a) Buyer and Seller may terminate
this Agreement by mutual written consent at any time prior to the Closing;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(b) [Intentionally omitted.];</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(c) Buyer may terminate this Agreement
by giving written notice to Seller at any time prior to the Closing in the event Company or Seller have breached any representation, warranty,
or covenant contained in this Agreement in any material respect; and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">(d) Seller may terminate this
Agreement by giving written notice to Buyer at any time prior to the Closing in the event Buyer has breached any representation, warranty,
or covenant contained in this Agreement in any material respect.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">12.2. <u>Effect of Termination</u>.
If any Party terminates this Agreement pursuant to <u>Section 11.5</u>, all rights and obligations of the Parties hereunder shall terminate
without any liability of any Party to any other Party (except for any liability of any Party then in breach).</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">13. <b>Miscellaneous</b>.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.1. <u>Expenses</u>. Except as
otherwise provided herein, Seller (and not Company on behalf of Seller or on behalf of itself) and Buyer shall each pay its own expenses
incident to the negotiation, preparation, and carrying out of this Agreement, including all fees and expenses of its counsel and accountants
for all activities of such counsel and accountants undertaken pursuant to this Agreement, irrespective of whether or not the transactions
contemplated hereby are consummated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.2. <u>Notices</u>. All notices
and other communications given or made pursuant hereto shall be in writing and shall be deemed to have been duly given or made if and
when delivered personally or by overnight courier to the Parties at the following addresses or sent by electronic transmission, with confirmation
received, to the email address specified below (or at such other address or email address for a Party as shall be specified by like notice):</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">To Seller:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">Scienture Holdings, Inc.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">ATTN: CEO</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">20 Austin Boulevard, Commack,
NY 11725</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 1.5in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">To Buyer:</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">TOLLO HEALTH, INC.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">ATTN: Gerald Commissiong</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1.5in">6308 Benjamin Rd Suite 708, Tampa
FL 33634</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Any such notice shall, when sent in accordance with
the preceding sentence, be deemed to have been given and received on the earliest of (i) the day delivered to such address, (ii) the day
sent by email, (iii) the fifth Business Day following the date deposited with the United States Postal Service, or (iv) 24 hours after
shipment by such courier service.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 26; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.3. <u>Assignment; Third Party
Beneficiaries</u>. Neither this Agreement nor any rights or obligations under it are assignable except that Buyer may assign its rights
hereunder. There shall be no third-party beneficiaries of this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">13.4.
<u>GOVERNING LAW</u>. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE INTERNAL LAWS OF THE STATE OF FLORIDA
APPLICABLE TO CONTRACTS EXECUTED AND FULLY PERFORMED WITHIN THE STATE OF FLORIDA.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in"><font style="text-transform: uppercase">13.5.
</font><u>Jurisdiction, Venue and Waiver of Jury Trial</u>. The Parties intend that all disputes concerning this Agreement shall be resolved
by arbitration as provided below. However, to the extent arbitration shall be held by a court of competent jurisdiction to be unenforceable
or shall otherwise be impossible, and any party submits any matter to a court, the Parties agrees as follows: any suit, action or proceeding
with respect to this Agreement shall be brought exclusively in the Florida state courts of competent jurisdiction or in the United States
District Court in each case located in Tampa, Florida. <font style="text-transform: uppercase">ALL PARTIES HEREBY IRREVOCABLY WAIVE ANY
OBJECTIONS WHICH THEY MAY NOW OR HEREAFTER HAVE TO THE PERSONAL JURISDICTION OR VENUE OF ANY SUIT, ACTION OR PROCEEDING ARISING OUT OF
OR RELATING TO THIS AGREEMENT BROUGHT IN ANY SUCH COURT AND HEREBY FURTHER IRREVOCABLY WAIVE ANY CLAIM THAT SUCH SUIT, ACTION OR PROCEEDING
BROUGHT IN ANY SUCH COURT HAS BEEN BROUGHT IN AN INCONVENIENT FORUM. The PARTIES HEREBY FURTHER IRREVOCABLY WAIVE ANY RIGHT TO A JURY
TRIAL IN ANY ACTION ARISING OUT OF OR IN CONNECTION WITH THIS AGREEMENT.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.6. <u>Dispute Resolution</u>.
Except as otherwise provided herein, in the event of any dispute, controversy or claim arising out of or relating to this Agreement or
the breach thereof, the parties shall meet promptly (through representatives with authority to resolve the dispute). If the parties cannot
resolve the dispute within thirty (30) days, the parties shall arbitrate the dispute in accordance with the Commercial Arbitration Rules
the American Arbitration Association, pursuant to the Commercial Arbitration Rules then in effect. The arbitrator selected shall be an
independent third party and shall have knowledge and experience in the matters addressed by the claim. Demand for arbitration must be
made no later than the time that such action would be permitted under the applicable Florida statute of limitation. Except as set forth
in <u>Section 13.5</u> and this <u>Section 13.6</u>, arbitration shall be the sole and exclusive remedy between the parties with respect
to any dispute, protest, controversy or claim arising out of or relating to this Agreement, provided, the arbitrators shall not have the
power or authority to award consequential, incidental or punitive damages. Unless all the parties to an arbitration otherwise consent
in writing, the location of the arbitration hearings and the place of entry of the award shall be in Tampa, Florida. The Parties consent
to exclusive jurisdiction of, and agree that sole venue will lie in, the state and federal courts applicable to Tampa, Florida, for any
allowable judicial proceeding relating to any arbitration under this Agreement, including entry of a judgment on the award. The arbitration
award shall be final and binding and shall not be reviewable in any court on any grounds except corruption, fraud or undue means of a
party or for evident partiality or corruption of the arbitrator. The parties intend to eliminate all other court review of the award and
the arbitration proceedings. Except as necessary in a judicial proceeding allowable under this <u>Section 13.6</u>, all matters relating
to any arbitration shall be confidential. The matters include the existence and subject of the arbitration. The parties hereby acknowledge
that any breach of the provisions of <u>Section 6.3</u> and <u>6.6</u> may give rise to irreparable injury to Buyer or Company (as the
case may be), inadequately compensable in monetary damages. Notwithstanding anything to the contrary stated herein, the non-breaching
party will be able to seek and obtain equitable relief, including injunctive relief, against the breach or threatened breach of any of
such provisions and the prevailing party shall be entitled to recover from the other party its reasonable attorneys&rsquo; fees and costs
incurred. This <u>Section 13.6</u> shall survive the Closing.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 27; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.7. <u>Counterparts</u>. This
Agreement may be executed in one or more counterparts, and by the different Parties in separate counterparts, each of which when executed
shall be deemed to be an original but all of which taken together shall constitute one and the same agreement. It is the express intent
of the Parties to be bound by the exchange of signatures on this Agreement via facsimile or email with scan attachment.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.8. <u>No Implied Waiver; Remedies</u>.
No failure or delay on the part of the Parties to exercise any right, power, or privilege hereunder or under any instrument executed pursuant
hereto shall operate as a waiver nor shall any single or partial exercise of any right, power, or privilege preclude any other or further
exercise thereof or the exercise of any other right, power, or privilege. All rights, powers, and privileges granted herein shall be in
addition to other rights and remedies to which the Parties may be entitled at law or in equity, except as provided otherwise herein.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.9. <u>Entire Agreement</u>. This
Agreement, including the Exhibits and Schedules attached hereto and the other Transaction Documents, set forth the entire understandings
of the Parties with respect to the subject matter hereof, and it incorporates and merges any and all previous communications, understandings,
oral or written as to the subject matter hereof and thereof.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.10. <u>Amendments; Actual Waivers</u>.
This Agreement may not be amended except by an instrument in writing signed on behalf of Buyer and Seller. Any agreement on the part of
Buyer or Seller to any such extension or waiver shall be valid if set forth in an instrument in writing signed on behalf of Buyer or Seller,
as applicable.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.11. <u>Headings</u>. The headings
of the Sections of this Agreement, where employed, are for convenience only and do not form a part hereof and in no way modify, interpret
or construe the meanings of the Parties.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.12. <u>Severability</u>. Any
provision of this Agreement which is invalid or unenforceable shall be ineffective only to the extent of such invalidity or unenforceability
without invalidating or rendering unenforceable the remaining provisions of this Agreement. Provided, however, in the event the provision
which is invalid or unenforceable pertains to a material element of the transaction such that the principal objectives of the transaction
provided for herein are materially impaired or are invalid or unenforceable, this Agreement shall be terminated.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 28; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.13. <u>Specific Performance</u>.
Seller, Buyer and Company each acknowledge that, in view of the uniqueness of the Business and the transactions contemplated by this Agreement,
each Party would not have an adequate remedy at law for money damages in the event that this Agreement has not been performed in accordance
with its terms, and therefore agrees that the other party shall be entitled to specific enforcement of the terms hereof in addition to
any other remedy to which it may be entitled, at law or in equity.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.14. <u>No Presumption Regarding
Drafter</u>. The Parties acknowledge and agree that the terms and provisions of this Agreement have been negotiated and discussed between
them, and that this Agreement reflects their mutual agreement regarding the subject matter of this Agreement. Because of the nature of
such negotiations and discussions, it would not be appropriate to deem either Buyer or Seller to be the drafter of this Agreement, and
therefore no presumption for or against the drafter shall be applicable in interpreting or enforcing this Agreement.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.15. <u>Other Interpretation Rules</u>.
As used in this Agreement, any reference to the masculine, feminine or neuter gender shall include all genders, the plural shall include
the singular, and the singular shall include the plural. Unless the context otherwise requires, the words &ldquo;hereof,&rdquo; &ldquo;hereby&rdquo;
and &ldquo;herein&rdquo; and words of similar meaning when used in this Agreement refer to this Agreement in its entirety and not to any
particular article, section or provision hereof. In interpreting the representations and warranties of this Agreement, the principle that
the specific governs and controls the general shall apply. Any representation and warranty made as to any past fact, situation, circumstance,
status, condition, activity, practice, plan, occurrence, event, incident, action, failure to act, or transaction relates any of the foregoing
that first occurred or came into existence within the three (3) year period prior to the date hereof, unless a different time period is
expressly provided.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">13.16. <u>Further Assurances</u>.
Each Party shall execute such documents and other papers and take such further actions as may be reasonably required or desirable to carry
out the provisions hereof and the transactions contemplated hereby.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center; text-indent: 0in">[<b>SIGNATURE PAGE FOLLOWS</b>]</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 1in">&nbsp;</p>


<!-- Field: Page; Sequence: 29; Value: 2 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="text-align: center; width: 100%"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">IN WITNESS WHEREOF, the Parties
have executed this Agreement as of the date first set forth above.</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 0.5in">&nbsp;</p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><font style="font-size: 10pt">&ldquo;<b>BUYER</b>&rdquo;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 5%">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: center"><font style="font-size: 10pt">&ldquo;<font style="text-transform: uppercase"><b>SELLER</b></font>&rdquo;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-size: 10pt; text-transform: uppercase"><b>TOLLO HEALTH, LLC.</b>, </font><font style="font-size: 10pt">a Delaware limited liability company </font></td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><font style="font-size: 10pt; text-transform: uppercase"><b>Scienture Holdings, INC.</b></font> <font style="font-size: 10pt">a Delaware corporation</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">By: </td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><i>/s/ Gerald Commissiong</i></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p></td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">By: </td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif">
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><i>/s/ Eric Sherb</i></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p>
    <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"></p></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Name: </td>
    <td style="font: 10pt Times New Roman, Times, Serif">Gerald Commissiong </td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Name: </td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Eric Sherb </td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">Title: </td>
    <td style="font: 10pt Times New Roman, Times, Serif">CEO </td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">Title: </td>
    <td style="font: 10pt Times New Roman, Times, Serif">Principal </td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">&nbsp;</p>


<!-- Field: Page; Sequence: 30 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase">Schedule
1</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>Schedule
of Seller</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center"><u>Name</u></td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: right"><u>Allocation of Shares of Stock</u></td><td style="font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">SCIENTURE Holdings, INC</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 20%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">100.00</td><td style="font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-decoration: none">&nbsp;</font></p>


<!-- Field: Page; Sequence: 31 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><b>&nbsp;</b></p>

<p style="font: bold 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase">Schedule
2</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>PURCHASE
PRICE</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><b>&nbsp;</b></p>

<table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 90%; font: 10pt Times New Roman, Times, Serif">
  <tr style="vertical-align: bottom">
    <td style="font-weight: bold; text-align: center"><u>Name</u></td><td style="font-weight: bold">&nbsp;</td>
    <td colspan="2" style="font-weight: bold; text-align: right"><u>Allocation of Purchase Price</u></td><td style="font-weight: bold">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="width: 76%; text-align: left">TOLLO HEALTH, LLC</td><td style="width: 2%">&nbsp;</td>
    <td style="width: 1%; text-align: left">&nbsp;</td><td style="width: 20%; text-align: right">100</td><td style="width: 1%; text-align: left">%</td></tr>
  <tr style="vertical-align: bottom; background-color: White">
    <td style="text-align: left">&nbsp;</td><td>&nbsp;</td>
    <td style="text-align: left">&nbsp;</td><td style="text-align: right">&nbsp;</td><td style="text-align: left">&nbsp;</td></tr>
  <tr style="vertical-align: bottom; background-color: rgb(204,238,255)">
    <td style="font-weight: bold; text-align: left">Total</td><td style="font-weight: bold">&nbsp;</td>
    <td style="font-weight: bold; text-align: left">&nbsp;</td><td style="font-weight: bold; text-align: right">100</td><td style="font-weight: bold; text-align: left">%</td></tr>
  </table>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left"><b>&nbsp;</b></p>


<!-- Field: Page; Sequence: 32 -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt; margin-bottom: 0pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: left">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><b>STOCK PURCHASE AGREEMENT</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">dated as of <b>April 8, 2025</b></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">by and among</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>TOLLO HEALTH,
LLC.</b><br />
</font>as Buyer,</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">and</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>SCIENTURE
HOLDINGS, INC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center">as Seller</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b></b></font></p>

<!-- Field: Rule-Page --><div style="margin: 0pt auto; width: 100%"><div style="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 1pt solid">&nbsp;</div></div><!-- Field: /Rule-Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"></font></p>

<!-- Field: Page; Sequence: 33; Options: Last -->
    <div style="margin-top: 0pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"><font style="text-transform: uppercase"><b>&nbsp;</b></font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: center"></p>



</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.03
<SEQUENCE>4
<FILENAME>ex1-03.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: right"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
1.03</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>THIS
PROMISSORY NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED. NO SALE OR DISPOSITION MAY BE EFFECTED EXCEPT IN
COMPLIANCE WITH RULE 144 UNDER SAID ACT OR AN EFFECTIVE REGISTRATION STATEMENT RELATED THERETO OR AN OPINION OF COUNSEL FOR THE HOLDER
SATISFACTORY TO THE COMPANY THAT SUCH REGISTRATION IS NOT REQUIRED UNDER THE ACT OR RECEIPT OF A NO-ACTION LETTER FROM THE SECURITIES
AND EXCHANGE COMMISSION.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>PROMISSORY
NOTE</b></font></p>

<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>$5,000,000</b></font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><p style="text-align: right; margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execution Date:</font></p>
                                                                                <p style="text-align: right; margin-top: 0; margin-bottom: 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampa,
    Florida</font></p></td></tr>
  </table>
<p style="text-align: center; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For
the purchase of Bonum Holdings Inc, Softell Inc, and Integra Pharma Solutions LLC (collectively the &ldquo;Subsidiaries&rdquo; of Scienture
Holdings Inc.), Tollo Health LLC., a Delaware corporation (the &ldquo;<b><i>Company</i></b>&rdquo;), promises to pay to <b>Scienture
Holdings Inc</b> or its assigns (&ldquo;<b><i>Holder</i></b>&rdquo;) the principal sum of five million Dollars <b>($5,000,000.00)</b>
together with accrued interest (defined below) thereon, each due and payable on the date and in the manner set forth below.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This
promissory note (the &ldquo;<b><i>Note</i></b>&rdquo;) is issued in connection with that certain Membership Interest Purchase Agreement
dated as of even date herewith and Stock Purchase Agreement dated as of even date herewith by and between the parties hereto.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>1.
Repayment. </b>All payments hereunder shall be in lawful money of the United States of America. Upon the Company&rsquo;s next equity
financing (one-time), 20% of the financing shall be used towards repayment of the Note. The remaining outstanding principal amount of
the Loan shall be due and payable <b><u>on June 30<sup>th</sup> 2030</u></b> (the &ldquo;<b><i>Maturity Date</i></b>&rdquo;). Company
retains the right to repay in the form of cash payment or stock in public shares of company based on the highest share price of the preceding
5 days at the time of repayment.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2.
<b>Interest Rate.</b> &ndash; prime interest rate</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>3.
Maturity.</b> The entire outstanding principal balance shall become fully due and payable on the Maturity Date or sooner at the option
of company.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4.
<b>Expenses. </b>In the event of any default hereunder, the Company shall pay all reasonable attorneys&rsquo; fees and court costs incurred
by Holder in enforcing and collecting this Note.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>5.
Prepayment.</b> This Note may be prepaid in full or in part without penalty.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6.
<b>Default. </b>If there shall be any Event of Default hereunder, at the option and upon the declaration of the Holder and upon written
notice to the Company (which election and notice shall not be required in the case of an Event of Default under Section 7(c)) this Note
shall accelerate and all principal shall become due and payable, provided. The occurrence of any one or more of the following shall constitute
an Event of Default:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)
The Company fails to pay timely any of the principal amount due under this Note on the date the same becomes due and payable, as and
when the same shall become due and payable and which default, is not cured within ten (10) days of written notice of such failure to
perform;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<!-- Field: Page; Sequence: 1 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)
The Company shall default in its performance of any covenant under the Agreement or any Note, and which default is not cured within ten
(10) days of written notice of such failure to perform;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)
The Company files any petition or action for relief under any bankruptcy, reorganization, insolvency or moratorium law or any other law
for the relief of, or relating to, debtors, now or hereafter in effect, or makes any assignment for the benefit of creditors or takes
any corporate action in furtherance of any of the foregoing; or</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>7.
Waiver. </b>The Company hereby waives demand, notice, presentment, protest and notice of dishonor.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>8.
Governing Law. </b>This Note shall be governed by and construed under the laws of the State of Florida, as applied to agreements among
Florida residents, made and to be performed entirely within the State of Florida, without giving effect to conflicts of laws principles.
The Note is further subject to the venue and arbitration provisions in the Agreement.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>9.
General Obligation. </b>This Note is a general unsecured obligation of the Company and in no event shall any officer or director of the
Company, or any affiliate of the Company, be liable for any amounts or damages due and payable pursuant to this Note.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>10.
Modification; Waiver.</b> Any term of this Note may be amended or waived with the written consent of the Company, the Parent and the
Holder.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">11.
<b>Assignment.</b> This Note may not be offered, sold, assigned or transferred by the Holder without the consent of the Company and the
Parent, which shall not require the consent of the Company.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 2.5in; text-indent: 0.5in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 50%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 3%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 47%"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Tollo
    Health LLC.</b></font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td>
    <td style="font: 10pt Times New Roman, Times, Serif">&nbsp;</td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">By:</font></td>
    <td style="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>Gerald
    Commissiong, CEO</u></font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>Tollo
    Health LLC</u></font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3000
    Baypoint Dr Suite 950, Tampa, FL 33607</font></td></tr>
  </table>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Holder:
<u>Scienture Holdings Inc</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Principal
Amount of Note: <u>$5,000,000.00</u></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Effective
Date of Note: June 30<sup>th</sup> 2025 or at time of Closing of MIPA and Stock Purchase of Integra Pharma Solutions LLC, Bonum Health
Inc, Softell Inc.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>


<!-- Field: Page; Sequence: 2; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#160;</font></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>5
<FILENAME>ex99-1.htm
<TEXT>
<!doctype html>
<html>
<head>
     <title></title>
</head>
<body style="font: 10pt Times New Roman, Times, Serif">

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; background-color: white">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: right; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Exhibit
99.1</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>SCIENTURE
announces the divestiture of its legacy subsidiaries for a total consideration of $5 million and dedicates its full focus to the Branded
and Specialty Pharma segment through Scienture, LLC.</b></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>TAMPA,
FL, April 08, 2025 (GLOBE NEWSWIRE) &mdash; SCIENTURE HOLDINGS, INC. (NASDAQ: SCNX) (the &ldquo;Company&rdquo;)</b>, a holding company
for existing and planned pharmaceutical operating companies focused on providing enhanced value to patients, physicians and caregivers
through developing, bringing to market, and distributing novel specialty products to satisfy unmet market needs, announced the divestiture
of its legacy Healthcare IT and Wholesale Operations subsidiaries Integra Pharma Solutions (IPS), Bonum Health, Inc., and Softell, Inc.
to Tollo Health, Inc. for a total consideration of $5 million.</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; text-align: justify; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
divestitures are part of a broader strategic realignment at the Company designed to sharpen operational focus and unlock long-term value.
It is aligned with the Company&rsquo;s commitment to streamline its core operations, optimize its portfolio, and accelerate growth in
the Branded and Specialty Pharma markets. The Company intends to use the proceeds obtained from the divestment to facilitate the high-growth
commercial and strategic product development activities at its Scienture, LLC subsidiary.&nbsp;</font></p>



<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"></font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The
Company believes that the key benefits of the divestitures include:</font></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; margin-left: 0; background-color: white"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<table cellspacing="0" cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>Increased
    Operational Efficiency</u><b>:</b> Streamlining the Company&rsquo;s structure aimed at strengthening its balance sheet, providing
    for leaner operations and a more agile decision-making framework.</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>Realize
    Synergies</u><b>:</b> Consolidating overlapping functions and eliminating redundancies intended to cause annualized cost savings.</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td></tr>
  <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#9679;</font></td>
    <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><u>Dedicated
    Focus</u><b>:</b> Affording the full focus and deployment of resources to the commercial products and the high value product pipeline
    in development at its Scienture, LLC subsidiary.</font></td></tr>
</table>

<p style="margin: 0">&nbsp;</p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This strategic move allows us to better align our resources with our long-term vision, focusing on our most high value business through Scienture, LLC,&rdquo; said Suren Ajarappu, Chairman of the Board and CEO of Scienture Holdings, Inc. &ldquo;By simplifying our operating model, we are on the path to realizing significant synergies and efficiencies, enhancing agility, reducing overhead, and improving our overall performance.&rdquo;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;This divestment enables us to better focus on our high value Specialty Pharma business at Scienture, LLC, where we can create the most value for patients, caregivers, our customers and shareholders. It&rsquo;s a decisive step in building a more resilient, future-focused organization.&rdquo; added Shankar Hariharan, Ph.D., CEO of Scienture, LLC. &ldquo;We&rsquo;re confident this decision enhances our ability to deliver excellent performance and build a stronger, more focused company.&rdquo;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&ldquo;Looking ahead, we&rsquo;re excited with the opportunities this streamlined structure brings across our operations&rdquo; said Narasimhan Mani, Ph.D., MBA, President of Scienture, LLC. &ldquo;As we continue to ramp our strong Sales &amp; Marketing and Supply Chain activities for our upcoming commercial product launches and achieve key milestones across our product pipeline, this has put us on a focused path to accelerate growth, drive innovation and deliver sustainable value creation.&rdquo;</font></p>



<p style="margin: 0">&nbsp;</p>

<!-- Field: Page; Sequence: 2 -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <div style="break-before: page; margin-top: 6pt"><p style="margin: 0pt">&nbsp;</p></div>
    <!-- Field: /Page -->

<p style="margin: 0">&nbsp;</p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>About Scienture Holdings, Inc.</b></font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCIENTURE
HOLDINGS, INC. (NASDAQ: &ldquo;SCNX&rdquo;), through its wholly owned subsidiaries, including Scienture, LLC is a comprehensive pharmaceutical
product company focused on providing enhanced value to patients, physicians and caregivers by offering novel specialty products to satisfy
unmet market needs. Scienture, LLC is a branded, specialty pharmaceutical company consisting of a highly experienced team of industry
professionals who are passionate about developing and bringing to market unique specialty products that provide enhanced value to patients
and healthcare systems. The assets in development at Scienture, LLC are across therapeutics areas, indications and cater to different
market segments and channels. For more information xplease visit <u>www.scienture.com</u>.</font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Cautionary Statements Regarding Forward-Looking Statements</b></font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>&nbsp;</b></font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">This press release contains certain statements that may be deemed to be &ldquo;forward-looking statements&rdquo; within the federal securities laws, including the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Statements that are not historical are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Forward-looking statements relate to future events or our future performance or future financial condition. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about our company, our industry, our beliefs and our assumptions. Such forward-looking statements include, but are not limited to, statements regarding our or our management team&rsquo;s expectations, hopes, beliefs, intentions or strategies regarding the future, including for the products we may launch and the success those products may have in the marketplace. In addition, any statements that refer to projections, forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. In some cases, you can identify forward-looking statements by the following words: &ldquo;anticipate,&rdquo; &ldquo;believe,&rdquo; &ldquo;continue,&rdquo; &ldquo;could,&rdquo; &ldquo;estimate,&rdquo; &ldquo;expect,&rdquo; &ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;ongoing,&rdquo; &ldquo;plan,&rdquo; &ldquo;potential,&rdquo; &ldquo;predict,&rdquo; &ldquo;project,&rdquo; &ldquo;should,&rdquo; or the negative of these terms or other similar expressions, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are subject to a number of risks and uncertainties (some of which are beyond our control) that may cause actual results or performance to be materially different from those expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any forward-looking statements. These risks include risks relating to agreements with third parties; our ability to raise funding in the future, as needed, and the terms of such funding, including potential dilution caused thereby; our ability to continue as a going concern; security interests under certain of our credit arrangements; our ability to maintain the listing of our common stock on the Nasdaq Capital Market; claims relating to alleged violations of intellectual property rights of others; the outcome of any current legal proceedings or future legal proceedings that may be instituted against us; unanticipated difficulties or expenditures relating to our business plan; and those risks detailed in our most recent Annual Report on Form 10-K and subsequent reports filed with the SEC.</font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Forward-looking statements speak only as of the date they are made. Scienture Holdings, Inc. undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise that occur after that date, except as otherwise provided by law.</font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Contact</b>:</font></p>

<p style="font: 12pt Arial, Helvetica, Sans-Serif; text-align: justify; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SCIENTURE HOLDINGS, INC.</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6308 Benjamin Rd, Suite 708</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Tampa, Florida 33634</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Phone: (866) 468-6535</font></p>

<p style="text-align: justify; font: 12pt Arial, Helvetica, Sans-Serif; margin-top: 0pt; margin-bottom: 0pt"><font style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Email: <u>IR@Scienture.com</u></font></p>


<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0">&nbsp;</p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p>

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <div style="margin-bottom: 6pt; border-bottom: Black 1pt solid"><table cellpadding="0" cellspacing="0" style="border-collapse: collapse; width: 100%; font-size: 10pt"><tr style="vertical-align: top; text-align: left"><td style="width: 100%">&nbsp;</td></tr></table></div>
    <!-- Field: /Page -->

<p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"></p>

</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>scnx-20250408.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" ?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
    <!-- Field: Doc-Info; Name: Misc; Value: 96Mps7xRiXgen8uDanwsWa2MubP9z5Z8mekhvWB4bUlqnyMsZLc/bixUkeAWoUwN -->
<schema xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:srt="http://fasb.org/srt/2024" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:SCNX="http://scienture.com/20250408" elementFormDefault="qualified" targetNamespace="http://scienture.com/20250408">
    <annotation>
      <appinfo>
        <link:roleType roleURI="http://scienture.com/role/Cover" id="Cover">
          <link:definition>00000001 - Document - Cover</link:definition>
          <link:usedOn>link:presentationLink</link:usedOn>
          <link:usedOn>link:calculationLink</link:usedOn>
          <link:usedOn>link:definitionLink</link:usedOn>
        </link:roleType>
        <link:linkbaseRef xlink:type="simple" xlink:href="scnx-20250408_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Presentation Links" />
        <link:linkbaseRef xlink:type="simple" xlink:href="scnx-20250408_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:title="Label Links" />
      </appinfo>
    </annotation>
    <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
    <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
    <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
    <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
    <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
    <import namespace="http://www.xbrl.org/dtr/type/2022-03-31" schemaLocation="https://www.xbrl.org/dtr/type/2022-03-31/types.xsd" />
    <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
    <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
    <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>scnx-20250408_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
    <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
    <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="dei_AmendmentDescription" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentDescription" xlink:to="dei_AmendmentDescription_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentDescription_lbl" xml:lang="en-US">Amendment Description</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="dei_DocumentRegistrationStatement" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentRegistrationStatement" xlink:to="dei_DocumentRegistrationStatement_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentRegistrationStatement_lbl" xml:lang="en-US">Document Registration Statement</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAnnualReport_lbl" xml:lang="en-US">Document Annual Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="dei_DocumentQuarterlyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentQuarterlyReport" xlink:to="dei_DocumentQuarterlyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentQuarterlyReport_lbl" xml:lang="en-US">Document Quarterly Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentTransitionReport_lbl" xml:lang="en-US">Document Transition Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="dei_DocumentShellCompanyReport" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyReport" xlink:to="dei_DocumentShellCompanyReport_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyReport_lbl" xml:lang="en-US">Document Shell Company Report</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="dei_DocumentShellCompanyEventDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentShellCompanyEventDate" xlink:to="dei_DocumentShellCompanyEventDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentShellCompanyEventDate_lbl" xml:lang="en-US">Document Shell Company Event Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="dei_DocumentPeriodStartDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodStartDate" xlink:to="dei_DocumentPeriodStartDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodStartDate_lbl" xml:lang="en-US">Document Period Start Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US">Document Fiscal Period Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US">Document Fiscal Year Focus</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xml:lang="en-US">Current Fiscal Year End Date</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="dei_EntityPrimarySicNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPrimarySicNumber" xlink:to="dei_EntityPrimarySicNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPrimarySicNumber_lbl" xml:lang="en-US">Entity Primary SIC Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address, Address Line One</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US">Entity Address, Address Line Two</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="dei_EntityAddressAddressLine3" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US">Entity Address, Address Line Three</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address, City or Town</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address, State or Province</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address, Country</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="dei_CountryRegion" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CountryRegion" xlink:to="dei_CountryRegion_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CountryRegion_lbl" xml:lang="en-US">Country Region</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="dei_Extension" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Extension" xlink:to="dei_Extension_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Extension_lbl" xml:lang="en-US">Extension</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Title of 12(b) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="dei_NoTradingSymbolFlag" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US">No Trading Symbol Flag</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="dei_Security12gTitle" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12gTitle" xlink:to="dei_Security12gTitle_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12gTitle_lbl" xml:lang="en-US">Title of 12(g) Security</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="dei_SecurityReportingObligation" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityReportingObligation" xlink:to="dei_SecurityReportingObligation_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityReportingObligation_lbl" xml:lang="en-US">Security Reporting Obligation</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="dei_AnnualInformationForm" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AnnualInformationForm" xlink:to="dei_AnnualInformationForm_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AnnualInformationForm_lbl" xml:lang="en-US">Annual Information Form</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="dei_AuditedAnnualFinancialStatements" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditedAnnualFinancialStatements" xlink:to="dei_AuditedAnnualFinancialStatements_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AuditedAnnualFinancialStatements_lbl" xml:lang="en-US">Audited Annual Financial Statements</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xml:lang="en-US">Entity Well-known Seasoned Issuer</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityVoluntaryFilers_lbl" xml:lang="en-US">Entity Voluntary Filers</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCurrentReportingStatus_lbl" xml:lang="en-US">Entity Current Reporting Status</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xml:lang="en-US">Entity Interactive Data Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFilerCategory_lbl" xml:lang="en-US">Entity Filer Category</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntitySmallBusiness_lbl" xml:lang="en-US">Entity Small Business</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityExTransitionPeriod_lbl" xml:lang="en-US">Elected Not To Use the Extended Transition Period</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="dei_DocumentAccountingStandard" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAccountingStandard" xlink:to="dei_DocumentAccountingStandard_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentAccountingStandard_lbl" xml:lang="en-US">Document Accounting Standard</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="dei_OtherReportingStandardItemNumber" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_OtherReportingStandardItemNumber" xlink:to="dei_OtherReportingStandardItemNumber_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_OtherReportingStandardItemNumber_lbl" xml:lang="en-US">Other Reporting Standard Item Number</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityShellCompany_lbl" xml:lang="en-US">Entity Shell Company</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityPublicFloat_lbl" xml:lang="en-US">Entity Public Float</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityBankruptcyProceedingsReportingCurrent" xlink:to="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityBankruptcyProceedingsReportingCurrent_lbl" xml:lang="en-US">Entity Bankruptcy Proceedings, Reporting Current</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock" />
      <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:type="arc" />
      <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xml:lang="en-US">Documents Incorporated by Reference [Text Block]</link:label>
    </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>scnx-20250408_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII" standalone="no"?>
    <!-- Field: Doc-Info; Name: Generator; Value: GoFiler Complete; Version: 5.25b -->
    <!-- Field: Doc-Info; Name: VendorURI; Value: https://www.novaworks.com -->
    <!-- Field: Doc-Info; Name: Status; Value: 0x00000000 -->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
    <link:roleRef roleURI="http://scienture.com/role/Cover" xlink:href="scnx-20250408.xsd#Cover" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ErrCompDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#AwardTimingDisclosure" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingArrangements" xlink:type="simple" />
    <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#InsiderTradingPoliciesProc" xlink:type="simple" />
    <link:presentationLink xlink:type="extended" xlink:role="http://scienture.com/role/Cover" xlink:title="00000001 - Document - Cover">
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
      <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentType" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
      <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentDescription" xlink:label="loc_deiAmendmentDescription" />
      <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAmendmentDescription" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentRegistrationStatement" xlink:label="loc_deiDocumentRegistrationStatement" />
      <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentRegistrationStatement" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAnnualReport" xlink:label="loc_deiDocumentAnnualReport" />
      <link:presentationArc order="40" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAnnualReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentQuarterlyReport" xlink:label="loc_deiDocumentQuarterlyReport" />
      <link:presentationArc order="50" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentQuarterlyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentTransitionReport" xlink:label="loc_deiDocumentTransitionReport" />
      <link:presentationArc order="60" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentTransitionReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyReport" xlink:label="loc_deiDocumentShellCompanyReport" />
      <link:presentationArc order="70" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyReport" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentShellCompanyEventDate" xlink:label="loc_deiDocumentShellCompanyEventDate" />
      <link:presentationArc order="80" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentShellCompanyEventDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodStartDate" xlink:label="loc_deiDocumentPeriodStartDate" />
      <link:presentationArc order="90" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodStartDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
      <link:presentationArc order="100" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="loc_deiDocumentFiscalPeriodFocus" />
      <link:presentationArc order="110" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalPeriodFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentFiscalYearFocus" xlink:label="loc_deiDocumentFiscalYearFocus" />
      <link:presentationArc order="120" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentFiscalYearFocus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CurrentFiscalYearEndDate" xlink:label="loc_deiCurrentFiscalYearEndDate" />
      <link:presentationArc order="130" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCurrentFiscalYearEndDate" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
      <link:presentationArc order="140" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
      <link:presentationArc order="150" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
      <link:presentationArc order="160" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPrimarySicNumber" xlink:label="loc_deiEntityPrimarySicNumber" />
      <link:presentationArc order="170" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPrimarySicNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
      <link:presentationArc order="180" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
      <link:presentationArc order="190" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
      <link:presentationArc order="200" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2" xlink:label="loc_deiEntityAddressAddressLine2" />
      <link:presentationArc order="210" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine2" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine3" xlink:label="loc_deiEntityAddressAddressLine3" />
      <link:presentationArc order="220" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressAddressLine3" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
      <link:presentationArc order="230" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
      <link:presentationArc order="240" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
      <link:presentationArc order="250" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
      <link:presentationArc order="260" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CountryRegion" xlink:label="loc_deiCountryRegion" />
      <link:presentationArc order="270" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCountryRegion" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
      <link:presentationArc order="280" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
      <link:presentationArc order="290" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Extension" xlink:label="loc_deiExtension" />
      <link:presentationArc order="300" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiExtension" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
      <link:presentationArc order="310" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
      <link:presentationArc order="320" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
      <link:presentationArc order="330" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
      <link:presentationArc order="340" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
      <link:presentationArc order="350" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_NoTradingSymbolFlag" xlink:label="loc_deiNoTradingSymbolFlag" />
      <link:presentationArc order="360" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiNoTradingSymbolFlag" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
      <link:presentationArc order="370" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
      <link:presentationArc order="380" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12gTitle" xlink:label="loc_deiSecurity12gTitle" />
      <link:presentationArc order="390" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurity12gTitle" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityReportingObligation" xlink:label="loc_deiSecurityReportingObligation" />
      <link:presentationArc order="400" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiSecurityReportingObligation" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AnnualInformationForm" xlink:label="loc_deiAnnualInformationForm" />
      <link:presentationArc order="410" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAnnualInformationForm" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AuditedAnnualFinancialStatements" xlink:label="loc_deiAuditedAnnualFinancialStatements" />
      <link:presentationArc order="420" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiAuditedAnnualFinancialStatements" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="loc_deiEntityWellKnownSeasonedIssuer" />
      <link:presentationArc order="430" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityWellKnownSeasonedIssuer" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityVoluntaryFilers" xlink:label="loc_deiEntityVoluntaryFilers" />
      <link:presentationArc order="440" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityVoluntaryFilers" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCurrentReportingStatus" xlink:label="loc_deiEntityCurrentReportingStatus" />
      <link:presentationArc order="450" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCurrentReportingStatus" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityInteractiveDataCurrent" xlink:label="loc_deiEntityInteractiveDataCurrent" />
      <link:presentationArc order="460" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityInteractiveDataCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFilerCategory" xlink:label="loc_deiEntityFilerCategory" />
      <link:presentationArc order="470" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityFilerCategory" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntitySmallBusiness" xlink:label="loc_deiEntitySmallBusiness" />
      <link:presentationArc order="480" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntitySmallBusiness" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
      <link:presentationArc order="490" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityExTransitionPeriod" xlink:label="loc_deiEntityExTransitionPeriod" />
      <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityExTransitionPeriod" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentAccountingStandard" xlink:label="loc_deiDocumentAccountingStandard" />
      <link:presentationArc order="510" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentAccountingStandard" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_OtherReportingStandardItemNumber" xlink:label="loc_deiOtherReportingStandardItemNumber" />
      <link:presentationArc order="520" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiOtherReportingStandardItemNumber" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityShellCompany" xlink:label="loc_deiEntityShellCompany" />
      <link:presentationArc order="530" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityShellCompany" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityPublicFloat" xlink:label="loc_deiEntityPublicFloat" />
      <link:presentationArc order="540" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityPublicFloat" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityBankruptcyProceedingsReportingCurrent" xlink:label="loc_deiEntityBankruptcyProceedingsReportingCurrent" />
      <link:presentationArc order="550" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityBankruptcyProceedingsReportingCurrent" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="loc_deiEntityCommonStockSharesOutstanding" />
      <link:presentationArc order="560" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiEntityCommonStockSharesOutstanding" xlink:type="arc" />
      <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="loc_deiDocumentsIncorporatedByReferenceTextBlock" />
      <link:presentationArc order="570" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentsIncorporatedByReferenceTextBlock" xlink:type="arc" />
    </link:presentationLink>
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
    <link:presentationLink xlink:type="extended" xlink:role="http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Apr. 08, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr.  08,  2025<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">SCIENTURE
HOLDINGS, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001382574<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-3673928<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">6308 Benjamin Rd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 708<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Tampa<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">FL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">33634<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(866)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">468-6535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, par value $0.00001 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">SCNX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( *: BUI&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( *: BUK6]2K([@   "L"   1
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MM5II ,,X?<D3$L/<@HL(2W@4R]9<X%L:+R/6ZK3;W5:$:6RA&$=D8'U>+&A
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M" "F@(M:EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M5!B@?%.9J+SV4VPYZ8Y>9WK_,'G4'EKG5LJ]AU>RY1AQ_)[E#U!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    " "F@(M:1L=-2)4   #-    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( *: BUK6
M]2K([@   "L"   1              "  <,   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( *: BUJ97)PC$ 8  )PG   3              "  > !
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ IH"+6I$AA_!J!
M(!$  !@              ("!(0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( *: BUJ?H!OPL0(  .(,   -              "  <$,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ IH"+6I>*NQS     $P(   L
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64$L%!@     )  D /@(  !44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="form8-k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>00000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://scienture.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="form8-k.htm">form8-k.htm</File>
    <File>scnx-20250408.xsd</File>
    <File>scnx-20250408_lab.xml</File>
    <File>scnx-20250408_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="23">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>17
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "form8-k.htm": {
   "nsprefix": "SCNX",
   "nsuri": "http://scienture.com/20250408",
   "dts": {
    "inline": {
     "local": [
      "form8-k.htm"
     ]
    },
    "schema": {
     "local": [
      "scnx-20250408.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "scnx-20250408_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "scnx-20250408_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 59,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 23
   },
   "report": {
    "R1": {
     "role": "http://scienture.com/role/Cover",
     "longName": "00000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "AsOf2025-04-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "AsOf2025-04-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "b",
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "form8-k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r11",
      "r13",
      "r14"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r12"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r15"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Elected Not To Use the Extended Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r19"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r16"
     ]
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r14"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r17"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r13"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r7"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r9"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r10"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r8"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://scienture.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r18"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>18
<FILENAME>0001641172-25-003812-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001641172-25-003812-xbrl.zip
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MY @2@3/71!;*O&L&3Z3[%<>Y@UF8K\]"D1/W;,R .1Z!9KV[MH5Z[XU@&=*
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M7 R82$/^ES*06NV.0T8!4!:<++Y4B/'<<30?34I:YOZ=:3G7U2*7$FPJ.]%
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M=,8=QL*-K7K<6UD02'RA'WB2ND,/]!N[X"J>PN80(<3NBE#QWACTDT,,0:$
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MTZP]+3)N<C([INYA<J*A +J#*Z?J+0IHJ]U5]8E@Y!MRNW9]ALOU/<<8&#)
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MT*A<N[N]([CT^.8T>13+.SP\7"+6UQ-\Y7UZBM+P-BL>,[-JVH5\6^LD#)4
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MO<HY5/G>E'M]6=5U=0U_B:J[+D!]+#+I 5DX,A$29@(SC[69>MY.82H^$-X
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MHN#'RJP5 A2JE\!L^)R\_0D%%HWJW^UN"J^'$^ 7V+H_7V:U"=.Z;9R&9C?
M/:@,[!!4[ OG;">/2A&5Q[%=+[C(*U&2HSP8*R(IYHR0+"]*M@LF/#K9$K6&
MZ!8G@(@2L9A$2AHRUS84@_E"QX Z PCTN95D=D/?R'CF8=!CUS^;^#KT5VGD
MQI[T;79L58\8DRZ+JK4=\E! S7G@ "]]5-$356]2!;$(I"#,DZ_HT S>J-*
M "B(/R%@J/Y(=<%"5S!6J%W=,JTLFO_85 VW&(\=GV'A?!YR?B1V^M!5 7W1
M[&<J5&;+)Z6;5H@EN;2TU$S%F(Y'-_E+N O6,Z)1Y[R]@<(A-6Z2FSPD,"(A
M"#KLU<!<UU@#F==9AS$G+E.B!EI5&\-M@8L(AJE;,!,,0SI(T\GFRO-'S!?<
M048K(8 /I@ Q0(W A97\3UPRLOYA>-5'$[MXR#6RBDLWQ4-P$&?N:LXN3E(^
M8^\7)<R%]:\N&SX\^ GW)V/NAN#3\WWPZ6L&GY[O@T_W(?@DZ@E[.MY5'I::
M@H8B*7\_Y4@^)<AM^+T)= @WG>R1R]X?!QI?#^[Y'J/\IAO1+2?*Z $1I7)?
M?<DG!@;Q87>"RUQDV9O26IF8V(OO!@<'8Y*"1 8IZ+.%J8+X9*4VI9SQPM#*
M#Q:ONGDRH9603: F)$$@$$@YVI_"-,PNE$Q_AAR%$8['A^WB>D+6@N9N^=!-
M0_83'UJF[) Q1E"#8*<AT<?.'5N"G$<*;R/5  3G@'N*L+H*1_4'[LS-,[SP
M0/)+KSR G$:!BXDQ2S+*))K(?.'89]E>>NCXM%J8Y@X3J16 8&"3F,/)UK D
M2A>J,>&A)3:%':GU(1(*"*9FQ@X(/#(\*P>= H:,VK"\/QM&O7>(4HZ%TO.'
M[ZSFS"YMG)I0;2 \_D)T?U(6&9U:>V[N*,/)5[PG$*@KA!J8"-N%;H/RT)==
M#29IPR74:K8\Y0)>(U&J5.A)F'[2L#'-2KT9UD.=5*4%9%MCM_:E7N<WKEX"
M4FO!AE2(/QG%F&)9+KSUO>)B>(W?9D/8PN;SY%:[@59JV ZBZ>DP9+R :;O[
MG8*0P314U!4.58;QIP:6F,HN0@$MR]PPD5=3)D77=!FDD=[D&?ER(_L?D,DB
M6O^ 4+8YXLHLT_"2%?=/&O+1TUCS)RX8*KTG:'-DU2.Z0Q6N*%F\6-!5\S.%
M_:2>VRGY=NZ-)GD7)_B3=3JU=YX9#8?T*U.C)>O,:+<@0^/2I7LVM,$I?+H1
MV9@$8.-X]!2__X=!BLD_CE&4.K3_($@QN0U&<2>7A<1YGE&4[63&:&Z4^#Z'
M@T)JNQR#>H8Q*'$RX:@(0AWV0<[L/Z!_H0Z:-<:ABD""52A=*NFH4R%\P[K8
M.29-,?71%7J\- )(,HWI#O3X0W+/[(HSW32$;WE5\7O.HL7_LQ&%RE]?7(8$
M!6XWI.)R55:?D*>9LE,QSS3\A=$T?SHK G]C[M%XY -&FFDNO0\G=B L7$]&
M9WXW]A%=4.: 8:T:. C>9O-LA97(X:QV]05J??423O+QZ$=7<(5B8Z/M\#'P
M3$(%>]3!IO%Y_##9G"*QN\,B)'VX.@9'!W[<+YZ'RM7G2^P(PK83\AE!<6U(
MHUH#HZBO!.]!JGKFJJX=*E<DP#'A]!*3=B^#JV*"><EN/M<@/Q:R)E.<\U/;
M"L'57-XZC>I;4^PZNA)C$+.J=*G4Z:0@DPD+L^%+IO'L*F_(QS24LB6X2N^N
M:N+P$1];I )Z@NT;0DIKJKT]3YC %_^RK+SXC*YA)(^PEC@_3B8&5LDAM:QS
MH9FH)G1T7V=HYS:IFI^2".D1"&MH(F_K;GX/132'SMN*+Q@LQ4=K811YL(4B
MW@9YB,$5+AX7!WN99ZTV>"8VC7<9IOKL(;,,?F ,\DE9@IHU57V8T*DA:.SQ
M7E/-= YTN*KOA+17)4"1+'S67'B+D\G+D0:PEYM.)YSS:VO'P!S+)2BR)-X"
M-P3B;[$2&;[IE4/LBPONJ+@[PO;,OE#^G0?-VW VPNDY_N AXHGCY%N! /E-
MX\F.C PIU7]NN!&@::(3\61&##CB*IZZ4T1X"NVQ NX)CN]?<H)"RS 987-(
MMD"IU-F*T2Q>4-]9?>$O#BE^NP\I?LV0XK?[D.*]"2D^>\B4@^?9YV1-VSK!
MDELL# 1(ZS/1:-.G1LBQIF-D-3OW/5-,0QYAK9GHQ+@G$16.@8AT&"606V:U
MQCDXIZJ%CH+>UM5RT/+3I=+ FLXEW\^0 # .(345$3,TK%L@X5J),1EO&]ON
M4-3'(?R$GJDL758G0J',E9 TDTC5S T$!P\WCN2MQW \NFD0^]8]4[A\%M^R
MA,#0SS]CL"._5P""W!L!?1<^LV_(G_<C!V5R)I&4;;#S_KQO!%,N:]6SS?G!
M$@WOI$V&I <LT[]4O@2CK'L%0?;-IC6V]>]V<E5J]<WL$*/ZP31"_GIOM02&
MLLCA&47@RVJ1E\[X6A$C1]%*)H#">+06<.]3"9* (2EQC;PO%/LG0"J&O)>L
MT<P)Z*!6E2 I)U7UR7(DWND8WH-9G!QN=(XENSXVT\UCL^M#,]L/S::A<?NA
MV30T\_W0;!J:BT.?L+#NB.QQK5<#U)Y/X3Q6PJ=='\O+P^2ZQG6%YA"6N!9_
M*%A$Z)PCM#OYD)A:DP?[%Z;7C/B3<Z7?3/(%ION#XE&L-BLENS[N6%*<PN*,
MOF)2?DZK0ZNY/URI^O*X]#;ZKQDI>M(T>4.<IN:7,"L.+>ER2C[&R/O=\_.O
M9>%02@*JAI(IIPU2Z&*Q+$Q94([GK 5P=GV&?^_-,%%VV"S \<B4M&=GL^=0
M^ZFHZGR6Q9-*-(E:'2>S@9Q0H-$OFUT?_D^'O9Q+\LUDGWNIJ%B3K[QX,*NN
M2SM93*_9FYNA@IC[\9;Q+@[7*H(UWH8=CW*BW>O@Q"[(=C41!XF-W)'?ZNX'
MD'TS4JTU\G?>VD5C84VW<<FP2V?G?3+VE)5:I+N^C;?X.'9]:/8NCKV+XP^Y
M.+A  U-HV].1I3!A;OHPIO\Q1^7V*/SQHWT4_BM&X8\?[:/P]R$*+P&]YQ1L
M?!5 C*!9O0]9BGUV+DP>&Z)/^!(RB37DG\<V#2.? A.^AU\&3J\ OTPUNX_1
M04+ 0) _I=5!""!BCPA7R'F"&(U'I#]8J-#(W6B3]R2V^EQBJ]OXY7<S,"_#
M<QSJ>.>4]0BK*@26?4FMB)/7 B/8MJ&(I^1."B4*>:-R+EB#EZP5WS#5/4)]
MEA[Z6.%Y1(O3VV "2O$/Y;P\?B8U';U)@#M&]+'!$5KY\&KLWS/E"2>(YD-L
MGC*@R,ZUO"T#0R3^"+ACT2]N%:C[OWEXM/-KD0D93C!5.)OZ<>M1+8JE?7XS
M;_<@W-74&)!J[#;\+TG.OBI"Y"8,=4F:MNZ8<R98[R;%6Y/%I3B=\BA6@TE"
MM\*_\BZ;#% V\NY"?F'951D?/</5"W=Z>3T146?)/"(,32@@:*0:8]UA*FS:
MPP:L_>W#6SL]$4]#UDZR3]O9.$S/E)_FC%-4,#N3BV"J$'Q7:5C(+%CB*Z-$
M&B5,'J -\,1M2$W5OQG#3Y60.+HR8ZX(P[>,;"@^U7E*[)Z4<^WO(S:8?*XW
M'T9<)KACF+X!/W$&".F_ONR45P"4!I0SD0A,*5+.A-*$2:[V@T1EP52=0=1_
M9Z_?Z9W'^&1OA@@RN3 ,0)SU%(XXDR(16!'[GNO 5V<24 S\-_**A\,L-(#X
M.D*^,:L^Y\KCH>8]+ VL@F9.U9Y7,;#8N&5V>FZY OG;7*'(G@^C\%^-1XUS
MGSRSW>^5[.$OL6M%6^;D,ZD\1SPYTRFE?HNRXR=YZ0)QKJ]GOIL3)3;QM[=P
M3]AZ-^O^B;#!-CLH;IK'N!;?1@<$YU%M]D!<Y@OC(,6-W'>9[MT18?%]*^Z(
MV-X67Y1)X_OOL:H'5D7/J"8?^)I5S7W\0LLYN<%PCFAM>[8RD6I&QO+QCAO+
MWRJYLC&6HQCU>#1D-_?R=FXPH/]%3>7U/?,_PV:^(:1SM _I?,V0SM$^I',?
M0CHB[1[_TPP7'^M15] ?,U9,-!CK#L?&BG%#;@@HWQLA<Q>3^V1ON=SSB1+U
M^>@1F2[_@7;)!L_=Y(?_Q%]W5,G7<3JB<7K#1<25QG/G$UUA6-C\61L8W.^G
M1,I!:2(A*=+GG*L&:JR HR,N=RW2]0#EP9^+&:JV9O!7#"*LL:[HY(<_U_3[
MH6?.J[34^WQ%O+6NG''@$XM2@ 56+XCK7YW_PEUCO5UK>>7A2\/&JWD:J22&
M5OCG0O(U4NB.HP*@*+ZJ%56DMW2_8(8CF7))URXX0U6MNK8&)8M>$KY$,7B
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MW-IC"B=B'-&9<&=68I!^YC !CI/+#1. CXN2-^1365T7;G;A?- =-'E\75E
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MJ3"6(M-1]!1\+1Q5D'%?1I</Z.*:>%%,(:F445EJ*@LH2<ALA7KTJ(FZEGW
M^6, ID"QA78,%D V-0K>I)?>Z-</Y3ZP,M54/+Q!&BTPC!B#0XEVA/IIXA'V
M]N=)R&V;,/?6J./-'(.WTC?5!7K_,04K>]ZC$U">X*< ZS?2&9JJ_"<BT?&F
MD6<EVVQ02F D:X-'_:*&?N@N*,&#,A@PS#F6@I866R%Y(^Q)/L>F44P1YBB_
MYSF9$*_!GKGR7&<11MTMR T:1[ 4DHE0'3!A;W^N'-&!IS6G$P(*3F!)T6[
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MW52V=54T?&VC?Q=TRNN'="3308WFA?R$E@FW&A@"R[QN6AG3SJT9G'OS;%:
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M"[9'T] Y.>.%G($5E'7A-N?VG22J!FJ.8LQJ%\$<[6#:X^=7[XZWZ:F?75:
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M:E=C;(7F$;9BC1/CT_0WS*X.37:8QUOVYXTF_X-9P>7UZY5?[D<3S2.C";K
M(A]8^14IGM&!PI89CC0[S]!63XJJH1E99GDAMX0I%PV!&\/5"-!%_>A5!4>I
M[W2&\^AY\I9B?<UW.(CWCIRGY\G?LJ+#KW<\ 3J$6$>/@]^:N=59?9Z<;=;P
M_.,:Y&/^/'D##@G/_)L*Y_,HREGJ5?C-?7+U%KVGT_<#?Q2W\'0R2 :^9ZVX
M<P[FZ^QJ%$94VC.<_ (ZC#DT@G&7KC5>0I%=@?70%61#:!A7@'<V=JNJ>20P
MQ&XF?/<6E<)77X=>P<?7?SBOR"\>1!.0Y"/840(X(C0+[8U?L@:M49%@ V.7
M LJ9:Z^<4Q#U1DJ 0FE/P@ #KL$<IFYW;DO\ F]?4WQW 5(*1L?)<NFB_&D4
MN;S S&2:./H18:?S&ARSAF(:O%)4YLHWQ6BPW%;<& 5Q!0#6S6 M_ M,$G!W
MN?@M0+TB=PA^%18<JTR:;M;D'N4JY:E8>03CVZ@;2[EU^K /6]LY42!=M$4]
MDO&"$_9[5PH(__=N<<[IR(4#S]"13N0H&]C?O,!-X[/8@IPGD_0*_.>=F]YW
M!#W=,K\>+L  U0@V8%"I=*1H&#[E_#\MC#A;5QGB3@*:4JJ_\*"2,!4'X7)P
M*T+,Q1Y0T\F.UC$H<GUD><B3!]^\PZ1+EF *19#<:1+5Q6-,!N6^FN?ZMX_.
MA7#,W =PDM]A=5JI+34?MW6'" 7]_E+@*326KD2GF1])\:GSK!2D,UPP9FN(
M;+#QXG9S=<^RCU$]19U$W[FQTBP,U[7XG<)#$"[L'(7++B6^(-DVK^J:-+DA
MW:#@Y?,:'?+:S5V^)D#ZQSGM=A_)F$XP>@O?=(W%$ZVS#19GT"GGE82.T\)%
MKK$\)1C*9SJF$%<<H,\^IB%'0+ $!\8PQE*HW F=7)^-@!_OGA0A>(>+T)(?
MJSFE/\>+^L ("J;I'DXE&1JBF)V46G*")51;MFV&?Y U2G%:6JJPV6<;YK,@
M=YL+._>Y]/)-53Y 2TBJX9AG S]\CT S$;XPI(:O8D@+Y[WB4LZ_,FP@^8T/
M%+S;J9-0>O]M> \L=#X,MJ[A<=BR"H.-Y*KEDB,V'*2.)V[GY.NWX],W6W+*
MOU7U!YAEKK;SF<I3!S953JFQ-Y7,L2"D=V_R)+C]DD/9T;;TU2?SK)AWA6XF
M\! H::&AWZ9;D87%G!OB67@R",Z5MK8L1/Q(PJ\7%>49?T0S#3DHAG><3K;=
M4BJ Q^]VZ\0>UT=@']T'6[]DL/71?;#U+@1;96,<$0G#.TT[$;V,Y-C?!WH>
MHG]A?H;=T,)'!\A.T?T0SX5GPJ$<MU*3=3\<).^[V>^2C$9MA_7(R@12JHTI
M;%V^'#;U-;)H'Q@>GPO7?UXHILA:JT[!IEX2?P@^":R96G6S11?LS)(=T9)Y
M67Z'&")>GE=ELNP0J3&D;Y',*5\"J\K3K.Q)\3*D\:\9I-1/Y_<>;[  >FA/
M)^LL7X2'P>*&:NE;X($YO"4>&'DNPMXBEB0&:#R08_"[Y,'#@T-2WOD/(O?3
MR3M.0'__EQQ5$M$E)6_+@:GQ-:?QZ%8FD9Z*6!"8G7^#&?V%4,\Y8H@V5/Z#
M4[0KLP#3<(RAA!6B4<$UZU@U<@4VXBO(CNWO.D9:H>B,)7!B;LBTSPDIPN;E
M,>SWK^\ZW)+>?41Z5V:"%>ZO)</)-.<!?C/.YX(QD(+%%RHLGM*Y3*1HWC9$
M)IC PR%#C@?RQ^&(T2494;V8$0'E"Z:X(RZ*V0__WI4N>?3P^Z9;_]!>?/\7
M_*\RF.(-*@$N*IQRY33OHCQ>F'IA$J_Q89 :^H+,>7=7+!Z36/PG)NM+SD(C
M#':%E7Z+@__:(>Z/HX,G-!4G'P6R^3HXW#0-T\GQLA45I)8=*2[0WQA&TLHX
M#&^"[,,_7&&0E(14!&VOS&BBUECF,7E/=&F6LX+K<9N<:N80JI=MV)H4T)02
M["DX3VFF2E2I,C27>YBH3UF68E )CRT_#X&+C TEV!?B11EU*F/@) *A"'ND
M:VYDPOK;;'Q2PW;[JH;4[<F8U@[8F=+:O+9*$:,\"$X:,#D&]07=066D-D7@
MR<DP$CH72A)D(\/_@*E6: 3V AP0N%G3HRYC#A)A*VM2BKQ'=3B4#B?<"=HL
M>8F9/1Q_'^9+L5G-E>M!\<(3MD2R&)>H^TVE>%I&%[[$5\7\_HQ(I5I_42IU
M[EE_6Y(VWY&#7:LV_GF1PG -$MYL+&Z%UB\ZQZ.\7H_0TT?C^YE?'WXW/GF@
M#MB5I9H/EPK5KC \X.00M#F:;C9[!6":/!(*AUV9L87.F*HI@S%NX$0V(+O1
MGPRAB2B[JTR*INHMVR;)=#> _&. 2:?_X/ AV@*Z">1&C(^G)<3TDF5/TRMV
M9<$<^W9;IO4L^SB=G+JVJT,]@QCMV<>P+,OHC) C0Y3&4LL@J&ZK&3U!OGK^
MXK/QXX_OLQ=?,GOQ^#Y[<1>R%ZP2ED.54.3$W1HS34XGX()];8?SEMFU[?DU
MYAAI#AG/KH01>\;'4CN9.Z%@[6I)_PP6-&9X:RE)[4K]RWP_ U4A,'-;MN:_
MG\_K#@T3OI[_"E\7.5AYB\P_(/S-[J?^#D-\K*5GCDJOX(-]@UD:O!K%_!%<
MM$.R\(B2?*<1X1:;U;\QXU:N>3[?;><@.4;@L *?$3'8S=EN]+DH9/)"M8H0
MJZIG7?HH!):+-4(5,WS^E7]^R(N!(8],_?XYJ>(7 G-_6TMDE[C%YJT!&E@V
M,D7*R^&](^&F1Y*[?!LA*6$J_G<'%RND1@)/:@KE38S\A'U$1>MT"]QTEW#M
M CYR'T'#:GP(3-+SJL(35P)4[%-HAR4J+,'?Z5,N,A4%V,U-#BNUKJZP-);*
M1SP=!]V:JJ)M]3>VF%("6W ZX6,,>H&4D%XB+!='^RE$X#A7Q^!#E*^\Y0K)
MNFUZ%R'LD:_A@<"W<Y#+35+%W/4H97G+!<U7H&^H\K3"C8$1S<1,)4W>/WBZ
M68,)W''!>'RE-[$3#D]=5+Z>@$?"DQ!/L6+\(VZ5*Y1XC@9>9(@ 8@<;(7EF
M"J@"7-YZ85Z;@NI<"$WEKT3<(-?#0##UD4NP&S<S1<3_884IO"&.T"^.-G,8
MLD#G/_1<&11'S%2%YE>+2IQ8/H&F$UXL7Z0\2C$3RN3QU>/OE@9[J%L"7]?^
MJHGZ:TDY,*BMR[SJ\!TPECUWL&_^P(N553P@W P4;,,UP6)FK/+%P$G$?$8E
M*$:T;/B#UV!#O3+&A<HC>ADF;;IG8*V]\R^1X<5-EH-7/)C_95YPQ#9B_M,Z
MY^!DU>Q]4:@AN%_1*\](\#P/1B 0QS.^B0D_9*@JE*!7\LO,KN3*2?UY7:T.
M(A535E&MS,[H?09 '*.C5#!LX965>-8I+S8%50UBFLY.&F-TJ3/$$M:1R=L"
M[H3.7 D&NS8^?>?5>J/J9NO3D_#P=#HA%1:H@4C[H6N=O$?E\BDW(4,@9V '
MROZ<Q\257)$V1B&&'\(>+KP ,4<W0U%];61S\TM@4=9FAZ@$'VEVET&H8DY\
M]>3='4"HY(,YR&$'G6$]\@ %*^037 >#X R453(*E,G?FE1<O)22)&\2P@9Q
M\J]\P(48&$T0B@V\$4&^1(:1[9,"7H;HT_ %65XB+K"XX=+$7%D%NLY 7505
M2-6I5 IRD!!_Q16:(+37N!@K!X4SV'-K] _6Q.&FE*.U(1_EIAN@T[L&F3/"
M6*1HF5.$G[ ]+7]_54NW'1_Z!FW#SD1D_JXSX<N!Y_'7;.W-*C!KO2VCH#$9
MM(XQ;B45NT(T6;ATTPD<34SEBGQ9[/P02U6![4KXEI9$MXD(<Z5TF%BHNM9;
MA'_@;3 +)[%L1)@'RF9:NU2S*BDA$OO4,F!].&0]0<\>B8>B&KPT9&12C!8N
M[-6+<#E^W=LW(+;1QJD"(T\\2&J+@15&+5'[( E9$6Q^2CT2DB25^EZQXIA2
M+.VQX^ !Q+M 75FI$!7&75DE7B19HS[/<9 LYE(RXQU7"J0X6";06F%322F'
M8@G@2J4@ A3TEF6GUQ4Z7KM"2I-U@V(ZWO?EY?@,:M5K>\]*(PNJ/48DI&S^
MYVQ([+T8N5PNZ3_87GY 03M1$N2P&5GN24#8Q*1=O&9A.R1G[FG*/&*,8(0)
MF& /MTX%_/E%"$_NP_A?,HS_Y#Z,?R?"^&)?S?:3;3BQ6]^G7W$:YF1FG@V!
MYZBM<AC-&1$^]#2D!%I%-WJ/[<9J1 5%5GBWMZ5+?@;# ",+[[B;5[*'^VO?
M(S+I=_+TZ<0_WB94,52Q8[%61CD>^]CE*1W/ET[MP.G$3_C0YR9XG ]E^L)8
MCHHF<5 4H^T?X0P3WUNL+)K^T3+>8!:2W8?]]M@DE!"GYT?K]:]M0]\-#8;"
MQ]UJI?;5=F@N$T.2;2-C59==1AM\[O$A&^9(C<[YA^<,'/9&_4TXX59H*@-!
M)3M@<%]QO&!*O#=&%>9;5D.&*1X03N* MM+8<'X- ^9MRZ5L_>D#J3.*'] U
MZ\KIKD]>E-:NRGML7_:+6\TX/AS)(@77,2.W]=&!]O_F:>=5GQ>94(9B)^7%
M9=X(:00/YWK![64G6'JW+Z=NCX65N)C(-B-W ;&H6B%+)0*VNUZZ17()7B;Y
M*,^MY9 / RS^0IQY9FS*V92M(G9%'8(K*59%=I=2&?K7'++0\LQ1/5GH@@&K
MY6\C)-R].S$AD.?JF&VL;8P<SG6W;I%N."^5WQ+]-$N^090M'8:Q2R(>O70;
M9?;4GA_@1:XJZAZ;8UEP[;F5.3Y'D3B=:!FPLD8R]6H5F*0-HS",5EC^+9\_
MTELQMZ?U@.)YF$[VQLELM>Y+^K*:S8EG5K]%[JY@]!\),/T-DI"72Y /N/94
M$PP_Y<A^))FHE])3<C<C?YY43-LQ-13]@Y%0ON>Z&@>I4-N9"9O1A!F)XCBI
MZ>H>$F;Y2,+L"=PAY,S:ZRR)OCUK%+TFK\*))>8.JS R0K9=>Y5ST0)3+,_E
M-3R^F4.:[@\$(B6$&]V1HCMZ2XK*;B-C)%HLY2BC;DO$4F85>V@FT(O[15E@
MC0$RP!UUM%LP*I_CN$Q-I_G5@%9E($\X^)2R?8]PDT+E3@%*FBJ8P9R/"XH1
MT'KEG#,$;_@BN1+R=4KD^;OM"_-^&DCR6&.OJH5)-W,PF<X,NB$<%\M<(,VI
M!*XS.#C[<:@0<\X*A?:'SXP93' 8"C=>Y/5";(]P^W.Q\+E95A@,PU"H!;@L
M',47.0SLXY32IB'08)L0:?SBF$S%"#.&3GT7 HJ[EABDX=D8F["6*=;-=$5,
M]$(2+T:TA0C4RMUA;!:-;:.)FM*%J@<_.?:L7W\_^^$_%9[;QR<@[NB_R"@>
MRJ?8/O)J&"EFD:(=Y46W*H4/VU-=ZV8#O>9S$?!OEFK4=B)WAORJFDL3"2?Q
M=I94T@B!.*W@O(),=79^CH8')BBXP"G9PD.Y2T<!AS/Z]D1BS0D3U_@2:OZ:
M2U7+*Z "18;Y 7BO"M2(W(&5I (B1X$H[HG<4),*2WI!?U"4EL!(-\Z-?'9,
MVW>G(>9/[V/37S(V_?0^-GTG8M/L(3UE^(-/-Z4)\Y[NJ"<4)N(S[?JG<(,A
MR"^@<R*K6,C'O8GI;62Q9@A2L=581EOVG[.68PM%2E#1Y+O!C!9+A >G%@"&
ML7QBUP40P9B-8JV18*_PR ;61S(T/KRILLT,F4YVSPYAE]1OV]P&X:MB@1$.
ML 7D>Z:Z&Q[3N3/HBPA^?'U9\G6882\.5%I/=JUV,X'[T@IR=Q49VG9#=$04
M;K!#[1:,\NGBE@8:*]_CA4=A!RV88S/HIN);;?XE@[T5:;W->-PW=-J$)J7O
M$;JP\H$W#3@9O?J-*E4*PV,4F.:V*[-NP;'?J%^1QT.(*QFQSWL^+*J 3!B9
M^1Z;K%+"X-%#HD8Y2EDZPB,"S[VY-=ZL[W[CU30$^,<A7-9@V]L-\I;U6!W&
M9V#G2%0>'3SC].*L<>+1O)2^$2\)V<3HH)-++R&CB/NQ\_A9.(Q!4\W=V#I'
M^2&OM6+]I@YYA:@GSIM1FS=QR&HGB.Q6_>J%C3QXLH_O_)F^16$]#P>K#ZEP
M*(0GP@_D\V)RSR5R0-YDMD(;%EVU!38_[WS?6NXUM=3*;!Z?=-4+89+0)+U&
MH%]+7=8E Y5K[]3]Y]P5*[J5P-2,>YIS!8-I;;R">U<+(M,(.1'LLH;Y,SB.
MX+[]V]8./-A.L-]Q[M28-]JXX@:>;RU/6& ]!@'/T =D,#[*'W)WP'A\%<-R
M2?1C;$SQ:P@]^"6:7R QIEA#Z@%Z,@3WUGH8?#M9)@6WF>HT)OR*^X6:L&L4
M.^H_A2)]T6-4'"A[*6^/1">4+<(T4L*4.9K+HA]+HT$R-;%/<3[C8(9I/R8R
M/P!P& 0%@_V('6?APPZ#MG[<TJ_);2QT#'07$&^FU.-Z,JU]GH%\GT&0&GWT
M(46DY"X;OY\D\,HPX@9]TKRYL/,RJ\J.9$O$'V<2-@7_4QN_1K?%EA%E(R%2
M;4R?4K-/#/$BDI!D-)2V:!][C0+#NY5I'%6Y]CU@*<DAB.I(]4-I+RG1J4L2
MER7LMSJ.[$>=5ZZ5-RO5IM$XAXW66=/Z+4V3ZM?-%_Y$R=SI!!0:JI2/++0A
MYEMSHGL] IS(>GU))1J\5;.ER8U[-=I%Z?7O]9R:0?(3/V@77/3F*EPWTT%2
M=PH!8W5#8=2]%H8A;26+5W/@S.JY:-AR6T(7J,0T#*0@&$V=80M'@J.*#I?W
MTY=ZH&P3[B.*CC]QKEM?(1R];B)$V8" 2M#YQI6+FK*.](<6P9>&I]C'!O12
M)?V@2<'X/3'^R%BWACX?_GSC-J!(AA@JN]FR-TV.S,#5KAS+K]BH9V\;?=8!
M<9/(H6?^456[?SF;5<)V)"99TS1@G6GTP*1T)!4&TD!,5:+NALLD^:#0IGF0
M1+[30=YO[H.\7S+(^\U]D/<.!7F_51C,KV7@6QJR-'ZJ;_5M#&#HE:9&1!M*
MDY$FG@*#.3>"9NWI506!1;<!O=8/JL")!U(%_R@VVHIY09H8G<>>I;@U6L 0
MY(%GJ%5?^Y2?9J]NFQ?Y+S&#1L',,0R1SMIK+-N="1D</NS'# *#F0CR6V,7
M80>;9@[FE=#F#"K8'T;2'(J6CN?:/3S5,"B*;N$6YRXR'D>O:B^H<*Y$P&D/
MO>AM]QB7$  6_G>L^ZY+K,ZJA?"29K74BU\_6O5[+($EG_>7N;MJKNM$!6;A
M0@KXP]LI-#.-8(L^9T"NC#S;QF0Y@-"$M@)D69A"J=MIM'IK,LV4)B?JZKT0
M5^\=:"NL1QMK_+2;";K>YCTT:3?6D!0BS@AIW#&\O5R$LG[DSTH'S*O]HD V
MU\6VQ5K%B@^LNBKXVH"R0+YBVFU(-,7.WG2BK(>/#Q_OS?;39&^._[-B)$^U
M'X(B"Q>@'2'#U_ABEU"K$+&TX_L9BN#35^^/D^,EXC-Z9-SDAI#'P4$#T#CG
M=;:"?V";L4WJ#Z'45V>:=F F((,UHL(<SX<MONJ2(',VM&&"']:E6&>H>+:&
M0P*DA3J-8@J&<,K>)=6/KURQ)/R4A&40PYU39-'$:<:C)J+D5EWIE"U"'!EP
MT0TQ%\;W0+&EL/CRSQYAR;*CM $R>I3\;TO'17,M2S,>N%%2S2 ZW(5. @6>
M,'/O$<D)+6ZJN5MZ"[2SJ$)@A:S%\/\X!!]#8/9:?MN(2;;_"^O2U0P/ZDF2
M=VSU!63&_(M=WSI ;NZ5&BFS*,O1,QU;>*.%XQ,*YXHAF;X0&2,;&H.C<92@
M84:?0D<@^;X;@?.-_,@'#>6XI')KCY=BOEU!SG,]"I43^:SV^#WE7G(3GX0B
MY1)2\Y37CV(!6>-I>(I-X+6EI@Z^WDUBSVP_Q!&S7I0SE5$;_K*M\W!P@UI-
M""XIU&59PAZMQHO926B)56G%NK8!$YN!;?1Z7EAL8= 8G=E!<G:=E56&N!8Z
M!YX&\?JQ8W?,<L$-,$4AP?-D'WDU0>*EF 4,I%8WSXJ>-=3D=?MAHQV+^$B1
M'+ND@ZG&J5!2)"H?PBP#&U+P'3('V>-FETY[!C68IIT&UC"=7-!^$:=/2T*_
M$T"[4.;9E9A7ZYQ39K@6@6P;7#DPH+WB'M_3AFR1FJ]H=H[2Q+[Q)S<CD"(Q
M[ =L.VQ2;H\\N@M$Z:PJ8@&A*M2L+#O*93%UV]Y/J&5P[F"\3YX\?.AO;OJ.
MEN,Y:1!%[4@J(T.J2-(^IJ,TVQ.LZJO:&R)C/NCV24DEKY@OQ[\'Q[E)]'@D
M\VCXRMRP%E/Q^=QF JLM]_29/$HP]F]*U8*U'!SL\JWYG&^K<SG;U:^6W^[!
M'-,A.QHO;702;YC#OC%YS:1-)Y3#1%I2?:(:&3T^>,^5$5>#7;,>1DH7H.<P
M1\>%NHVK+S',T._R>EY7W3IDKBP]!^4BF<(*;(%ZQ3>20D:V)'%*_(&6:EJQ
M*.C [DH_A_Y%-='DCX-Z.@F)"ON6VT]LM<_1<:;C<>M<A*,U'=P[[.#(2B7:
M+IOCXYQQS4UT%6*7268DF*"V[(%2M*:.0;E:PMX-!BJ!&L2P8S"1*8N@?)'/
M3 07)97TI4QUS5U&%A0)8;^;\%W;7/A/FN:4TVVP%QR"^]Z^.#W&PU$Z_JF.
MX_H7%)://!IR*5!KK1G"(8]9YHL.]%1MW\<*'0Q2:RCUI\IC:\5=?> PQH\R
M"V@LU;GW-5J8\N'E/4%2PW:HCDE](&2'WDQG&GPSV5"H4(+&3<?5]^'A@__P
M>IMULO(;L5IFW5=7I#0Z%*DUULMLZ;(\^B+3B9\''>7/K]X='R-^XC*;;W2!
M_#AF ;+'#>]=Q+PT:@2+HN,;4U#TXXCNG4Y>G;Z'[1%ED9!]$X0 _LG][M2G
M_71U>>OFSO49I&?W&:0OF4%Z=I]!NA,9I*C8:5R;]D#S@=> S'0.[SA60I:)
MHQ>?"#]DMEXI^PL0^BUH^2$%,[B*WH?T89[1JR7:S2<R5_6%$L#1HY$X.+<?
M+#XVXRT)YFN83D*P9HP' 0-4H:ON$+#<Y_\BFE%E#6RD?K;A8@'AL3#Q1&,=
M:I#'6/X'R<EUSD_K&4QAD0+I<]Q>Y_%#=(YM8#/,%'M#]D:>V#>^R9/A37 ^
MI1,; 2AQ!CC/E\8-3-S'=1Y#U ,)-P9B%HRC$\M/(<#T?+"VPL2>H8G7U4AT
M$\*Q\!@\X># +L%)F>O9/^M:'[G:N%;0?[C@VOW-":RSFLG29\DRNZQJ>E1T
M8*91/1VF:30< //XE\%IFB9,:>(-<"+)1E.2)H.7$,]<9D8N>-YK"M-E=-JC
MQ(75)$F2X@"\ [XN93RGDW_/P,*!<1QBOO/AP^>A'!7T!4@ED:O@'(O-)U.K
M]=!H::[74K=*D;.L9RJ(?1 ]6ZAYD)"[9[-/)S$Y.LWL]GD5^AIN*XA#]3!=
M3NCZ()1(C;4%XQM1Y&8NACJ&B.!A2)M"LL?E,<2LWC7NIB@A<8S@ID#[.,L+
MLR>V[*MZ9',<)'!22KP51/,BGV&*&_S=D#4>B38G(\'FQ]]^\R3:=I4?00-#
M>$J3^/CA-R8@+=-JF":YD#0>_W3R^.$S<U6T 'U+\)H(Y9E-L<9-^BA(3#W]
M3()RF .E<\"D;'W^D@+ENIP)-FN8YVOR</8,0 M\9?";G#YI:;"A^YZ=9KOC
MBN$]_A'7%H0:]&M>^AJM/,_0 U5VZ>#&XK]MNH*<(T):$!EEO]W?=(+]GJX]
MCRQ8VKBCPA04)Q"2?O[ SJ#'1]CP!,B>P@WW#ZA.VBPS0C;HZ-*&B00'#ZQ3
M-A^]/7*\96Q-) 32N@\T3YK\B(Y8*V#"9?(ZFU5U#VX;M7=T[%I_AC2_D1--
MORZW3%_>:(:<R;-*RL%G!:?^S[#+RZ<_-NF?M4=XH.K6C'<\J@.8'6P:"7\\
M>QAIG=B\0QU?;"AQ(S&)@&5M#-[41T4BG"]6PG?.=*CV)5EWV"W\BE;W0MEF
MWC%FG": 8^$B1&$UMDD1F5"7U*HFI N->0IZ%$V5BAB-4?2] LP99MY/'(Z)
M&$<C^(S,&Y.?]O$^0;W?E P=.YX>[1T92=W+3)(QGA>;^#;8$NQEG3RB.W8S
MLH:2%_C7&?WSE3F?Y)._F8\J<Q@?'D4[X;8%\?KXQ+?W\8DO&9_X]CX^<9?B
M$TXUY7M7+!^\P@!SR _T@L>1 KWQ%/Y7ZD]_CC<XREQ&N?:J4W*:34"M1.4<
M>W'?-_(PZ&++SB]MQ+#^:OV *OL8[..'DJ$]P9YT\W4K36_Y-%U*#,L J5[
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M3V+"XL9H)?@6;:[TS9X5][<P0V08(_M,.IAN3T0=QTTB*UXLPM^.3]]X\)>
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M*C0/>7R(H=\=E?]JGZ3,^L-++[B!\)\,%&T4R*Q"!5@3#")YSZ7Y*M[F7OD
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MNGD:6]T Z*'>L&,@O\]<LUU1BT=Q"$C0JY?B9T65'E8=$JH P71>;5ROA/!
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M%@^F2-$LW?O!%QPXXX<96A-/D]&P]1-02P,$%     @ IH"+6B6U"'YB#
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M>.ONA[<>_/&JS6G)/C"G3Y//O^V]K]W:T5WZQ\K<OUY&_\C9?P%02P,$%
M  @ IH"+6DHARW2$#P  D4T   H   !E>#DY+3$N:'1M[5SK<Q,Y$O^>JOP/
M6NZ.@BK;!%BRD&2I"]FPI(X-',X5]U6>D6T1C30KS<1X__K[=4LS'C\2V%LV
MRR-\P+9&C^Y6O[LG!]_E+JOFI1+3JC!/M[<.VD\E<WP*^G=0Z<JHIP?WXB>>
MWDN/#T8NGXM0S8WZ\=;8V6I/W-\I*W&F"Q7$J9J)-ZZ0MA<'>F*HO![?PD(L
M+7_ONGU12#_1ME^Y<D]@>CLP<E7EBN4QH\;8=6=?5.I]U9=&3^R>\'HRQ921
MS,XGWM4V[V?..+\G9E-=J5M/;]M1*/</[I6?+X@'!$L7KOY8%MK,]SX$&<\-
M^C<5$<%.HZ?'[Z=ZI*OMK2=/!O</[HUPQS3MZ;53X!K0;>[V#R/8O:U,V4KY
MCT3Z>NYT>'1R?'KVGS?'VUO26IR688=JJD2N+U2 "-=>"3<6N@K"J(G,(,#U
M*.A<2Z\Q=>R\D*)RE30B<Q8/E)>5=I86_?V1 &"&?DF;BUSE.I,55M%NX]H8
M+,]JG.?XR&<>LU1.D.1B6*I,2U/-Q>NI](4404T*T \S093)5 PSC9\ KR=>
MOCP:W/#C-:F<=S788CR_+@8]._SE]6%O>^OYRYXX++TV8N=Q3SS8>?!(W/GY
MY:MGQ^+T^.WP[<F;X[OB=I'+,-T7+5.+%Z]>_G1R^O.P)TY.CP;BSNGA\*?#
M?^]AQNE_[XH[Q'6W3?YK[?:/7%%*.[_M^===8J<>.'OJ3*[M!+S-C[>WB.'5
M>PT:8)08M300'(5/9M-,U168W A7LB"T2Z.P@-LQ%?)0>G>A>6=EIQ)2EXL+
M:6I%LE!B'5@;="FG\Z A!C;P49GT:@*Y]&%[JQ&#7%THXTKLU!,CCP_:$YO@
M"L]5U8N"!W"]'M4,CG58($(K7H DK[.*I3#@Y#">B]H6JDI;"*M4'FBCJ![R
M5?6PO;6L'UXH[#LE6,7)&9__%E1401HE7I5)/81E-7("Q3CQLI'UH3-UG'7G
MY/7P;D\\<[8NTLZX2YL-(F9#-ZZ4,7$(1''BS!GCEF9^K(X:?&O2]6WJE+,I
M.+;#OA M<&HI?47L("%$3H)!<!:8!.*6":\83+8^LF+V3]H"TA?PA&0"P@/>
M+95M)-]9V=@WXM3:&I>="^/LI \GH(CB#IX]J83&%!/WF>EJVCWAM@^DCP)I
MD4)7T0(Z D[)PFBK6/(R1U:ZE:T>OE>Z -+\M'2^&CNP>)09F67*T%0E0.H9
MSM.6]$EK@,5&^QNU01B(LP[^&G)K<]8=T&P,./1)1AI#N%$E->$T]J[H*(T&
MA[',M-$5P4$/IW!E^Q&@[2W"5GD"@(%9W$725HW:BW>25?I"5Z1'<#V$\;)O
ML% U\\%&GK]Q%KXP!+]BU%@]->(U4D:#T<DC3XKG7-&H56-B<^BK%5L,U]IF
MIL[5WE=,HLWL7<D1' RH-A-*:!8[^?'6SBW^7<H\;W[_;B+,=%Y-:>K./X"<
M\S -A)B190! S;=;G/TXJ/SO/P#N''N,C2T$N6^E7,I!E?_? .\,'CS2]D\D
M>Y5_GE#^[<GN#T\^%9@;G)1/JL?JI_!08<H#A;T$Y:N.\W \'FLR9-G\X%Y-
ML= >125BV-A^]O0WN JPEC"1%+A+')^3421_P4XPF1>1[AA)0V$'O!9%84(;
MCT0PR&4V2EKX00NW(GH/HB!G0TXTI"V'CQ#PJ%_(<]IX[&6A9LZ?#[KTQW_^
M<Y&/SU0@/E.P_G0!6(?UAEFN%ZPO3%V^H5CL-Q5A',ZAH";P^Y?TXQ%4%:*=
M/&9?'%@")KID]53;;*')X%L5VL997N7P6* 0-;M0%-3$H"Z3%-=(:VL^-X?%
M#T!&7F!5N-%R7P58-UKN<[R5;UG+_90J)<DI?$Y9I"4==SB&AY8W#F"GE!+K
M+*5Q<TZ-($)$4.AJSV6=6&;IY%;:W"\M:Y(P*1'=9%I*72I*-$50M%U.O7PH
MW[*!Z?%!H=I*6!KC2$0$E]=5-V8,/VDX^TEY+M85SJ8Z=/)7!>R1D,:X61"Q
M\C52504WF_$2N*G.A7$RD(8Z64/VMWOQMMF^Q44%F:7.[8WHJ0KADG)9+]4Y
M8,ET+H88MN+PG?0PE'5/'$VE]L"Q23 \<]+'K.#1\2L:;#<3+V)])*14>T+Z
MV5P$790&-\0PUKY3#RE<KDQ/S!0G7@$_9PTEY3U=S+7^1M,HL:H1 $FZC\;0
M1\/=Q$6:Z!_K)UR-F5 ^<=YC:YXUQI^:#V+B$Q!1E-, A&>X" &X($L%!4.#
M1)5+<R=?& =>G0;\PI#IB%,GCZPLZ9(568JJ,$E&1RC6<MJME$"/K0B(F$T5
MV!-<"@X4%*.G/#5+6MR/HN1%L6Y1G>OQP8 !A,#/F,+&B8JJB1@8B).JC=9E
MBJ*A%T*E2M*PHUK'JF,*MJ$1P-DX!7)?$XC]MI+H)]+JWS@^;[A7R)R<UR'$
MXEQZ\4)ZC;.)Q*^G@Y\&O34AC@7T1G;?J@2:)U-AQSJ/57>B>PKWFYIE8#SE
MB,6.Z _!)@((]9[R;K2N(UU,!D8->$$C0J<IWXL8-OBD,NN-('[&R$0V>>D<
MIWQDU*^S#M?@]G75K66YDDI0M8TUFBI9Q%3 RCOY*BY@0R0R[T+HF@W$;$L6
MZQ0,#0L#+A2_0 !:UO[EV2&^D[SDR?VYA,L/ XLVD-,V5MV]+$H^,K*F&$K2
M*[<QNH\SJ/;55/R'=5F:.5M)VRT^D3J@#>H2;)PJ_RN>EC 2,>@T&3*932F]
MSTE]7 9TFK-J"?U5)ZP7J3>5091U):*6DZWX-%9TK<37$[DG#:.M=1>Q]AT]
MQ2BO 5P'9#B#'E4;*[R.4KFR8G:Y[_9=OR^>:V7R/?%:3M0^N.K7&I8;W/1
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MV&,+#ZE-,RZC.'4EB6$"M1=+WA%'MVA]5MTS8J$I>B<+B:"<1^KZC1[23+%
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MG#E$ ,X2O4F]=1RGS7SG<+)<TFQJKA$0TC860 !_[G@-ZK']&?3!.+-W\[U
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M%V;O%=D>]D<! 9#PZL\(&7(Q.CPC7Q1'7D0,GF?278*&,4--WK=VB [VG#F
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M0H:U&K5()+@1+"Z%54FTCRZ+EI%Z*EM6KX1%"_?5;2=L&$[:Y)O6,#\8RAV
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M@-#I=@@0)(-0,\HG2',6<?',:X\[S/A6#H#[&8_A%4I/E%NH!C6AB59G2$"
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M0I0KO?3_9\R>Q/8YB_9W@D>$J*>LTFJTZKO^-C#:+3-O:E*3ID&A 7'V%K\
M@8<J4*V.#[49R^?%//70N,KFQJ.GQ2.6!_!VFZ5J!I7&X*O@G4&.;R\,:(!Q
MDZ$C(B#T!MB$;CCDD2@/_8"*8%2+]G1^EAZR )+X\_Z>/!"AWCM8DEWV6>[H
MJ>,,8T"LZ[.WP<TQ3^9Z X. \*UNH5.]%-4K0"OUC%A9!?I-58+R6FR_7U[?
M="T_R<UZD_QKA5,BM_P74$L#!!0    ( *: BUI'0 H*W@<  /)>   5
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MOG 9;C7/;2"4"D FHBPG8SX\DS'_?,L::@]UHDB8K&KB9$AY5O\W8[-CTJC
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M7J_VE]V@W!SY!U!+ 0(4 Q0    ( *: BUK^NKM^;7\  %GP @ *
M      "  0    !E>#$M,#$N:'1M4$L! A0#%     @ IH"+6FBWL=CS?
MG= "  H              ( !E7\  &5X,2TP,BYH=&U02P$"% ,4    " "F
M@(M:);4(?F(,  #\3   "@              @ &P_   97@Q+3 S+FAT;5!+
M 0(4 Q0    ( *: BUI*(<MTA \  )%-   *              "  3H) 0!E
M>#DY+3$N:'1M4$L! A0#%     @ IH"+6LDFAE%A&P   JL   L
M     ( !YA@! &9O<FTX+6LN:'1M4$L! A0#%     @ IH"+6C3FN%TH P
MY@L  !$              ( !<#0! '-C;G@M,C R-3 T,#@N>'-D4$L! A0#
M%     @ IH"+6B'+R6;^"@  @(8  !4              ( !QS<! '-C;G@M
M,C R-3 T,#A?;&%B+GAM;%!+ 0(4 Q0    ( *: BUI'0 H*W@<  /)>   5
M              "  ?A" 0!S8VYX+3(P,C4P-# X7W!R92YX;6Q02P4&
/  @ " #> 0  "4L!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>form8-k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="scnx-20250408.xsd" xlink:type="simple"/>
    <context id="AsOf2025-04-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001382574</identifier>
        </entity>
        <period>
            <startDate>2025-04-08</startDate>
            <endDate>2025-04-08</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:AmendmentFlag contextRef="AsOf2025-04-08" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="AsOf2025-04-08" id="Fact000004">0001382574</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="AsOf2025-04-08" id="Fact000009">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="AsOf2025-04-08" id="Fact000010">2025-04-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="AsOf2025-04-08" id="Fact000011">SCIENTURE HOLDINGS, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="AsOf2025-04-08" id="Fact000012">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="AsOf2025-04-08" id="Fact000013">001-39199</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="AsOf2025-04-08" id="Fact000014">46-3673928</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="AsOf2025-04-08" id="Fact000015">6308 Benjamin Rd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="AsOf2025-04-08" id="Fact000016">Suite 708</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="AsOf2025-04-08" id="Fact000017">Tampa</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="AsOf2025-04-08" id="Fact000018">FL</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="AsOf2025-04-08" id="Fact000019">33634</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="AsOf2025-04-08" id="Fact000020">(866)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="AsOf2025-04-08" id="Fact000021">468-6535</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="AsOf2025-04-08" id="Fact000022">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="AsOf2025-04-08" id="Fact000023">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="AsOf2025-04-08" id="Fact000024">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="AsOf2025-04-08" id="Fact000025">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="AsOf2025-04-08" id="Fact000026">Common stock, par value $0.00001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="AsOf2025-04-08" id="Fact000027">SCNX</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="AsOf2025-04-08" id="Fact000028">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="AsOf2025-04-08" id="Fact000029">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
